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Immunity to an asexual erythrocytic Plasmodium chabaudi chabaudi AS infection in 
NIH mice is mediated sequentially by Thl and Th2 cells. The predominantly Thl 
mediated response is responsible for the control of the acute phase of infection and there 
is then a switch to predominantly Th2 mediated response(s). Cytokines and 
inflammatory mediators are important molecules involved in the parasiticidal 
mechanisms induced by Th 1 and Th2 cells during the course of a P. chabaudi infection. 
IFNy (Thl associated cytokine) and EL-4 (Th2 associated cytokine) production during a 
P. chabaudi infection reflects the sequential involvement of Thl and Th2 cells. EL-6 is a 
cytokine which is involved in Th2 mediated responses but can also stimulate the 
production of inflammatory mediators such as acute phase proteins. The actual role of 
individual cytokines during the course of experimental malaria infection can be 
investigated by depletion of the cytokine by antibody treatment or addition of exogenous 
cytokine and observing the outcome of the infection. Studies were performed, utilising 
cytokine or cytokine receptor gene deficient mice to investigate the role of individual 
cytokines during the course of P. chabaudi infection.
The induction of inflammatory mediators, such as nitric oxide (NO) and acute phase 
proteins, by cytokines is an important aspect of the protective immune response to P. 
chabaudi AS infection but it is unclear where and how these molecules can mediate a 
protective response. During P. chabaudi infection, mature asexual erythrocytic stage 
parasites sequester to the liver, making this non-lymphoid organ a potential site of a 
protective immune response. Serum amyloid P (SAP) and NO are two inflammatory 
mediators that are synthesised in the liver and may participate in parasiticidal 
mechanisms.
IFNy receptor (IFNyR) deficient mice are more susceptible to a P. chabaudi infection 
than intact mice. A high mortality rate was observed in the IFNyR deficient mice 
whereas none of the control mice died. The IFNyR deficient mice consistently had a
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higher peak primary parasitaemia compared to the control mice but this was never 
statistically significant. Total IgG2a and parasite-specific IgG responses in the serum of 
IFNyR deficient mice were reduced compared with control mice, whereas both groups 
had similar total IgGl levels in their serum. Interestingly, a large total IgE response was 
observed in the serum of the IFNyR deficient mice. Control mice had negligible levels of 
total IgE in their serum, which is the normal IgE response during a primary P. chabaudi 
infection. Analysis of leukocytes present in the spleen and liver during the course of 
infection revealed that there was a reduction in the numbers of lymphoid cells in the 
spleen at peak parasitaemia and a reduction of lymphoid cell, monocyte and 
polymorphonuclear (PMN) cell numbers present in the liver of P. chabaudi infected 
mice during the acute phase of the infection. This study demonstrated the importance of 
IFNy mediated responses during a primary erythrocytic P. chabaudi infection.
The role of the Th2 associated cytokines during a P. chabaudi infection was investigated 
by infecting, in separate experiments, IL-4 and IL-6 deficient mice. P. chabaudi 
infection of IL-4 deficient mice consistently resulted in an exacerbation of the peak of the 
primary parasitaemia compared to that of intact control mice. This observation was 
repeated in P. chabaudi infection of IL-4 deficient mice on three different genetic 
backgrounds. There was a reduction in the total IgGl response in the serum of the IL-4 
deficient mice during the acute phase of P. chabaudi infection compared to that of 
control mice but both groups had similar total IgG2a and parasite-specific IgG 
responses. Analysis of leukocytes present in the spleen and liver during the course of a 
P. chabaudi infection revealed a reduction in the number of lymphoid cells in the spleen 
and a reduction in the number of lymphoid cells, monocytes and PMN cells in the liver 
of IL-4 deficient mice compared with intact controls. These studies confirmed previous 
reports that IL-4 is not essential for the control of a primary P. chabaudi infection.
Infection of IL-6 deficient mice with 1x10^ parasitised erythrocytes of P. chabaudi 
consistently resulted in an exacerbated peak of the primary parasitaemia (not statistically
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significant) and a significantly reduced rate of parasite clearance compared to intact 
control mice. There was no exacerbation of the peak of the primary parasitaemia in IL-6 
deficient mice compared to control mice following infection with 2x10^ parasitised 
erythrocytes of P. chabaudi. The reduced rate of parasite clearance was, however, still 
evident in the IL-6 deficient mice. Total IgGl and total IgG2a responses in the serum of 
the IL-6 deficient mice (for both challenge doses) were reduced compared to the intact 
control mice and there was no significant difference observed in the production of 
parasite specific IgG. Hence, IL-6 deficient mice have a slower rate of parasite clearance 
than control mice and also demonstrated dose-dependent immune responses illustrated 
by the loss of the exacerbation in the peak parasitaemia observed in IL-6 deficient mice 
infected with 1x10^ pRBCs upon infection with 2x10^ pRBCs.
To examine if the liver was involved in a protective immune response to the asexual 
erythrocytic stage of a P. chabaudi infection, lymphomyeloid (LM) cells were isolated 
from the livers of P. chabaudi infected mice. An increase in the numbers of LM cells 
was observed during the acute phase of a primary P. chabaudi infection with peak 
numbers of LM cells present in the liver one or two days after the peak of the primary 
parasitaemia. Adoptive transfer of LM cells isolated at this time of the infection, 
significantly protected irradiated recipient mice against a P. chabaudi challenge compared 
to leukocytes isolated from spleens and peripheral blood of P. chabaudi infected mice at 
the same time in the course of infection and leukocytes isolated from the spleens of naive 
mice. Preliminary data was also obtained on the role of the resident liver macrophages, 
Kupffer cells, during P. chabaudi infection. Depletion of Kupffer cells in mice resulted 
in an exacerbation of the peak of the primary parasitaemia of a P. chabaudi infection. 
These experiments suggest that the liver may be a site of a protective immune response 
involving the recruitment of effector cells, and Kupffer cells.
P. chabaudi infection of mice was shown to induce the production of SAP, the major 
acute phase protein in mice. SAP levels were elevated during the course of a P. chabaudi
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infection compared to non-infected mice. In vitro studies using SAP isolated from serum 
taken from P. chabaudi infected mice at day 11 post infection, demonstrated that SAP 
may have a direct effect on the growth of erythrocytic stage malaria parasites and is 
potentially an important immunomodulatory molecule. The liver is a site which has the 
potential to produce a high local concentration of NO, an inflammatory molecule which 
has been shown to have parasiticidal activity. In vitro studies were performed, using a 
NO donor, to investigate if NO had any effect on the development of asexual 
erythrocytic stage parasites. Late stage parasites were found to be more susceptible to 
NO and the effect of NO may be cytostatic rather than cytotoxic.
Chapter One 
General Introduction
Background
Malaria remains one of the most prevalent diseases in man today. Approximately 40% of 
the world's population are at risk of infection and 2-3 million people are killed by 
malaria each year, most of these being children in sub-Saharan Africa (WHO 1993) and 
there are between 200-300 million clinical cases of malaria each year. Eradication of 
malaria appears to be a more difficult objective to achieve now than at any other time. 
Several different problems are compounding the difficulties faced by clinicians and 
researchers. The increasing incidence of drug resistance in the parasite and insecticide 
resistance in the vector mosquitoes are allowing the disease to spread, which could result 
in malaria returning to regions where it has been eradicated for years. Reduced funding 
for control programmes, political unrest and the problem of refugees in the Third World 
are all adding to the biological problems already faced. The prospects for an effective 
malarial vaccine in the immediate future have diminished slightly. The much heralded 
SPf66, produced by Manuel Patarroyo and colleagues has disappointed in recent trials in 
Africa and Thailand (Nosten et a l, 1996, Alonso et a l, 1994) following promising 
results initially (Valero et a l, 1993). SPf66 has shown that partial immunity to malaria 
can be generated by a peptide polymer and the controversy surrounding the SPf66 
vaccine trials has led to better definition of the conduct for future trials of a malaria 
vaccine.
The Parasite
There are four species of malaria parasite which infect humans, Plasmodium falciparum, 
P. vivax, P. malariae and P. ovale. P. falciparum  is responsible for the majority of 
deaths attributed to malaria infection and hence is regarded clinically as the most 
important species. A diagrammatic summary of the malaria life cycle is illustrated in 
figure 1.
Infection is initiated in humans when a female Anopheles mosquito takes a blood meal. 
During this process, anticoagulant from the salivary glands is released and introduces the 
infective sporozoites (of malaria) into the bloodstream. These pass rapidly to the liver 
and penetrate hepatocytes, initiating the pre- or exo-erythrocytic stage (Fairley, 1947, 
Sinden and Smith, 1982). Following growth and replication within the hepatocyte, the 
liver schizont ruptures releasing thousands of merozoites into the circulation (Garnham, 
1966). The duration of this stage of the life cycle depends upon the species of the 
parasite. The exo-erythrocytic stage of P. falciparum  infection lasts approximately 5-6 
days. In P. vivax and P. ovale dormant exo-erythrocytic forms, known as hypnozoites, 
can remain in the liver for several months (Krotoski et al., 1982). The merozoites, 
released from the ruptured liver schizont, quickly attach to and invade circulating 
erythrocytes where they undergo asexual replication repeatedly. It is this phase of 
infection, the asexual erythrocytic stage that causes the morbidity and mortality 
associated with disease. The parasite develops through ring stages to trophozoite and 
then schizonts which rupture releasing merozoites into the bloodstream which repeat the 
cycle by invading new erythrocytes (Dvorak et al., 1975). Each asexual erythrocytic 
cycle can be 24,48 or 72 hours depending upon the species of malaria.
In the final third of the asexual cycle of P. falciparum  and a few other species, the 
infected erythrocytes classified as late trophozoite/schizont stages, stop circulating and 
adhere to the endothelial cells of post capillary venules. This process is known as 
sequestration and the infected erythrocytes can cytoadhere to endothelial cells in post 
capillary venules of several organs including the brain, heart, kidneys, gut and liver.
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Merozoites, following invasion of an erythrocyte, can differentiate into gametocytes 
which are the sexual forms and infective to the mosquito during a blood meal. These can 
then mature in the mid-gut of the mosquito to the extracellular gametes. Fertilisation 
produces a zygote, the only stage of the life cycle where the parasite is in a diploid form, 
which develops into a motile ookinete. This burrows into the mid-gut wall where it 
encysts on the outer surface. The oocyst, develops and grows to release sporozoites 
which migrate to the salivary glands of the mosquito ready to infect at the next blood 
meal (Vanderberg, 1975).
The P, chabaudi Laboratory Model
In order to produce a successful malaria vaccine, it is logical that a comprehensive 
understanding of immunity to malarial infection will facilitate the achievement of such a 
project. The definition of immune responses induced by malarial antigens will aid the 
decision of what type of antigens are to be included in a vaccine and the identification of 
the type of immune response which will be required to be induced by the prospective 
vaccine. To achieve this aim, studies are required to elucidate the mechanisms of 
protective immune responses induced by either specific malarial antigens or malaria 
infection. It is possible to culture human malaria parasites in vitro but there are 
limitations to any in vitro system making it difficult to extrapolate any observations made 
to an in vivo situation. Human Plasmodium species are host specific restricting infection 
studies of animal models with human malaria parasites. Furthermore, experimental 
infections of volunteers with human Plasmodium species, are strictly controlled with the 
welfare of the volunteer of the utmost importance. For these reasons, researchers have 
turned to animal models which allow examination of malaria infections in vivo. Rodent 
models are mainly used because of the availability of the mammalian hosts, rats or mice, 
and due to the fact that it is relatively easy to maintain a supply of the respective rodent
parasite species. Animal models have supplied researchers with a convenient method of 
studying immunity to malaria infections.
During the studies undertaken in this thesis, the parasite species used was P. chabaudi 
chabaudi AS. This species represents a reasonable model of P. falciparum  infection 
because it shares several important features with P. falciparum. Both species invade 
normocytes, sequester from circulation during the latter stages of their asexual cycle 
(although P. chabaudi has a 24 hour asexual cycle compared with P. falciparum's 48 
hours) and undergo antigenic variation. Hence P. chabaudi infection in mice provides a 
relevant model which can be utilised to analyse immunity to malaria infection.
Clinical manifestations of malaria
Malaria infection can result in a spectrum of disease manifestations, from asymptomatic 
to fatal infections. The parasite species can determine the outcome of infection. P. 
falciparum  is responsible for the majority of deaths associated with human malaria 
infections. Transmission intensity, anti-malarial drug use, the drug resistance of 
parasites and host resistance are all known to contribute to the severity of malaria 
infection. The ability of different parasite strains to induce cytokine production and their 
rosetting or cytoadherent properties may also influence the nature of malaria infection 
(Molyneux, 1995).
Fever, headaches, chills, rigors and sweating are common symptoms of all human 
malarias (Warrell, 1993) although the intensity of individual symptoms varies depending 
upon the infecting Plasmodium species (Shute, 1952, Covell and Nicol, 1951). These 
symptoms are associated with uncomplicated malaria infection and anaemia may develop 
if infections are prolonged (Molyneux, 1995). Malaria infection is considered severe 
when it is life threatening. For research purposes severe malaria is defined by the 
presence of any of the following complications: coma, renal failure, severe anaemia.
acidosis, respiratory distress syndrome, hypoglycaemia, bleeding, shock or 
intravascular haemolysis. Other characteristic symptoms include altered consciousness, 
weakness, convulsions, jaundice and hyperparasitaemia. It is thought that approximately 
one infection in a hundred of children with severe malaria may be fatal in the absence of 
drug treatment (Greenwood et a l ,  1987). Children in intense transmission areas 
(subSaharan Africa) are at greatest risk of developing severe malaria. Severe anaemia, 
cerebral malaria, acidosis, hypoglycaemia and respiratory distress are the five main 
symptoms in African children with severe falciparum malaria (Molyneux, 1995). 
Cerebral malaria, characterised by altered consciousness and convulsions is the main 
cause of death due to malaria in children (Molyneux, 1995). In adults, severe malaria 
infection differs from that in children because complications such as acute renal failure 
and respiratory distress syndrome are more common.
Host resistance to malaria
Natural resistance
Susceptibility and resistance to malaria infection are influenced by several factors which 
are not immunologically mediated responses. Erythrocytic stage malaria parasites gain 
entry into the erythrocyte through a complex process following interaction between 
molecules on the parasite surface and receptors on the erythrocyte membrane (Butcher, 
Mitchell and Cohen, 1973, Miller et al., 1973). If the erythrocyte lacks this receptor then 
the merozoite is unable to penetrate the cell. P. knowlesi merozoites are unable to enter 
cells lacking the Duffy blood group antigens (Miller et al., 1975). This observation is 
extended to the human malaria P. vivax and it is possible that the absence of P. vivax in 
areas of West Africa can be explained by the incidence of Duffy negative individuals 
(Miller etal., 1976).
The intracellular environment of the erythrocyte can also influence the growth of malaria 
parasites. Alteration in the haemoglobin constitution due to the genetic disorder, sickle­
cell anaemia, may have an inhibitory effect on the development of malaria parasites. 
Sickle-cell haemoglobin has a single amino acid mutation in the p chain, which results in 
the erythrocyte adopting a sickle-like shape due to the precipitation of sickle-cell 
haemoglobin (HbS) when the oxygen concentration is reduced. An inhibitory effect of 
HbS on the growth of P. falciparum  blood-stage parasites was suggested by the high 
frequency of the sickle-cell gene in areas of hyperendemic malaria transmission (Allison, 
1954). Homozygotes for the sickle cell gene tend to die young often as a result of 
infection, renal failure, cardiac failure or thrombosis. Recently, a report has 
demonstrated a higher resistance to P. falciparum infection in patients homozygous for 
sickle-cell in Western Kenya (Aluoch, 1997). Furthermore, transgenic mice expressing 
high levels of HbS are protected against a lethal infection of P. yoelii (Hood et al., 
1996). The growth rate of P. falciparum in vitro in homozygous or heterozygous 
erythrocytes for the sickle-cell trait is normal but as the oxygen level is reduced, 
development of the parasite is inhibited (Friedman, 1978). It is thought that the 
mechanism of growth inhibition may be due to a loss of potassium under hypoxic 
conditions (Friedman et al., 1979).
A number of other haemoglobin mutations and erythrocyte abnormalities are thought to 
be positively selected for by malaria infection in populations within areas of high 
transmission. Thalassaemias, genetic disorders of haemoglobin synthesis are thought to 
confer protection against malaria infection (Williams et a i, 1996, Senok et al., 1997). 
Deficiencies in red cell enzymes, such as gIucose-6-phosphate dehydrogenase, are also 
thought to influence resistance to malaria infection. A double genetic defect of 
thalassaemia trait and severe glucose-6-phosphate dehydrogenase deficiency has been 
correlated with enhanced protection against malaria infection (Oo et a i ,  1995). 
Individuals carrying the sickle-cell trait have a significant retardation in the switch from 
foetal to adult haemoglobin during the first five years of life (Giardina et al., 1995).
Persistence of foetal haemoglobin may contribute to host resistance because P. 
falciparum  growth is retarded in cord blood cells containing approximately 85% foetal 
haemoglobin, in erythrocytes that contain 20% foetal haemoglobin from infants and in 
erythrocytes containing foetal haemoglobin from adult homozygotes for hereditary 
persistence of foetal haemoglobin (Giardina et a l, 1995). It is thought the retardation of 
P. falciparum  growth in all these cells illustrates a role for foetal haemoglobin in 
mediating an increase in oxidative stress which may lead to early elimination of 
parasitised erythrocytes (Nagel and Roth, 1989).
Dietary intake is another factor which may influence host resistance to malaria infection. 
Variation in diet has been shown to alter the outcome of experimental malaria infection 
and has been proposed to have a role in host resistance to human malaria infection. P. 
berghei infection in rats can be suppressed by a milk diet (Maegraith, Deegan and 
Sherwood Jones, 1952). It was shown that milk is deficient in p-aminobenzoic acid 
(PABA) and that PABA supplementation could reverse the suppression of P. berghei 
infection in rats and P. knowlesi in rhesus monkeys (Hawking, 1954). Mice fed a diet 
containing cod liver oil survive for a significantly longer period following infection with 
lethal P. berghei infection (Godfrey, 1957). The protective effect was reversed by the 
addition of vitamin E and subsequently a vitamin E-deficient diet has been shown to 
suppress lethal P. yoelii infection in mice (Taylor et a l, 1997). Restriction of the dietary 
intake of mice (food was restricted to produce a body weight loss of 1-2%) during a P. 
berghei ANKA infection reduced mortality compared to mice fed ad libitum (Hunt, 
Manduci and Thumwood, 1993). The reduction in the level of protein intake in mice and 
rats (fed on a cassava meal which has a low protein content compared to controls which 
were given a protein-rich diet) has been shown to reduce the severity of P. yoelii, P. 
berghei and P. vinckei infections (Ibekwe and Ugwunna, 1990, Edirisinghe, Fern and 
Targett, 1981). The addition of vitamin E free fish oil to antimalarial chemotherapy 
treatment of Chinese patients with P. falciparum, enhanced the rate of clinical cure 
(Levander et a l, 1994). The development of P. falciparum in vitro can be inhibited by
the addition of omega-3-fatty acids derived from fish oil to culture medium (Fevang, 
Bjorkman and Hostmerk, 1992, Kumaratilake etal., 1992).
Acquired immunity to malaria
The complexity of the life cycle of the Plasmodium species in the mammalian host, the 
large number of different parasite antigens presented to the host and the ability to evade 
the immune response through mechanisms such as antigen diversity results in the slow 
development of immunological memory in humans to malaria infection. Effective levels 
of natural immunity to infection develop slowly and only upon repeated exposure. 
Infants up to the age of 6 months are protected from infection possibly because of the 
presence of maternal antibodies (Bruce-Chwatt, 1952), or the lack of PABA in the milk 
diet of the infants. The persistence of foetal haemoglobin may also contribute to the low 
frequency of malaria during the first 6 months of life. Children from 6 months to 5 years 
are most at risk from P. falciparum infection (McGregor, 1964) but the development of 
immunity is largely determined by the level of malarial transmission. Clinical malaria in 
children less than 1 year of age occurs in hyperendemic areas with the major 
manifestation being anaemia (Brewster, Kwiatkowski and White, 1990, Snow et a l, 
1994). Seasonal or less intense transmission of malaria results in levels of exposure 
which are insufficient to induce significant protecive immunity. Hence individuals of all 
ages are susceptible to severe infection. Anaemia is the main clinical symptom in 
children of under 1 year, while cerebral complications manifest in the older groups. 
Recently, it has been suggested that naturally acquired immunity in adults develops after 
only 1-2 years of exposure to hyperendemic malaria and that this is an age-dependent 
phenomenon (Baird et a l,  1991, Baird et a l ,  1993). An age-dependent decrease in 
susceptibility to high-grade and frequent parasitaemia was observed in transmigrants 
with limited history of exposure to endemic malaria (Baird et a l,  1993). The authors 
suggest that a protective immune response to an endemic falciparum malaria is governed 
by a relatively brief heavy exposure and an unknown intrinsic immune factor(s) which
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are associated with the host. The brief period of heavy exposure to malaria infection 
conferred greater protective advantage to adults than children. However, one parameter 
that is ignored is the greater antigen load that adults will have compared to children and 
this may be a factor in the development of the age-dependent, naturally acquired 
immunity.
Immunity to malaria is traditionally regarded as stage-specific but the potential exists for 
effector mechanisms generated in response to one stage of the life cycle to act against 
another stage which is present in the host at that time.
Immunity to Pre-erythrocytic Stage
Information on immunity to sporozoites and intra-hepatic stages comes mainly from 
experimental immunisation of volunteers or animals with attenuated (u.v., x-ray or y-ray 
irradiated) sporozoites which are able to invade and partially develop in hepatocytes 
(Ramsey, Beaudoin and Hollingdale, 1982). Irradiated sporozoites of P. falciparum and 
P. vivax induced protective immunity in a high proportion of immunised volunteers 
(Clyde et a l, 1973, Clyde e ta l,  1975).
The major immunodominant protein found during the sporozoite stage of the parasite's 
life cycle is the circumsporozoite protein (CSP). The CSP consists of a central region 
which has immunodominant, multiple repeat sequences and two flanking regions. 
Region I and Region II. The repeat region is unique for each species of parasite but 
Region I and II are highly conserved and found in the CSP of all species (Phillips 
1994a). The motility of the sporozoites is linked with the secretion of the CSP from the 
apical end of the parasite and its translocation posteriorly (Stewart and Vanderberg, 1988 
and 1991). Region II of the CSP has a relatively high degree of homology to 
thrombospondin, (Cerami et a l, 1992) an adhesion molecule and hence it has been 
suggested that the CSP is involved, via Region II, in the binding of the sporozoite to the
11
hepatocyte prior to invasion. When the sporozoite enters the hepatocyte, substantial 
quantities of the CSP are shed into the hepatocyte cytoplasm (Khan, Ng and 
Vanderberg, 1992). As the intrahepatic parasite developed, the CSP was localised 
around the periphery of the parasite but the function of this distribution of the CSP 
remains unclear. The demonstration that sporozoites release quantities of CSP suggests a 
possible mechanism for the presentation of fragments of the CSP to the immune system 
which may induce a CSP specific response to the intrahepatic parasite. This protein has 
been demonstrated to induce immune responses mediated by both antibody dependent 
and independent mechanisms (Mazier et al, 1988).
Antibody-dependent protective mechanisms against the pre-erythrocytic 
stage
Evidence that protective immunity to pre-erythrocytic stages of malaria, is mediated by 
antibody-dependent mechanisms is mainly provided by immunisation experiments. 
Serum from mice immunised with irradiated P. bergehi sporozoites inhibited sporozoite 
invasion and development of exo-erythrocytic forms in vitro (Chatterjee et a l, 1996). 
The antibody recognised both Region II sequences of P. falciparum  CSP and Liver 
Stage Antigen-1 (LSA-1) based repeat sequences. Antibodies from mice immunised with 
irradiated P. bergehi or P. yoelii sporozoites, protected recipient mice against a viable 
homologous sporozoite challenge (Potocnjak e ta l, 1980, Charoenvit et a l, 1991). The 
repeat region of the CS protein was the epitope recognised by these protective 
antibodies.
A monoclonal antibody which recognises a 17kDa protein found on the parasitophorous 
vacuole membrane of hepatocytes or erythrocytes infected with P. yoelii, can inhibit the 
development of intrahepatic forms of P. yoelii in vitro (Charoenvit et a l, 1995). Cross­
species protection to the pre-erythrocytic stage has been reported (Sina et a l, 1995). 
Following immunisation with P. falciparum sporozoites, mice were protected against a
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p. berghei sporozoite challenge (Sina et a l, 1995). Serum and monoclonal antibodies 
derived from these mice recognise a novel 42/54 kDa antigen designated 
circumsporozoite protein 2 (CSP 2), in both P. falciparum  and P. berghei and can 
inhibit P. falciparum and P. berghei sporozoite invasion of hepatoma cells in vitro (Sina 
et a l, 1995). Anti-CSP 2 monoclonal antibody was also shown to protect mice from a 
P. berghei sporozoite challenge (Sina et al, 1995).
The mechanism by which an antibody protects or prevents the development of the 
parasite at the pre-erythrocytic stage of the parasite's life cycle remains unclear. Anti- 
CSP antibodies have been shown to inhibit sporozoite penetration into hepatocytes 
(Mazier et a l, 1987, Mazier et a l, 1986, Nudelmann et a l, 1988) but there have also 
been reports of 'protective' antibodies failing to block the penetration of sporozoites 
(Mellouk ef 1986a, Mellouk gf a/., 1986b).
Involvement of anti-CSP antibodies in post-penetration inhibitory events was observed 
with P. falciparum  (Mazier et a l, 1988) where it was noted that attachment of the 
sporozoite to the hepatocyte membrane and subsequent intrahepatocytic development of 
the parasite were interfered with by the anti-CSP antibodies. It has been suggested that 
the antibodies may destroy the intracellular parasite (through their presence) in the 
parasitophorous vacuole. Antibodies have been observed in the parasitophorous vacuole 
following staining with fluorescent labelled anti-IgG (Nudelmann et a l, 1988). Anti- 
CSP antibodies have also been reported to enhance the penetration of the sporozoite. 
Low titres of antibodies against the CS protein of P. falciparum  (Hollingdale et a l, 
1988) and P. yoelii (Nudelmann et a l, 1988) show an increase in the number of liver 
parasites when compared with controls. Enhancement was observed with both 
polyclonal and monoclonal antibodies.
Most of the reports regarding the activity of protective antibodies against the exo- 
erythrocytic stage, the majority of these being anti-CSP antibodies, are experiments
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performed in vitro. Hence the results should be interpreted with caution because the 
results obtained in an in vitro system may not define the role of these protective 
antibodies in vivo. Indeed, although repeated exposure of humans to sporozoites may 
result in detectable antibody levels in serum (Nardin et a l, 1979) there is still a lack of 
strong evidence that this antibody is actually protective (Hoffman et al, 1987).
The assumption that the protection observed in immunised volunteers (Clyde et a l, 
1973, Clyde et al, 1975) was mediated by a protective antibody, led to the design of the 
first P. falciparum  vaccines based on the immunodominant B cell epitope, (NANP)n 
from the conserved central region of the CS protein. These vaccines had very little 
success (Ballou et a l, 1987, Herrington et a l, 1987, Fries et a l ,  1992) and indicated 
that there were antibody independent mechanisms which were important in the protective 
response against the exo-erythrocytic stages. However, recently an immunogenic 
recombinant CSP vaccine has been developed which protects adults, with no previous 
exposure to malaria, against experimental challenge with P. falciparum  sporozoites 
(Stoute et a l ,  1997). The vaccine contains CSP central tandem-repeat epitopes and 
carboxy-terminal epitopes which are fused to hepatits B surface antigen (HBsAg) and is 
expressed together with unfused HBsAg. The vaccine is given in conjunction with a 
potent adjuvant and can induce large titres of antibodies against the CSP repeat epitopes 
(Stoute a/., 1997).
Protective immunity to pre-erythrocytic stages mediated by antibody- 
independent mechanisms
The demonstration that it was possible to induce protection in B cell deficient mice 
following immunisation with irradiated sporozoites (Chen, Tigelaar and Weinbaum, 
1977) gave an early indication that protective responses induced may involve antibody- 
independent mechanisms. Similar to the experiments demonstrating antibody-dependent
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protective immunity, the understanding of the nature of antibody-independent mediated 
responses in immunisation experiments comes from in vitro observations.
C ytotoxic CD8+ T cells
CD8+ cytotoxic T lymphocytes (CTL) recognise antigens which have been processed by 
antigen presenting cells and are presented in association with MHC Class I (Townsend 
and Bodmer 1989). A series of in vivo depletion experiments (Schofield et a l, 1987b, 
Weiss et a l, 1988) and adoptive transfer of T cell clones (Egan et a l, 1987) has 
demonstrated that CTL are protective in some rodent models following immunisation 
with irradiated sporozoites. Since CTL function is MHC restricted, the target of their 
cytotoxic function would appear to be the intracellular form residing within the 
hepatocyte because this cell is capable of expressing functional MHC class 1 peptides. 
CTL taken from mice immunised with irradiated sporozoites have been shown to inhibit 
the development of exo-erythrocytic parasites cultured in mouse hepatocytes (Hoffman 
et a l, 1989). The need for parasite derived liver stage antigens presented in association 
with MHC class 1 to CD8+ CTL in order to induce effective protection has been 
illustrated by studies using beta2-microglobulin (beta2m) knockout mice. Beta2m 
knockout mice are resistant to T. gondii (Denkers et a l, 1993) and T. cruzi (Tarleton et 
a l,  1992) infections but failed to develop protective immunity against a P. berghei 
sporozoite challenge following immunisation with attenuated P. berghei sporozoites 
(White, Synder and Krzych, 1996).
Fragments or epitopes of the CSP have been shown to be one of the main targets for 
CTL (Kumar et a l, 1988, Weiss et a l, 1990). In vivo depletion of CD8+ CTL 
abrogated protection following vaccination with attenuated vaccinia virus (NYVAC) 
recombinants expressing the CSP (Lanar et a l, 1996). MHC class 1 restricted CD8+ 
CTL against the CSP protect mice from a P. yoelii challenge (Malik et a l, 1995). 
Immunisation with synthetic peptides, derived from the CSP of P. berghei, failed to
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protect mice against a subsequent challenge (Renggli et a l, 1995). CTL clones, 
harvested from mice immunised with synthetic peptides derived from the CSP of P. 
berghei, were expanded in vitro (long term culture, re-stimulated every 7-10 days with a 
specific synthetic peptide), and were able to protect naive, recipient mice upon adoptive 
transfer against a P. berghei sporozoite challenge (Renggli et a l, 1995). No protection 
against a P. berghei sporozoite challenge was observed in the mice immunised with the 
peptides. It is thought that CTL-dependent protection may require the migration of CTL 
to the liver and that this is achieved when the CTL are adoptively transferred but does 
not seem to occur efficiently in peptide immunised mice (Renggli et al., 1995). 
Immunisation with irradiated sporozoites produces a significant increase in CD8+ CTL 
in the livers of challenged mice (Faure et a l, 1995). In vivo, the effector function of 
CSP specific CD8+ CTL clones, appears to be related to the expression of CD44 and 
VLA-4 (Rodrigues et a l, 1992). These adhesion molecules have important roles in cell 
trafficking and their expression may be a critical step in the migration of CD8+ CTL to 
the liver. A CTL clone which recognises an epitope within the P. berghei CSP, in a 
MHC class 1 restricted manner, can protect mice against a homolougous sporozoite 
challenge if administered in conjunction with IL-2 (Romero et a l, 1989). Salmonella 
typhimurium  recombinants expressing the P. berghei CSP gene have been used as a 
delivery vehicle to induce protection mediated by specific CD8+ CTL (Aggarwal et al, 
1990).
The sporozoite surface protein 2 (SSP2) is another protein which has been shown to be 
a target of CDS'*" CTL (Khusmith et al, 1994, Wizel et al, 1995). Mice immunised with 
irradiated P. yoelii sporozoites produce CTL against CSP and P. yoelii SSP2 (PySSP2). 
In vivo depletion of these CD8+ CTL abrogated the protection (Khusmith et a l, 1994). 
CD8+ CTL clones specific for PySSP2 were able to protect naive recipient mice against 
P. yoelii following adoptive transfer (Khusmith et a l, 1994). This illustrates that CD8+ 
CTL against PySSP2 could protect mice against a P. yoelii sporozoite challenge in the 
absence of other parasite specific immune responses. The clones appear to recognise and
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eliminate infected hepatocytes because protection was still mediated even when the 
CDS'*" CTL clones were transferred to recipients three hours after sporozoite inoculation 
which is a time when the sporozoite will have entered the hepatocyte (Khusmith et a l,
1994).
As already stated the evidence demonstrating a protective role for CDS'*" CTL comes 
from either immunisation or in vitro experiments. The majority of experiments involve 
the rodent parasites P. berghei and P. yoelii. These parasites can infect mice but their 
natural hosts tend not to be used in laboratory models. Indeed, if correctly matched host- 
parasite combinations are used, they are often not as effective as using P. berghei 
sporozoite infection in mice. However, protective immunity induced by irradiated 
sporozoites is not observed in all mouse strain-P. berghei or P. yoelii combinations 
(Suhrbier 1991). In some examples of parasite-mouse strain experiments protection is 
CDS'*" CTL independent.
A second point to consider when analysing results from sporozoite infection of mice is 
the infectivity of the sporozoite itself. If non-irradiated sporozoites are highly infective to 
the mouse strain, often the protection induced by immunisation with irradiated 
sporozoites from the same parasite species is weak and correlates with a poor CDS'*" 
CTL response (Suhrbier, 1991). Poor infectivity of sporozoites in some models, such as 
P. berghei sporozoite infections of mice, induce a strong CDS"*" CTL response. Large 
numbers of P. berghei sporozoites are thought to perish shortly after invasion of the 
hepatocyte in vitro (Suhrbier, 1991), releasing sporozoite antigens into the cytoplasm of 
the hepatocyte. The sporozoite antigens are then processed and associate with MHC 
Class I molecules, resulting in the induction of a strong CDB'^ CTL response (Suhrbier 
et al., 1990). Hence, the infectivity of the sporozoite, which is dependent upon the host- 
parasite combination, will influence the level of the CDS'*" CTL response. Release of 
CSP by P. berghei sporozoites has been described in vivo (Khan, Ng and Vanderberg, 
1992) and, therefore, the strong CDS"*" CTL response induced by immunisation with
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irradiated sporozoites may be related to the poor infectivity of the sporozoites. Poor 
infectivity is not believed to occur in human malarias (Rosenberg et a i, 1990). Hence 
the question remains as to which immune responses observed in animal models actually 
occur during natural infections in humans.
Immunisation of volunteers, with irradiated sporozoites of P. falciparum, induced a 
CDS’*" CTL response, which recognised a region of the CSP (Malik et a l, 1991). Adult 
Kenyans (Sedegah et a l, 1992) and Australians (Doolan et a l, 1991) who lived in a 
malarious area were found to have CDS’*" CTL circulating, which recognised the same 
region of the CSP as the CD8+ CTL found in the immunised volunteers. Studies in the 
Gambia have provided indirect evidence that CD8+ CTL play a protective role against P. 
falciparum  (Aidoo et a l, 1995). Further studies in the Gambia (Hill et a l, 1991, Hill et 
a l ,  1992) have demonstrated an association between individuals expressing HLA- 
Bw53, a gene of the MHC, and a reduced incidence of severe P. falciparum. A small 
number of these individuals were found to have a CDS'*' CTL which recognised a 
peptide from the LSA-1 (Hill et al, 1992).
CD4^ T cell mediated immunity to pre-erythrocytic stages
The importance of CD4^ T cells in the protective immune response against the exo- 
erythrocytic stage has slowly emerged. A CD4^ T cell clone, which has cytotoxic 
activity in vitro, was shown to mediate protection against a P. berghei challenge (Tsuji et 
al, 1990). Several CD4^ T cell determinants have been identified in the CSP (Zvering et 
al, 1992) but it is unclear which epitopes can induce protective immunity. CD4^ T cells 
which recognise epitopes from the CSP can eliminate infected hepatocytes in vitro 
(Renia et a l, 1993) and following adoptive transfer can protect naive mice against a 
sporozoite challenge, apparently by direct killing (Renia et al., 1993). Activation of 
CD4‘^ T cells in response to the P. falciparum  CSP in individuals from Papa New 
Guinea has been observed (Doolan et a l, 1994). As with the evidence demonstrating
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MHC Class I restricted CD8^ CTL activity, it appears that processed fragments of exo- 
erythrocytic parasite derived proteins can be expressed in association with MHC Class 
II. Hepatocytes do not express MHC Class II antigens constitutively but its expression 
can be upregulated during infection (Franco et al, 1988).
Mice primed intrasplenically with exo-erythrocytic forms of P. yoelii were protected 
against a sporozoite challenge but this protection was abrogated following in vivo 
depletion of CD4^ T cells prior to the sporozoite challenge (Renia, Rodrigues and 
Nussenzweig, 1994). Numbers of CD4^ T cells in the extravascular hepatic 
compartment of the liver, following priming with live P. yoelii sporozoites were raised 
when compared with controls (Faure et a l, 1995).
The division of murine CD4^ T helper cells into T helper 1 (Thl) or Th2 CD4^ T cells 
(Mosmann and Coffmann 1987) according to their cytokine profiles, led to a change in 
the approach for studying the role of CD4^ T cells in the immune response to the exo- 
erythrocytic stage of malaria. Each subset of T helper cell can influence the immune 
system through their cytokine production. Thl cells produce IL-2 and IFNy, and IL-4, 
IL-6 and IL-10 are produced by Th2 cells (Mosmann and Coffmann 1987). One of the 
most studied cytokines in this area is the Thl associated IFNy. In vivo and in vitro 
studies have demonstrated that IFNy can inhibit the development of rodent and human 
pre-erythrocytic stage malaria parasites (Ferreira et a l, 1986, Mellouk et a l, 1987, 
Maheshwari et a l, 1986). Administration of IFNy systemically will protect rhesus 
monkeys against a P. cynomolgi B sporozoite challenge (Maheshwari et a l, 1986). The 
sterile immunity observed in mice immunised with irradiated sporozoites is abrogated 
following anti-IFNy neutralising antibody treatment (Schofield et a l, 1987b). 
Immunisation of mice with P. berghei sporozoites induces IFNy production (White, 
Jarboe and Krzych, 1994). IFNy does not exert an inhibitory effect on free sporozoites 
but on the intracellular development of liver stage parasites (Mazier et a l, 1988). 
Optimal inhibition of P. berghei sporozoite development was observed when the primary
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hepatocyte culture was treated with IFNy 6 hours prior to the addition of the sporozoites 
(Schofield et a l, 1987a). Addition of IFNy to developed intracellular liver stages, 
resulted in the lysis of parasites (Mellouk et al, 1987). This demonstrates that IFNy can 
have a cytotoxic effect on liver stage parasites as well as the cytostatic role defined by the 
inhibition of development of parasites intracellularly (Mazier et al., 1988). There are 
several mechanisms through which IFNy can mediate inhibition of growth. IFNy 
receptors are found on the hepatocyte (Schofield et al, 1987a) and it is thought that the 
binding of IFNy to its specific receptor induces intracellular alterations which result in an 
unsuitable environment for parasite development (Schofield et a l, 1987a). However, 
IFNy induced tryptophan starvation, a mechanism which can kill the intracellular 
pathogen Toxoplasma gondii, does not appear to participate in the inhibitory effect on 
malaria parasite development mediated by IFNy (Schofield et a l, 1987a). The density of 
IFNy receptors present on hepatocytes may explain the observations that in vitro 
(Mellouk et al, 1987) and in vivo (Vergara et al, 1987) some parasites are able to evade 
the inhibitory action of IFNy. A lower density of receptors may result in a failure to 
reach a threshold level of IFNy stimulation of the hepatocytes and consequently the 
parasite is able to develop within the cell.
IFNy may mediate anti-parasite immunity by stimulating resident liver macrophages, 
Kupffer cells, to phagocytose sporozoites (Seguin et a l, 1989). Another function of 
IFNy during this phase of infection may be to stimulate an increase in antigen 
presentation by hepatocytes or Kupffer cells through the upregulation of MHC Class II 
expression. Subsequently this would increase the presentation of parasite antigens to 
CD4^ T cells and result in an amplification of IFNy production and other T cell products. 
Hence, IFNy can upregulate its own production via the stimulation of antigen presenting 
cells ensuring that enough is present locally in the liver to mediate protective immunity. 
Initially it was thought that CD8^ CTL were the source of IFNy in the liver (Schofield,
1989) but the demonstration of CD4^ T cell presence in the liver (Faure et a l, 1995) 
provides another source of IFNy. Indeed it has been shown that during P. yoelii
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infection, IFN y can also be produced by a non-T cell source presumably natural killer 
(NK) cells which require IL-12 and TNF stimulation (Sedegah, Finklemann and 
Hoffman, 1994).
The only direct role that Th2 CD4+ T cells appear to have in the immune response to the 
exo-erythrocytic stages is as a possible source of IL-6 which has been shown to be an 
important mediator in the protective response (Pied et a l, 1992). An important indirect 
mechanism, which Th2 cells are vital for is the production of a humoral response. Th2 
cells supply crucial "helper" signals which are involved in the stimulation, differentiation 
and proliferation of B cells. This results in plasma cells producing an antibody response 
which, as already discussed, can prevent the development of the parasite by various 
means. This "help" is usually the production of cytokines which are classically Th2 
associated. There is however, very little evidence for a large production of IL-4 during 
this phase of the infection. No IL-4 production was observed during in vitro 
proliferation of splenocytes following immunisation of mice with P. berghei sporozoites 
(White, Jarboe and Krzych, 1994). However, a systemic increase in IL-4 production 
was noted following immunisation with P. yoelii CSP plasmid DNA (Mor et a l, 1995). 
The increase in IL-4 was associated with a primary humoral response following the first 
immunisation but this switched to an IFNy mediated response after the booster of P. 
yoelii CSP plasmid DNA. IL-4 production was found not only in the lymph nodes but 
in several lymphoid organs. This experimental immunisation model illustrates a 
mechanism which may explain the absence of evidence for an IL-4 mediated response. 
In this model there are low levels of parasite derived antigen and under these conditions 
B cells are involved in antigen presentation which results in a preferential activation of 
Th2 cells (Mamula and Janeway, 1993, Ron and Sprent, 1987) and consequently an 
increase in IL-4 production. The levels of parasite derived antigen in other experimental 
immunisation models is probably higher and would result in activation of Thl CD4+ T 
cells and an increase in IFNy production.
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The Th2 associated cytokine, IL-6, has been extensively studied in conjuction with IL-1 
and TNFa. They are known as endogenous pyrogens and are important mediators of the 
acute inflammatory response to various stimuli. TNF has been shown to inhibit the 
development of malarial exo-erythrocytic forms (Schofield et a l, 1988). No inhibitory 
effect mediated by TNF was observed when using a primary culture of hepatocytes in 
vitro (Mazier et al, 1990). The addition of non-parenchymal cells, such as lymphocytes, 
NK cells and Kupffer cells, restored the inhibitory effect of TNF (Mazier et a l, 1990). 
Elevated IL-6 concentrations were observed in these in vitro cultures. Addition of anti- 
IL-6 monoclonal antibodies resulted in a decrease in the TNF inhibition suggesting that 
IL-6 is a crucial mediator in the protective mechanism (Mazier et a l, 1990). IL-6 was 
observed in the sera of mice infected with P. yoelii sporozoites (Pied et a l, 1992). 
Intraperitoneal administration of IL-6 significantly reduced the development of P. 
berghei, liver schizonts in rats (Vreden e ta l, 1992). Administration of anti-IL-6 resulted 
in a 40% increase of liver schizonts (Vreden et a l, 1992). IL-6, IL-1 and TNF mediate 
their protective response via their role as inducers of the acute phase response. They 
participate in an intricate network which results in the stimulation of hepatocytes and 
non-parenchymal cells. These endogenous pryogens can act in synergy (Vreden et al, 
1992, Mazier et al, 1990) and can also induce the production of each other (Pied et al,
1992). This inflammatory network can induce the production of a series of proteins 
known as acute phase reactants (Ramadori et a l, 1985). Acute phase proteins are 
synthesised mainly by the hepatocyte and include C-Reactive protein (CRP), a2 - 
macroglobulin, serum amyloid A and serum amyloid P. Rapid increase in systemic 
levels of these proteins is observed following various stimuli. CRP has been shown to 
prevent sporozoite penetration into the hepatocyte and can block parasite division 
through an antibody-like effect (Pied et a l, 1991). Acute phase reactants represent a 
non-specific response stimulated by inflammatory cytokines. Another non-specific 
response, which is an effector mechanism stimulated by IL-6 and TNF is the production 
of nitric oxide (NO). NO is derived from L-arginine and can inhibit the development of 
Toxoplasma (Adams \99Ql) 2x\à. Leishmania (Green gf a/., 1990). Macrophages,
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Kupffer cells and hepatocytes have all been shown to produce NO upon stimulation 
(Nussler et al., 1991a, Billiar et a l, 1989, Klotz et al., 1995). Inhibition of NO 
production by inhibitors of NO synthesis resulted in the abrogation of the protective 
effect mediated by TNF and IL-6 (Nussler et al., 1991a). In vitro experiments have 
demonstrated that the protective effect observed with IFNy is also mediated via NO 
(Mellouk et a l, 1991). The production of NO is now regarded as one of the major 
protective mechanisms against the exo-erythrocytic stages of malaria infection.
Immunity to the asexual erythrocytic stages of malaria
Naturally acquired immunity to the asexual erythrocytic stages of malaria is manifested 
in individuals who harbour a low grade parasitaemia with no clinical symptoms. As the 
asexual blood-stage parasites are responsible for the morbidity of the disease, it has been 
hypothesised that immunity is partly anti-parasitic and partly anti-toxic (Sinton, Harbhag 
and Singh, 1931), a theory which has been redefined recently as anti-parasite and anti­
disease immunity (Playfair et a l,  1990). Humoral responses may be sufficient for the 
anti-disease immunity but it is thought that a combination of humoral and cellular 
mechanisms is required for the development of effective anti-parasitic immunity, 
however, the exact nature of the anti-malarial mechanisms are unclear.
There are difficulties in investigating the immune response in humans and these studies 
usually involve a serological approach or analysis of peripheral blood mononuclear cells 
usually by restimulation in vitro. Often the history of exposure to malaria for an 
individual is unknown and concurrent infections other than malaria may influence the 
serological profile or the composition of the cells in the peripheral blood. Hence, much 
of our understanding of the immune mechanisms to the blood-stage of infection comes 
from experimental models. The mechanism of protective immunity in these models often 
depends upon the host-parasite combination. However, this does reflect the situation in 
human malaria infection because the genetic background of the host and the strain of the
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infecting Plasmodium species will influence the development of the protective immune 
response and ultimately the outcome of the infection.
Humoral Immunity
Transfusion of y-globulin or purified umbilical cord IgG isolated from immune adults, to 
non-immune children during falciparum malaria infection results in a decrease in 
parasitaemia (Cohen, McGregor and Carrington, 1961, Sabchareon et al., 1991). 
Passive transfer of IgG from immune donors protects Thai patients against P. falciparum 
infection (Bouharoun-Tayoun etal., 1990) and the antibodies which demonstrated this 
clinical effect were able to mediate inhibition of P. falciparum development in vitro by a 
process termed antibody-dependent cellular inhibition (ADCI) (Bouharoun-Tayoun et 
a l, 1990). Antibodies that proved clinically ineffective in the same individuals did not 
promote ADCI. The mechanism of ADCI is dependent upon IgG binding to monocytes 
via their FcyRII receptors which induces the release of soluble factors, thought to 
include TNF, which act upon young intraerythrocytic parasites (Bouharoun-Tayoun et 
a l, 1995). A correlation between the presence of cytophilic or non-cytophilic antibodies 
and the clinical status of protection has been observed (Bouharoun-Tayoun and Druilhe,
1992). An increase in IgGl and IgG3 correlated with the development of clinical 
immunity whereas a susceptible group of the population in an endemic area produced the 
non-cytophilic antibodies, IgM and IgG2 in response to infection (Bouharoun-Tayoun 
and Druilhe, 1992). It has been suggested that anti-malarial antibody may block invasion 
of host erythrocytes by merozoites (Cohen and Butcher, 1970, Phillips et a l,  1972) and 
may also prevent cytoadherence (David et a l ,  1983). However, the interaction of 
malarial antibody with cellular mechanisms was demonstrated by the requirement for the 
presence of antibody to enable PBMN cells to reduce the growth of P. falciparum  
(Brown and Smalley, 1980).
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Mice immunised with a recombinant fusion protein incorporating the carboxy-terminal 
region of P. yoelii MSP, are resistant to a homologous challenge (Daly and Long, 
1995). Furthermore, resistance was passively transferred by immune serum or purified 
Ig from the immunised mice to recipient mice challenged with P. yoelii (Daly and Long, 
1995). It has been reported that during a primary infection with P. chabaudi there is a 
polyclonal activation of B cells resulting predominantly in the production of IgG2a 
(Langhorne, Kim and Asofky, 1985, Falanga et a l ,  1987). Protection against re­
infection appears to involve IgGl (DTmperio et a l ,  1996). IgGl has also been 
implicated in the control of the recrudescence parasitaemia of a primary P. chabaudi 
infection following treatment of mice with recombinant IL-6 (Akanmori, Kawai and 
Suzuki, 1996), a cytokine known to stimulate B cells to secrete immunoglobulins 
(Teranishi e ta l ,  1982, Muraguchi et a l, 1988, Takatsuki e ta l ,  1988). Both IgGl and 
IgG3 have been proposed to confer protection against human malaria (Groux and Gysin,
1990).
Cell mediated immunity - rodent malaria
Immunity to the asexual blood-stages of malaria in rodent models can be transferred with 
immune spleen and lymph node cells (Stechschulte, 1969, Roberts and Tracey-Patte, 
1969, Phillips, 1970, Kasper and Alger, 1973). Rats infected with the blood-stages of 
P. berghei rapidly control the infection after receiving immune spleen cells (Phillips and 
Jones, 1972). Thymectomized mice are more susceptible to P. chabaudi infection than 
controls (McDonald and Phillips, 1978b). Adoptive transfer of immune spleen cells 
protects irradiated mice against a P. chabaudi challenge (McDonald and Phillips, 1978b). 
Unfractionated spleen cells were observed to confer better protection than enriched T cell 
populations demonstrating the requirement for both T cells and B cells. The same 
observation was made by Jayawardena et a l, (1982) where both T cells and B cells 
recovered from P. yoelii infected mice, conferred protection to non-immune irradiated 
recipients to a homologous challenge. However, it was noted that optimal protection was
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obtained by the adoptive transfer of B cells and CD4+ T cells (Jayawardena et a i ,  
1982). B cell depleted mice are able to control an infection with P. chabaudi adami or P. 
vinckei petted  (Grun and Weidanz, 1981, Grun and Weidanz, 1983, Clark, 1987, 
Kumar et a i, 1989, Cavacini, Parke and Weidanz, 1990) demonstrating the importance 
of T cell regulated cell-mediated immunity. The role of CD4+ T cells in protection 
against the asexual erythrocytic stage of infection in mice has been the focus of extensive 
research. Depletion of CD4+ T cell function by a monoclonal antibody during the 
primary parasitaemia of a P. chabaudi infection confirmed the essential role which CD4+ 
T cells have in mediating the control of this acute erythrocytic stage (Langhorne, 1989). 
Analysis of splenic lymphocytes from mice during a primary infection of P. chabaudi, 
showed a greater frequency of Thl CD4+ T cells characterised by the production of 
IFNy and IL-2 (Langhorne, 1989). As the infection progressed, the frequency of these 
cells decreased, replaced by Th2 cells characterised by the production of IL-4. Hence, it 
appears that Thl cells mediate the acquired immunity to the acute phase of a P. chabaudi 
infection but there is a switch to Th2 mediated immunity (see Diagram 2). This implies 
that early protective mechanisms are antibody-independent with a switch to antibody- 
dependent mechanisms during the later stages of infection. This was clearly 
demonstrated when SCID mice, reconstituted with CD4+ T cells from naive animals or 
infected mice, survived a P. chabaudi infection but a persistent recrudescence 
parasitaemia was observed (Meding and Langhorne, 1991). However, the transfer of B 
cells in addition to the CD4+ T cells, resulted in the SCID mice eliminating the parasite.
Characterisation of CD4+ T cell clones from P. chabaudi infected mice recovering from 
a primary parasitaemia or from mice which had cleared a secondary infection, confirmed 
the polarisation of the CD4+ T cell response during P. chabaudi infection (Taylor- 
Robinson and Phillips, 1992). The clones derived from the period when the acute 
primary parasitaemia was in decline, were of the Thl phenotype whereas the clones 
derived from mice which had cleared a secondary infection were characteristic of Th2 
cells. Adoptive transfer of both the Thl and Th2 clones conferred protection against a P.
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chabaudi challenge in immunocompromised hosts (Taylor-Robinson and Phillips,
1993). However, the transfer of the Th2 clone also required the transfer of splenic B 
cells to be fully protected in immunocompromised hosts. The Thl clone is thought to 
regulate the development of protective immunity through the production of IL-2 and 
IFNy possibly via a NO dependent mechanism and the Th2 clone mediates protection by 
promoting the production of a specific antibody via the secretion of IL-4 (Taylor- 
Robinson and Phillips, 1993, Taylor-Robinson et a l,  1993).
B cells appear to have an important role in the development of the Th2 responses during 
P. chabaudi infection, thus extending the function of B cells beyond that of specific 
antibody production. As already mentioned, SCID mice require the transfer of both 
CD4"*" T cells and B cells to resolve a P. chabaudi infection efficiently (Meding and 
Langhorne, 1991). Passive transfer of immune IgG did not confer protection to P. 
chabaudi challenged SCID mice (von der Weid et al., 1994), demonstrating that the 
presence of B cells is required for efficient elimination of the parasite. The B cells, most 
likely act as antigen presenting cells and produce cytokines or display important co­
stimulatory molecules which promote Th2 cell development (Troye-Blomberg, Berzins 
and Perlmann, 1994).
The interaction between Thl and Th2 cells and their respective responses is a crucial 
factor in the development of a protective immune response to not only P. chabaudi 
infection in mice but several other infectious diseases. Inappropriate responses can often 
contribute to the pathology of a disease. As already described CD4+ T cells are 
subdivided into two distinct subsets by the pattern of cytokine secretion. Thl cells 
produce IL-2 and IFNy whereas Th2 cells characteristically produce IL-4, IL-5, IL-6 
and IL-10 (Mosmann and Coffman, 1989). Both Thl and Th2 cells provide help for B 
cell function through the secretion of IFNy and IL-4 or IL-5 (Mosmann and Coffman, 
1989). Thl cells mediate delayed type hypersensitivity inflammatory reactions (Cher and 
Mosmann, 1987) whereas Th2 cells are associated with allergic responses (Mosmann
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and Coffman, 1989). IFNy can inhibit the proliferation of Th2 cells (Gajewski and 
Fitch, 1988) but does not affect proliferation or lymphokine production by Thl cells 
(Fernandez-Botran et al., 1988). IL-10 can inhibit antigen presenting cell induced 
cytokine production by Thl cells (Fiorentino et al., 1991). Hence, Thl and Th2 cells 
can regulate the proliferation and expansion of the other subset which has important 
consequences on the response to a pathogen.
During P. chabaudi infection in mice, the sequential involvement of Thl and then Th2 
mediated responses results in efficient control of the infection. The regulation and 
differentiation mechanisms of the CD4+ T cell response are unclear. Naive CD4+ T 
cells, when first stimulated produce IL-2 and then differentiate into either the Thl or Th2 
phenotype (Mosmann and Sad, 1996). T cells expressing the cytokines from both Thl 
and Th2 phenotypes have been designated ThO (Romagnani, 1996). The differentiation 
of effector Thl or Th2 cells proceeds through this ThO phase of expressing multiple 
cytokines (Mosmann and Sad, 1996).
There are several factors which can influence the process of Thl/Th2 differentiation. 
One of the most important factors is the microenvironment of the responding Th cell. 
The presence of IL-4 is a strong stimulus for Th2 differentiation whereas IL-12 is 
regarded as the main stimulus for Thl development (Seder and Paul, 1994). During an 
initial response, antigen specific T cells are present at a low frequency and hence, other 
cells can produce the cytokines necessary for the induction of the required Th response. 
Mast cells, basophils and a subpopulation of T cells, NK1.1+ cells may be a source of 
early IL-4 production and macrophages are major producers of IL-12 (Mosmann and 
Sad, 1996). Naive ThO cells have recently been shown to produce IL-4 in small 
quantities upon initial activation and it is thought that this may promote differentiation 
from naive ThO cell to a Th2 cell (Romagnani, 1996). Early IFNy production, by NK 
cells for example, may inhibit the development of Th2 cells (Seder and Paul, 1994) and 
hence promote Thl expansion.
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It was initially thought that antigen presenting cells (APC) may be able to influence the 
Thl/Th2 decision. Thl cells respond optimally to purified adherent cells from spleen 
cells, while Th2 cells had optimal proliferative responses when splenic B cells were used 
as APC (Gajewski et al., 1991). However, it is now known that dendritic cells, 
macrophages and B cells are all capable of inducing differentiation of Thl or Th2 cells in 
the presence of the appropriate cytokines (Mosmann and Sad, 1996). Recently, IL-6 
derived from APC was shown to be capable of inducing polarisation of naive Th cells to 
Th2 cells by stimulating IL-4 production in CD4+ T cells (Rincon et al., 1997). Hence, 
a role for APC in the induction of Thl or Th2 cells cannot be excluded because they may 
exert an influence via the cytokines they secrete or as has been recently suggested, the 
expression of co-stimulatory molecules on APC may selectively influence the Thl/Th2 
decision.
B7-1 and B7-2 molecules are expressed on activated B cells, dendritic cells, activated T 
cells and monocytes (Constant and Bottomly, 1997). They bind to CD28 on T cells and 
CTLA-4 on activated T cells (Lenschow, Walun as and Bluestone, 1996). The presence 
of either B7 molecule is essential to induce naive CD4+ T cells to produce IL-2 and 
proliferate (Chen and Nabavi, 1994). B7-2 expression is induced more rapidly than B7- 
1 (Hathcock e ta l ,  1994) and a 100 fold higher level of B7-2 expression than B7-1 was 
shown on dendritic cells (Inaba e ta l ,  1994). Both B7-1 and B7-2 have been shown to 
induce Thl or Th2 differentiation (Seder and Paul, 1994) but B7-2 appears to be the 
dominant costimulatory molecule during primary responses whereas B7-1 may be 
important in maintaining primary and secondary responses (Mosmann and Sad, 1996).
Antigen dose is another factor which may influence the Thl/Th2 decision. Early in vivo 
studies suggested that low doses of antigen, either Leishmania or Trichuris muris 
infection, induced a Thl response, but an increase in antigen dose induced a Th2 
response (Bretscher, Wei and Menon, 1992, Bancroft, Else and Grencis, 1994).
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However, conflicting reports indicated that using various soluble proteins as antigens, 
an increase in antigen dose skewed the response to a Thl phenotype (HayGlass et a l,  
1986, Chaturvedi et a l ,  1996). Hence, the type of antigen may account for the 
discrepancies in the studies with Thl responses induced by low doses of parasites as 
immunogens whereas Th2 responses were observed following administration of low 
doses of soluble proteins. A further explanation may be that at high doses of antigen, 
Thl cells are more susceptible to activation-induced cell death (apoptosis), and therefore, 
high doses of parasite antigen may promote the expansion of Th2 cells because the 
negative cross-regulation of Thl cells is eliminated (Constant and Bottomly, 1997). The 
regulation of Thl/Th2 differentiation by antigen dose may also involve the interaction of 
the T cell receptor (TCR) with the antigen. The strength of this ligation and the role of 
various co-receptors will determine if there is a sustained pattern of signal transduction. 
It has been suggested that for a naive Th cell to produce IFNy (Thl phenotype) a 
threshold of activation is required (Constant and Bottomly, 1997). If the interaction 
between the TCR and antigen is strong, this will lead to constant signal transduction, 
sustained activation and IFNy production. A weak interaction between the TCR and 
antigen may result in a transient pattern of activation, resulting in IL-4 production (Th2 
phenotype). The role of antigen dose in the induction of Thl or Th2 responses is 
complex and the studies performed have to be interpreted with caution because there are 
many variable factors involved and hence, it is difficult to construct a clear hypothesis.
The induction of either Thl or Th2 responses during P. chabaudi infection is an 
important step in the development of protective immunity. The sequential involvement of 
Thl mediated responses followed by Th2 induced effector mechanism is required for the 
efficient elimination of the parasite. The mechanisms of induction of the initial Thl 
differentiation and secondly a switch to Th2 mediated responses during P. chabaudi 
remain unclear. The cytokine environment, various APC and the level of antigen dose 
have all been proposed to induce the appropriate type of Th cell response and effector 
functions. Investigation into these mechanisms will have important consequences on the
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research for a vaccine targeted to the asexual blood stages because the demonstration that 
human Thl and Th2 cells exist (Romagnani, 1996) illustrates that the vaccine will need 
to induce the appropriate CD4+ T cell response.
CD8+ T cells do not appear to have a significant role in the protective immunity to the 
asexual blood-stage of malaria infection in rodents. Adoptive transfer of CD8'*' T cells 
was shown to confer a degree of protection against a P. yoelii infection (Mogil, Patton 
and Green, 1987) but this was contradictory to reports demonstrating that only CD4+ T 
cells were required for protection against P. yoelii (Vinetz et a l, 1990). However, mice 
immunised with a crude P. falciparum antigen were partially protected against a P. yoelii 
challenge and this protection was apparently CD8+ T cell mediated (Lucas et al., 1993). 
CD8+ T cells were also proposed to participate in the resolution of the later phases of P. 
chabaudi adami and P. chabaudi AS infection (Weidanz, Melancon-Kaplan and 
Cavacini, 1990, Podoba and Stevenson, 1991). Infection of p2-microglobulin deficient 
mice, which lack surface expression of the MHC class I molecule on nucleated cells and 
are, therefore, essentially devoid of a functional CD8'*" T cell response, with either P. 
chabaudi AS, P. chabaudi adami or P. yoelii resulted in a similar resolution of infection 
as in the intact control mice (van der Heyde etal., 1993). This observation suggests that 
the role of CD8+ T cells during a primary malaria infection in mice is minimal, although 
the possibility of compensatory mechanisms, such as increased production of IFNy by 
another source cannot be ignored.
Cell mediated immunity - human malaria
Investigations of the role of cell-mediated immunity in human malaria infection has 
mainly consisted of studies examining the in vitro response of PBMN cells from infected 
patients or malaria-immune donors. However, these studies have to be interpreted with
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caution because they are influenced by various factors. Details of an individual's 
parasitological history and current parasitological and immune status are sometimes 
unknown. Non-malaria related illness and pregnancy can also influence the parameters 
measured in these studies (Riley and Greenwood, 1990). The proliferative response and 
the ability to produce cytokines in response to stimulation with malarial antigen are the 
main parameters analysed in the studies of human T cell responses during malaria 
infection. As in mice, human CD4"*" T cells can be separated into distinct subsets by 
cytokine profiles (Troye-Blomberg and Perlmann, 1988). CD4+ T cell derived IL-4 
production can be induced by stimulation of PBMN cells from immune donors in vitro 
with malarial antigens (Troye-Blomberg et al., 1990a). Clinically immune adults were 
shown to give strong proliferative and IFNy responses to a soluble malarial antigen 
(Riley et al., 1988). Both IFNy and IL-4 have been implicated in protective immune 
mechanisms during blood-stage malaria infection (see later). IFNy, a potent activator of 
effector cells (Boehm et al., 1997), is thought to be involved in the killing of blood-stage 
parasites (Ockenhouse, Schulman and Shear, 1984, Shear etal., 1989). Increased IL-4 
levels in the serum of aparasitaemic individuals from an area of perennial and 
holoendemic P. falciparum transmission, suggests this cytokine may be involved in an 
anti-parasitic response (Mshana, Boulandi and Mshana, 1991).
The role of CD8+ T cells in immunity to the asexual blood-stage of human malaria 
infection is thought to be a minor one. There are several reports of increased numbers of 
CD8+ T cells in individuals who have recently recovered from an attack of malaria 
(Hoffman e ta l ,  1984, Troye-Blomberg eta l., 1984). Malaria-specific CD8+ T cell 
clones have been isolated from the peripheral blood of recently infected individuals 
(Sinigaglia, Matile and Pink, 1987). However, it is thought that the role of CD8+ T cells 
may be immunoregulatory and indeed may be immunosuppressive (Troye-Blomberg, 
Berzins and Perlmann, 1994). Removal of CD8+ cells from isolated PBMN cells by 
anti-CD8+ treatment, enhanced the proliferative and IFNy responses of cells which were 
normally low responders to in vitro stimulation (Riley, Jobe and Whittle, 1989). As
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already described, CD8+ T cells have an important role in the protective immune 
response to the intra-hepatic stage of malaria infection and that this mechanism is partly 
IFNy dependent. The production of high levels of IFNy by CD8+ T cells in response to 
the pre-erythrocytic stage of infection could influence the immune response of an 
individual to a concurrent blood-stage infection. Furthermore the demonstration that 
CD8+ T cells (Mosmann, Li and Sad, 1997), as with CD4+ T cells, can be separated 
into different subsets, characterised by their cytokine secretion profiles (Mosmann and 
Coffman, 1987) demonstrates the potential immunoregulatory role of CD8+ T cells 
during human malaria infection.
A characteristic of the T cell response of patients with acute falciparum malaria is an 
antigen-specific immunodépression. This unresponsiveness may be due to an absence of 
antigen-specific T cells in the peripheral blood possibly due to a sequestration of the 
appropriate T cells to sites from the peripheral blood (Hviid et al., 1991, Hviid et al.,
1993). Defective IL-2 production may contribute to the immunosuppression observed 
(Troye-Blomberg et a l, 1985, Ho et a l, 1988). PBMN cells from patients with acute 
falciparum malaria fail to produce IL-2 or express IL-2 receptors upon stimulation with 
malaria specific antigen (Ho et a l, 1988). Serum from malaria patients can suppress in 
vitro cellular responses of PBMN cells from children with acute malaria to restimulation 
with malaria antigens, non-malaria antigens and mitogens (Riley et a l ,  1988). It has 
been shown that prostaglandin E, which can inhibit antigen and mitogen-induced 
blastogenesis (Leung and Mihich, 1980), is in part responsible for the suppression of 
the in vitro cellular responses of PBMN cells from malaria patients (Riley et a l,  1989). 
However, Ho and Webster (1990) in contrast, report that they have been unable to 
consistently demonstrate suppressor serum factors including prostaglandin E. It has 
been suggested that the counter regulatory roles of CD4+ T cell subsets may contribute 
to the immunosupression through the production of inhibitory cytokines such as IFNy or 
IL-4 (Ho and Webster, 1990). The induction of NO production by Thl mediated
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inflammatory responses may also contribute to the immunosuppression observed 
(Rockett âf/., 1994).
Role of yô T cells in immunity to the asexual erythrocytic stages
Recent evidence has suggested that T cells expressing the y5 T cell receptor may be 
involved in immunity to the blood-stages of malaria infection. yÔ T cells constitute only a 
small minority of peripheral T cells in man and mouse (Falini e ta l ,  1989, Haas, Pereira 
and Tonegawa, 1993, Allison, 1993). These cells are characteristically CD3"*" but in the 
majority of cases do not express CD4 or CD8 (Haas, Pereira and Tonegawa, 1993). A 
protective role for y5 T cells in various infectious and parasitic diseases has been 
proposed (Modlin et a i,  1989, Minoprio et al., 1989, Hiramatsu et al., 1992, Russo et 
al., 1993). Elevated numbers of yô T cells in the peripheral blood of patients during 
acute P. falciparum  infection or convalescence has been reported (Ho et al., 1990, 
Roussilhon et a l, 1990). Recently, two studies have demonstrated the activation of yô T 
cells during human malaria infection (Rzepczyk et al., 1996, Worku et al., 1997), 
confirming the possible protective and/or immunomodulatory role for yô T cells in 
malaria. Preliminary reports have suggested that human yÔ T cells can inhibit the growth 
of P. falciparum in vitro (Elloso etal., 1994).
These observations in human malaria are confirmed in experimental malaria infections, 
yô T cell numbers increase in the spleen of mice resolving a P. chabaudi infection 
(Langhorne, Pells and Eichmann, 1993, van der Heyde et al., 1993b). There is a 
pronounced increase in the yÔ T cell number in P2-microglobulin deficient mice and B 
cell deficient mice during experimental malaria infection (van der Heyde et al., 1993b, 
Langhorne, Pells and Eichmann, 1993). Mice lacking T cells with the yô TCR were able 
to control a P. chabaudi infection with a slight delay in the time of clearance of the acute 
phase of infection and higher recrudescent parasitaemias were observed compared to 
controls (Langhorne, Mombaerts and Tonegawa, 1995). It was observed that the
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increase in the splenic yô T cells in P. chabaudi infected mice was localised in the red 
pulp areas of the spleen (Langhorne, Pells and Eichmann, 1993). This occurs during 
human malaria infection as well (Bordessoule, Gaulard and Mason, 1990). The location 
of yô T cells in the red pulp of the spleen would allow these cells to be in close contact 
with parasitised erythrocytes and hence, yÔ T cells may have a role in parasite 
destruction. yÔ T cells are known to produce IFNy and TNFp (Patel, Wacholtz and 
Duby, 1989, Kabelitz, Pechold and Bender, 1991, Ferrini, Prigione and Bottino, 1989) 
and resemble NK cells, lymphokine activated cells and aP  T cells in that they can lyse 
target cells (Borst et a l, 1987, Lanier, Ruitenberg and Phillips, 1986). Therefore they 
have the potential to mediate or perform parasiticidal activity. However, it must be noted 
that a p  T cell deficient mice were unable to control a P. chabaudi infection despite a 
functional yô T cell response (Langhorne, Mombaerts and Tonegawa, 1995). It is 
possible that in the absence of ap  T cells, yÔ T cells are not able to provide the required 
help for antibody production which is necessary for parasite elimination. Furthermore, 
yô T cell deficient mice have been shown to be able to control a P. chabaudi infection 
with a similar efficiency to that of control mice (Taylor-Robinson et a l ,  1994b) 
suggesting that yô T cells do not play a significant role in control of blood-stage malaria
infection.
Role of cytokines in immunity to asexual erythrocytic stages
The interactions of cytokines clearly influence the development of immunity to the 
asexual blood stage of malaria infection. IFNy, produced by CD4+ Thl cells, CD8+ T 
cells and NK cells, has been shown to activate macrophages to kill intracellular malaria 
parasites (Ockenhouse, Schulman and Shear, 1984). T cell clones derived from PBMN 
cells from individuals living in an endemic region, immune to P. falciparum  infection, 
produce IFNy upon re-stimulation with malarial antigen in vitro (Sinigaglia and Pink, 
1985). T cells isolated from patients acutely infected with P. falciparum produce IFNy in 
vitro following antigen specific stimulation (Troye-Blomberg e ta l ,  1985). IFNy has
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been detected in the sera of patients with either P. falciparum  or P. vivax (Rhodes- 
Feuilletee et a i, 1985, Kern et al., 1989). In vivo treatment of P. chabaudi infected mice 
with recombinant IFNy enhanced protection (Clark et al., 1987) and mice treated with 
anti-IFNy antibodies during P. chabaudi infection were found to have an exacerbated 
parasitaemia (Stevenson et al., 1990). The role of IFNy during P. chabaudi infection 
appears to be restricted to the primary parasitaemia with peak production occurring 2 or 
3 days prior to the peak of the primary parasitaemia (Slade and Langhorne, 1989, 
Stevenson et al., 1990). IFNy can activate macrophages to secrete inflammatory 
molecules such as NO and oxygen radicals, IL-1, TN Fa and IL-6 (Phillips, 1994a, 
Taylor-Robinson, 1995) which have all been proposed to be involved in parasiticidal 
mechanisms (Phillips, 1994a, Taylor-Robinson, 1995). The macrophage has a pivotal 
role during the development of immunity to the asexual erythrocytic stages because it is 
involved in the induction of the immune response via antigen presentation and is also an 
effector cell.
TNF is an important macrophage product which is induced by IFNy stimulation 
(Langhorne, 1989, Stevenson et al., 1990, Taylor-Robinson and Phillips, 1992, Waki 
et a i, 1992) or directly by stimulation with parasite derived toxins (Kwiatkowski et al., 
1989, Schofield and Hackett, 1993, Bate et al., 1990, Bate et al., 1992). Mononuclear 
cells isolated from the peripheral blood of patients with acute malaria are primed to 
secrete enhanced levels of TNF (Bate et a l, 1990). Macrophages from the spleens and 
livers of mice infected with rodent malarial parasites have also been shown to have an 
enhanced capacity to secrete TNF (Bate et al., 1990). High levels of TNF have been 
detected in the sera of patients infected with P. falciparum (Scuderi et al., 1986, Kern et 
a l,  1989, Grau et a l, 1989b, Kwiatkowski et al., 1990). Recombinant TNF treatment 
of P. chabaudi adami infected mice resulted in an earlier resolution of the parasitaemia 
and an earlier appearance of crisis forms (Clark et a l ,  1987). Human recombinant 
TNFa treatment protects susceptible A/J mice against a lethal P. chabaudi AS infection 
(Stevenson and Ghadirian, 1989). An increase in TNF expression in the spleen
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correlates with resistance to a P. chabaudi AS infection (Jacobs, Radzioch and 
Stevenson, 1996). TNF may not have a direct cytotoxic effect on parasites because the 
recombinant molecule had no cytotoxic effect on P. yoelii (Taverne et a l,  1987) or P. 
falciparum  (Hviid et a i, 1988). Hence, TNF mediated parasite destruction may be 
through the activation of various cells such as macrophages, neutrophils, lymphocytes 
and endothelial cells (Stevenson, Nowotarski and Yap, 1990).
Raised levels of IL-1 and IL-6, both macrophage products, have been observed in the 
serum of patients infected with P. falciparum (Jakobsen et al., 1994) and both IL-1 and 
IL-6 can synergise with TNF in mediating the characteristic malarial fever 
(Kwiatkowski, 1995). IL-12 has been recently shown to mediate protection to P. 
chabaudi infection via IFNy and TNF induction of NO secretion (Stevenson et al.,
1995). IL-12 promotes the development of Thl mediated immunity and the production 
of IFNy by both NK cells and T cells (Trinchieri, 1995) and hence is an important 
mediator of cell mediated immunity. There is no direct evidence that IL-12 has a role 
during human malaria infection but it is proposed that it is important in the induction of 
cell mediated immunity during the acute phase of infection.
The Th2 associated cytokines IL-4 and IL-10 are important for the development of the 
humoral immunity to the asexual blood stages of malaria infection. Th2 clones derived 
from P. chabaudi infected mice protected recipient mice in an IL-4 and B cell dependent 
manner (Taylor-Robinson and Phillips, 1993). IL-4 is primarily responsible for the 
production of IgE (Finkelman et a i, 1990) and hence, elevated concentrations of IgE in 
the semm of P. falciparum infected individuals may reflect elevated IL-4 levels (Helmby 
et a l, 1996, Perlmann et a l, 1997). Elevated levels of IL-10 have been detected in the 
sera of patients infected with P. falciparum (Peyron et a l, 1994) and in mice challenged 
with a lethal P. yoelii infection (Kobayashi et a l, 1996). However, it is unclear if the 
elevated levels of IL-10 are detrimental because they are capable of inhibiting cellular 
immune responses or beneficial by reducing parasite-induced inflammatory responses.
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Malarial Pathology
The erythrocytic stage of malaria causes the pathology associated with the disease. 
Symptoms can range from mild fever and oedema to cerebral malaria. Malaria pathology 
depends upon the strain of parasite and the immune status of the host (White and Ho, 
1992). Non-immune individuals in endemic areas are at the most risk of developing 
severe pathology but this is rarely observed in individuals older than 7 years of age.
Although T cells are regarded as being crucial for the host response to malaria infection, 
they were first examined in the pathology of the disease. Wright (1968) proposed that 
thymic atrophy found in children suffering from Kwashiorker (a protein deficiency 
disease) explained the low incidence of cerebral manifestations in these children when 
they became infected. Neonatally thymectomised hamsters survived P. berghei infection 
much longer than control animals (Wright, 1968). P. berghei ANKA strain is regarded 
as a reasonable laboratory model for examining the pathology of malaria infection. P. 
berghei infection in some strains of mice, leads to the development of cerebral malaria. 
In vivo depletion of CD4+ T cells in P. berghei infected mice with an anti-CD4+ 
monoclonal antibody prevented the development of cerebral malaria without any direct 
effect on the parasitaemia (Hermsen et a l, 1997). Adoptive transfer of CD4+ CD8" T 
cells from mice with cerebral malaria exacerbated mortality in infected euthymie mice 
(Grau and Behr, 1994).
TNF has emerged as the crucial mediator in the development of cerebral malaria. 
Injection of anti-TNF antibodies prevented the onset of cerebral pathology in mice 
infected with P. berghei ANKA (Grau et a l, 1987). Overproduction of TNF appears to 
be mediated by CD4+ T cells (Grau et a l, 1987). IFNy is another T cell product which 
has been implicated in the pathology of malaria. Administration of neutralising anti-IFNy 
antibody reduced the incidence of cerebral symptoms in infected mice with P. berghei
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ANKA (Grau et al., 1989a). Susceptibility to cerebral malaria is accompanied by the up- 
regulation of IFNy gene (Grau and Behr, 1994) and the expression of IL-4 and TGFp, 
both antagonists of IFNy/TNF mediated responses, are significantly down-regulated in 
susceptible mice. Therefore the balance of Thl and Th2 cytokine production appears to 
be important in determining resistance or susceptibility. IFNy is capable of activating 
macrophages to produce TNF and can induce the up-regulation of TNF receptors 
(Pandita et al., 1992). Thus overproduction of IFNy and TNF leads to the activation of 
endothelial cells resulting in the up-regulation of many adhesion molecules such as 
ICAM-1 which have been implicated in the pathogenesis of cerebral malaria. Two recent 
studies have demonstrated the importance of IFNy, TNF and ICAM-1 in the 
development of pathology. IFNy receptor deficient mice following P. berghei ANKA 
infection did not develop cerebral malaria (Rudin et a l, 1997a). TNF ot/p deficient mice 
were completely resistant to P. berghei ANKA induced cerebral malaria (Rudin et a l, 
1997b). In both studies the normal up-regulation of ICAM-1 observed during P. berghei 
ANKA infection of normal mice is reduced in IFNy receptor deficient mice and TNF cx/p 
deficient mice, illustrating the importance of IFNy or TNF induced up-regulation of 
ICAM-1 expression to the development of cerebral malaria in this model.
It is well established that IFNy and TNF can synergise to stimulate the production of NO 
by macrophages (Drapier, Wietzerbin and Hibbs, 1988) but the role of NO in cerebral 
malaria remains unclear. Sequestered parasitised red blood cells which adhere to 
endothelial cells can induce the release of cytokines locally at high concentrations which 
will stimulate the production of NO. It has been proposed that NO could alter brain 
functions and possibly lead to coma (Clark, Rockett and Cowden, 1991). Another 
effector mechanism in the development of cerebral malaria could involve platelets (Grau 
et a l,  1991). Treatment of P. berghei ANKA infected mice with anti-LFA-1 monoclonal 
antibodies, even when mice developed neurological symptoms prevented cerebral 
lesions and death ensuing (Grau et a l,  1991, Falanga and Butcher, 1991). Platelets 
express LFA-1, the ligand for ICAM-1 expressed on endothelial cells and hence the
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adherence between platelets and endothelial cells may have an important role in 
mediating the microvascular damage observed in cerebral malaria.
P. berghei ANKA infection in mice has provided evidence that a Th 1 mediated response 
may be responsible for the development of cerebral malaria. Indeed, it has recently been 
proposed that Thl CD4+ T cells may initiate the inflammatory response to malaria 
infection in non-immune individuals and contribute to the pathology of the disease (Dick 
et ah, 1996). However, the same T cell subset has been shown to be critical in the 
control of P. chabaudi erythrocytic stages (Langhorne etal., 1989, Taylor-Robinson and 
Phillips, 1992). Therefore, it appears that the balance of Thl versus Th2 mediated 
responses is vital for the protection against malaria but overproduction of Thl mediated 
inflammatory responses is involved in the development of pathology.
Immunity to sexual stages
Immunity to the sexual stages of malaria infection is referred to as transmission blocking 
immunity because it will reduce the infectivity of the parasites to mosquitoes and hence, 
reduce transmission. There are two main mechanisms involved in immunity to the sexual 
stages. The first is mediated by non-specific factors such as TNF and IFNy which 
reduces the infectivity of gametocytes to mosquitoes (De Naotunne e ta l ,  1991). T cells 
isolated from individuals previously infected with P. falciparum  produce IFNy m vitro 
following stimulation with a gamete antigen (Good et a l ,  1987). PBMN cells from 
semi-immune individuals can be stimulated in vitro by a P. vivax antigen to produce 
TNF (Karunaweera et a l ,  1992). It is thought that NO may be the effector molecule 
stimulated by TNF and IFNy to reduce the infectivity of malaria sexual stages (Motard et
oA, 1993).
The second mechanism of transmission blocking immunity is mediated by a humoral 
response. Antibodies directed against surface antigens of gametes or gametocytes of
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malaria parasites can modify the infectivity to mosquitoes (Carter e ta l,  1988). There are 
various target antigens on the surface of the sexual stages which elicit a humoral 
response. Antibodies to the glutamate-rich repeat region of Pf 11.1 in the presence of 
complement were found to suppress transmission (Feng et a l,  1993) and it has been 
suggested that these antibodies can penetrate the membrane of a gametocyte infected 
erythrocyte because Pf 11.1 (also known as Pfs2400) is confined to the parasitophorous 
vacuolar membrane (Scherf et a l, 1992). Complement mediated lysis of gametes has 
also been shown with antibodies to Pfs230, a gamete surface antigen (Quakyi et a l ,  
1987, Healer e ta l,  1997). Pfs 48 and Pfs45 are an antigenically similar doublet, present 
in gametocytes and on gamete surfaces (Carter et al., 1990). The Pfs48/45 doub;et 
forms a non-covalent comples with Pfs230 (Kumar and Wizel, 1992). Antibodies to 
Pfs48/45 have transmission blocking activity and bind to known B cell epitopes present 
in the Pfs48/45 doublet (Kaslow, 1993). The binding of one monoclonal antibody to 
one epitope on Pfs48/45 appears to enhance the binding of monoclonal antibodies to 
Other epitopes, perhaps explaining why some monoclonal antibodies do not suppress 
transmission when tested alone but do block transmission when mixed together (Rener 
et a l,  1983). Pfs40 is another possible antigen which may be a target of antibodies 
which mediate transmission blocking immunity. (Rawlings and Kaslow, 1992). Pfs25 
is a zygote/early ookinete target antigen which in a recombinant form can induce 
antibodies which block transmission (Kaslow et a l ,  1991, Barr et a l ,  1991). The 
humoral response to sexual stage antigens appears to require the presence of complement 
and hence, for a successful transmission blocking vaccine it must induce antibody 
isotypes which fix complement efficiently such as IgGl or IgG3 (Healer et a l, 1997).
The strategy of developing a vaccine designed to prevent transmission is an attractive 
one. A transmission-blocking vaccine could be used to control or prevent the re- 
introduction of malaria in areas where malaria is currently absent. The transmission- 
blocking vaccine may be included in a multi-component malaria vaccine which would 
target several stages of the malaria life cycle. The problems of antigenic diversity and
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poor immunogenecity of gametocyte target antigens will have to be overcome to ensure 
the vaccine will induce the correct immune mechanisms which mediate transmission- 
blocking immunity.
Project aims
The development of a protective immune response to the asexual erythrocytic stage of P. 
chabaudi AS infection in mice has been the focus of extensive research within Professor 
Phillips' laboratory and others. It is well established that immunity to P. chabaudi 
infection in mice is mediated by a sequential Thl/Th2 response (Langhorne etal., 1989, 
Taylor-Robinson and Phillips, 1992). The cytokines secreted by each of these CD4+ T 
cell subsets are important mediators of the effector mechanism induced by either Thl or 
Th2 cells. Experiments were performed to define further the role of individual cytokines 
during a primary P. chabaudi infection using cytokine or cytokine receptor gene deficient 
mice. IFNy deficient, IL-4 deficient and IL-6 deficient mice were used in these studies 
which allowed the comparison of responses to P. chabaudi infection in mice with 
dysfunctional Th 1 responses (IFNyR deficient mice) or Th2 responses (IL-4 and IL-6 
deficient mice).
One characteristic of P. chabaudi is that it undergoes sequestration, similar to P. 
falciparum. The liver is a main site of sequestration during P. chabaudi infection in mice. 
It has been proposed that the liver may be a site of a protective immune response during 
experimental blood-stage malaria infection in mice (Dockrell, DeSouza and Playfair, 
1980). Extensive research has been performed on the immune response present in the 
liver against the intrahepatic stage of malaria following experimental infection initiated 
with sporozoites (reviewed in Suhrbier, 1991). Experiments were designed to 
investigate if there was a protective immune response present in the livers of mice during 
P. chabaudi infection. Lymphomyeloid cells were isolated from the liver of P. chabaudi 
infected mice during the course of infection and adoptive transfer studies were
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performed to see if the lymphomyeloid cells could protect recipient mice from a 
homologous challenge. The role of Kupffer cells (tissue macrophages resident in the 
liver) during a blood-stage infection was also investigated by depletion of the Kupffer 
cells in mice before and during a P. chabaudi infection.
The liver is the main site of acute phase protein synthesis and C-reactive protein has been 
shown to inhibit pre-erythrocytic stage parasite development (Pied et al., 1989). Studies 
were performed to determine if infection of mice with the erythrocytic stages of P. 
chabaudi induced an acute phase response, indicated by the production of SAP (the main 
acute phase protein of mice) and to determine the role, if any, of SAP during the course 
of a P. chabaudi infection.
During the process of sequestration, the parasite progresses from schizont to merozoite, 
the two stages of the parasites' life cycle which are probably the most vulnerable to 
immune attack from cytotoxic molecules such as NO. The liver is a site where potentially 
a high local concentration of NO may be produced. In vitro studies were performed, 
using a NO donor to determine if NO has a direct effect on the development of asexual 
erythrocytic stage malaria parasites.
The aim of the final section of studies presented in this thesis was to continue ongoing 
studies within the laboratory of Professor Phillips investigating the interaction of 
chemotherapy with protective immune mechanisms. Chloroquine has been previously 
shown to inhibit TNFa and IL-6 production by macrophages (Picot et a l ,  1993). In 
vitro studies were designed to determine if chloroquine could also inhibit NO production 
by macrophages.
4 4
Chapter Two 
Materials and Methods
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Mice
Inbred female NIH mice were used routinely for experimental infections. These mice 
were purchased from Harlan Oak (Bicester, UK) and kept in the University of Glasgow 
Joint Animal Facility at 22°C and 50-60% humidity. They were maintained in 12 hours 
artificial light from 0700 to 1900 and given pelleted CRM breeder diet (Labsure Ltd). 
Both food and water were given ad libitum.
Male IL-6 -/- (129SVJ)F2, IL-4 -/- (129SV x C57BL/6)F2, IL-4 -/- (B6 x 129SV)F2, 
IL-4 -/- (Balb/c)F2 , IFNy receptor -/- (129 SVEV)F2  were generated as described (Kopf 
et al., 1994, Kopf et al., 1993, Huang et a l ,  1993). These and wild-type control 
animals of the same strain combination were obtained from Professor J. Alexander, 
University of Strathclyde. The original breeding pairs were obtained from H. 
Bluethmann, Basel. The mice were bred and maintained in the animal facility at the 
University of Strathclyde in 12 hours artifical light (0700 to 1900) and given pelleted 
CRM breeder diet (Labsure Ltd.). Food and water were given ad libitum.
All mice used for experimental purposes were aged 6-12 weeks old and weighed 
approximately 25 grams.
Parasites
Plasmodium chabaudi chabaudi AS was originally isolated from adult thicket rats 
{Thamnomys rutilans) from La Maboke, Central African Republic, in 1969 by Professor 
David Walliker (University of Edinburgh). The strain was established in laboratory mice 
and cloned by limiting dilution (Walliker, Carter and Morgan, 1971). Stabilates of 
parasites, derived from the original AS parent parasite clone, were maintained by 
frequent cryopreservation and subpassage through mice. P. berghei K SPll parasites 
were maintained in a similar fashion to the P. chabaudi AS stabilates.
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Maintenance of P, chabaudi AS
For long-term preservation, vials of blood infected with P. chabaudi AS parent are kept 
in liquid N2  (-196°C). Infected blood was recovered for experimental use by immersion 
of the vial in a 37°C waterbath (Gallencamp). Once defrosted, an equal amount of a 
solution of 15% glucose added slowly dropwise with frequent mixing. The diluted 
blood was administered by i.p. or i.v. injection into one or two recipient naive mice 
from which the experimental groups were infected.
Maintenance of P. falciparum
P. falciparum erythrocytic stage parasites were cultured routinely by the in vitro culture 
method developed by Trager and Jenson (1976). The strain of P. falciparum  used was 
the JS strain which was culture adapted in Professor Phillips' laboratory in 1994 and 
originally derived from Malawi. Briefly, RPMI 1640 medium was prepared with 25 mM 
HEPES buffer at pH 7.2. Sodium bicarbonate was added to a final concentration of 
0.2% to form incomplete medium. Human serum, normally AB (heat-inactivated at 
60°C for 30 minutes) was added to a final concentration of 10%, forming complete 
malaria medium. P. falciparum stabilates were stored in liquid N2  until required. The 
stabilate was thawed and transferred to a 20 ml universal (Greiner). 0.5 ml of 4.5 % 
saline was added dropwise, followed by the addition of 3.5% saline dropwise in order 
to prevent lysis of the erythrocytes. The suspension was centrifuged for 5 minutes at 
250g and the supernatant discarded. The pellet was resuspended in incomplete malaria 
medium and washed twice (250g for 5 minutes). The final pellet was resuspended in 1.5 
ml of complete malaria medium and transferred to a sterile petri dish (35x10mm, 
Falcon). A few drops of washed, packed O group erythrocytes were added to the 
culture. The petri dish was placed in a candle jar and incubated at 37°C, 5% CO2 , 5-18% 
O2 . The medium was changed on a daily basis and the growth of the parasites was
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monitored by daily preparation of thin blood smears fixed with methanol and stained 
with Giemsa’s stain. The cultures were diluted on a regular basis by the addition of 
fresh erythrocytes and complete malaria medium.
Cryopreservation of blood
Infected blood at a parasitaemia of 5-10% containing ring stage parasites was collected 
by cardiac puncture into a syringe containing sodium heparin (1000 i.u./ml) in 
phosphate buffered saline (PBS, pH 7.2) as an anticoagulent at 10 i.u. heparin per ml of 
blood from mice, sacrificed in a CO2 chamber. The infected blood was diluted 1:1 with a 
solution of sorbitol-glycerol (38% glycerol, 2.9% sorbitol, 0.63% NaCl). 200ml 
aliquots were dispensed into 1.2 ml cryopreservation vials and labelled with the species 
of parasite and a code. The vials were snap frozen by immersing in liquid N2 and stored.
Challenge infections
The infected blood was obtained by cardiac puncture as described. The parasitaemia was 
determined from Giemsa’s stained thin blood smears. The blood was diluted in RPMI 
1640 medium to the required concentration. The mice were placed in a warm box at 
32°C for 10 minutes to allow vasodilation. Mice were infected with 1x10^ pRBCs 
(except where stated) administered i.v. as a 200|il inoculum using a 1ml syringe fitted 
with a 26 gauge needle. Experimental groups consisted of 5 or 6 mice.
Determination of parasitaemia
The parasitaemia of infected mice was determined by daily examination of Giemsa’s 
stained thin blood smears from peripheral blood. Samples were taken between 0900- 
1030 each day by piercing the tip of the tail with a lancet. A new lancet was used for 
each experimental group. A drop of blood was placed at one end of a glass microscope
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slide (BDH Ltd), smeared and allowed to dry at room temperature. The smear was fixed 
in 100% methanol (Analar, BDH Ltd) and then stained in Giemsa’s stain (1:10 of 
Giemsa’s stain in Giemsa’s phosphate buffer, pH 7.2, see appendix). The slide was 
then rinsed in tap water, air dried and examined under oil immersion using xlOO 
objective and xlO eyepiece lenses on a Leitz S.M. Lux binocular microscope. 
Parasitaemias were obtained by calculating the number of pRBCs from a total number of 
RBCs. At least 20 fields containing at least 200 erythrocytes were examined. Infections 
were considered sub-patent when no parasites were observed in 50 fields. The day of 
infection was termed day 0 and smears were normally taken from day 3 post infection 
until at least day 50 post infection.
Presentation of parasitaemic data
The course of infection of a group of mice was represented by plotting the geometric 
mean of the parasitaemia (mean logio of the number of pRBC in 10  ^RBC) or the mean 
percentage parasitaemia against time. For clarity's sake the standard deviation for each 
data point has been omitted but significant differences at specific timepoints are noted in 
the text.
Collection of serum
Mice were sacrificed as described and blood was obtained by cardiac puncture if large 
volumes of sera were required. The blood was allowed to clot, loosened from the edges 
of the container and allowed to contract overnight at room temperature. The serum was 
harvested and contaminating RBC were removed by centrifugation for 5 minutes at 
9000g. The sample was then labelled and stored at -20°C until required. Smaller 
samples were collected from tailbleeds of mice during the course of the infection and 
processed as for larger volumes. Immune serum from infected mice was collected from 
individual mice in different groups from day 0 onwards. Each mouse within an
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experimental group was bled on an equal number of occasions to ensure anaemia did not 
result from repeated bleeding of an individual mouse.
Irradiation of mice
Mice were irradiated with whole body gamma irradiation from a ^^Co source chamber 
(Nuclear Engineering) in the Department of Veterinary Physiology, University of 
Glasgow. The mice were exposed to sub-lethal irradiation (400 rads). Irradiation of 
recipient mice prior to adoptive transfer and challenge infection, occurred no earlier than 
24 hours previously.
Analysis of anti-malarial antibody production during infection
The slide IF AT procedure of Van Meirvenne et a l ,  (1975) modified by McLean, 
Pearson and Phillips, (1982) was used to determine total anti-malarial antibody levels in 
the serum of infected mice. The procedure is an adaptation of the indirect fluorescent 
antibody method described by Voiler (1964) and O’Neill and Johnson (1970).
To prepare malarial antigen slides, trophozoite/schizont stage parasites were harvested 
from infected mice as the source of antigen. Mice with a parasitaemia of 5-15% were 
bled and the infected blood was mixed with 10 i.u./ml heparinised PBS. The pRBCs 
were washed three times in 20 ml PBS (pH 7.2) by centrifugation (250g for 5 minutes) 
and resuspension. The pellet was then resuspended in PBS to a volume approximately 
equal to the original blood volume and used to prepare thin blood smears covering a 
microscope slide. The slides, following overnight dehydration in a desiccator, were 
wrapped in tissue, packed with silica gel and stored at -20°C until required (Manawadu 
and Voiler, 1978).
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For use in IF AT, the antigen slides were brought up to room temperature in a desiccator 
for 1-2 hours. The slides were fixed in absolute acetone (Rhone-Poulenc Ltd.) for 5 
minutes and air dried. An H series texpen (Deacon Laboratories) was then used to mark 
out reaction zones on the antigen slides which were allowed to dry for 1 hour in a 
dessicator. The slides were washed in successive coplin jars of PBS (pH 7.2), drained 
and rehydrated in a third jar of PBS (pH 7.2) for 15 minutes. 20pl of sample were 
applied to each reaction zone. Each slide contained a PBS sample, a negative serum and 
a hyperimmune serum as controls. Test samples were assayed at an initial dilution of 
1:20 and diluted until the sample became negative (see later). The slide was then 
incubated in a humid chamber at room temperature for 15 minutes. Excess sera was 
poured off and washed in PBS (pH 7.2) as described previously. The edges of the slide 
were dried and 1 ml of FITC-conjugated sheep anti-mouse IgG (SAPU) diluted 1:200 in 
PBS (pH 7.2) containing Evans Blue (1:10,000 w/v) (Merck) and incubated for 15 
minutes in the humid chamber. The Evans Blue acts as a counter-stain (El Nahel and 
Bray, 1963). The excess conjugate-PBS solution was poured off and the slide washed 
as above. A coverslip (22x55mm, Chance Propper Ltd) was mounted with a 1:1 
solution of non-fluorescent PBS:glycerol (Merck).
The slide was examined for fluorescence by a Leitz Ortholux linked to an Epson PX4 
computer through a Leitz MPV Compact 2 microscope photometer. The overhead u.v. 
source used was a Wotan HBO-50 mercury lamp with 2 x kP490 exciting filters and a 
TK 510 dichroic beam-splitting mirror and a k515 suppression filter. The slide was 
examined by a x600 water immersion objective. The endpoint titre of the sample was 
considered to be the last dilution of serum with which specific fluorescence was 
observed. The control zones of hyperimmune and normal serum and PBS (pH 7.2) 
were examined for comparison.
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Determination of total antibody production
Sera were collected as described previously and assayed for production of total IgGl, 
IgG2a or IgE antibodies. Capture anti-antibody monoclonals were diluted to the required 
concentration (anti-IgGl at 4|ig/ml and both anti-IgG2a and anti-IgE at 2pg/ml) in 
coating buffer (bicarbonate buffer, pH 8.2). 50|il of capture antibody were aliquoted per 
well on an Immunlon 4 ELISA plate (Dynatech) and incubated overnight at 4°C. The 
plate was washed twice with PBS/Tween (0.05%). For each wash, wells were filled 
with PBS/Tween and allowed to stand for at least one minute. The PBS/Tween was 
discarded and the plate was pounded onto paper towels after the final wash. The wells 
were then blocked by the addition of 200fxl/well of 10% FCS/PBS for one hour at 37°C. 
The plate was then washed twice as described above. Standards and samples were then 
added at 50fxl/well in the required concentration. Standard IgGl was added at Ipg/ml, 
IgG2a at 0.4pg/ml and IgE at Ipg/ml. The serum samples were diluted 1:100 for both 
IgGl and IgE assays and 1:500 for the IgG2a assay. The standards and samples were 
diluted in 10% FCS/PBS. The plate was washed four times as before. Detecting 
monoclonal antibodies were diluted in 10% FCS/PBS to the required concentration. 
Biotinylated anti-IgG2a and IgE were both used at 2|xg/ml. Biotinylated anti-IgGl k and 
1 chains were added in a 1:1 mixture at 2jig/ml each. 50pl of the respective detecting 
antibody were added per well and incubated at 37°C for one hour. The plate was washed 
six times in PBS/Tween and lOOpl of streptavidin-peroxidase (Sigma) at 2jig/ml were 
added per well. The plate was incubated at 37°C for one hour and then washed 8 times 
as before. lOOpl/well of 3,3%5,5’-tetramethyIbenzidine (TMB) substrate (KPL) was 
added and colour (blue) was allowed to develop (5-30 minutes). The plate was read at 
630 nm with a reference filter at 405 nm on a MRX plate reader (Dynatech). The results 
of the unknown samples were calculated against a standard curve of known 
concentrations plotted using Biolinx software (Dynatech).
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Preparation of spleen cell suspensions
Mice were sacrificed and the spleens removed aseptically. The spleens were disrupted 
mechanically using the plunger from a sterile syringe to disrupt the tissue through a 
sterile stainless steel sieve (mesh size 0.025 mm^) and collected in a 9 cm Petri dish 
(Sterlin) containing incomplete RPMI 1640 medium. The supernatant was harvested 
using a sterile Pasteur pipette after allowing sedimentation of tissue debris and clumps of 
cells. The spleen cells were washed in 10% Foetal Calf Serum (FCS) RPMI 1640 
medium (250g for 5 minutes) and then resuspended in 1 ml of 10% FCS RPMI 1640 
medium. Contaminating erythrocytes were lysed by incubating 1 ml of spleen cell 
suspension in 9 ml 0.83% Tris-ammonium chloride (Tris-NH^Cl, pH 7.4) for 5 minutes 
at room temperature. The spleen cell suspension was washed twice with 10% FCS 
RPMI 1640 medium at 250g for 5 minutes. The pellet was resuspended in 1 ml of 10% 
FCS RPMI medium for determination of cell viability and number.
Preparation of liver lymphomyeloid cells
Livers were excised from mice aseptically, cut into small pieces and digested in a 
warmed (37°C) solution of RPMI 1640 medium containing 50 U/ml collagenase 
(Sigma) for 30 minutes under constant agitation at 37°C. The suspension was washed in 
10% FCS RPMI 1640 medium (250g for 5 minutes). The remaining tissue was 
mechanically disrupted as previously described and washed in 10% FCS RPMI 1640 
medium (250g for 5 minutes). The cell suspension was then passed through a packed 
glass wool column to remove tissue debris and clumps of cells. After a further wash in 
10% FCS RPMI 1640 medium (250g for 5 minutes), the cell suspension was washed in 
100% FCS for 3 minutes at lOOg and then washed in 10% FCS RPMI 1640 medium as 
described above. The cell suspension was pipetted onto a petri dish and incubated at 
37°C, 5% CO2 for one hour to allow adherent cells to stick to the plastic. The non­
adherent cells were harvested and washed in 10% FCS RPMI 1640 medium.
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Contaminating erythrocytes were lysed by treating with Tris-NH^Cl and then washed in 
10% FCS RPMI 1640 medium. 6ml of the cell suspension were layered onto 3 ml 
NycoPrep™ in a 15 ml centrifuge tube and centrifuged at 600g for 15 minutes. The 
mononuclear cells formed a layer at the interface between the NycoPrep^^ and the 
medium with the hepatocytes found at the bottom of the centrifuge tube. The 
lymphomyeloid cells were harvested by a pasteur pipette and washed in 10% FCS 
RPMI 1640 medium. The final pellet of lymphomyeloid cells was resuspended in 1 ml 
of 10% FCS RPMI 1640 medium for determination of cell number and viability.
Preparation of peripheral blood mononuclear cells
Mice were sacrificed and bled as described previously. The whole blood was diluted by 
the addition of an equal volume of 0.9% sodium chloride and then separated by density 
centrifugation. 6 ml of the diluted blood were layered over 3 ml NycoPrep^^ 
(Nycomed) in a 15 ml centrifuge tube and centrifuged at 600g for 15 minutes. The 
peripheral blood mononuclear (PBMN) cells were harvested from the interface between 
the plasma layer and the NycoPrep™ solution using a sterile pasteur pipette. The PBMN 
cells were washed twice in 10% FCS RPMI 1640 medium and then resuspended in 1 ml 
of 10% FCS RPMI 1640 medium for determination of cell number and viability.
Preparation of murine splenic macrophages
Mice were sacrificed and the spleens removed aseptically. The spleens were 
mechanically disrupted as described previously and harvested in a Petri dish containing 
10% FCS RPMI 1640 medium. The spleen cell suspension was incubated at 37°C, 5% 
CO 2  for one hour to allow the macrophages to adhere to the plastic of the petri dish. 
Non-adherent cells were discarded and the adherent cell population was harvested using 
a pasteur pipette and washed three times with 10% FCS RPMI 1640 medium (250g for 
minutes). Contaminating erythrocytes were lysed with Tris-NH^Cl as described
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previously. The adherent cell suspension was washed twice with 10% FCS RPMI 1640 
medium as described above and then resuspended in 1 ml of 10% FCS RPMI 1640 
medium for determination of cell number and viability.
Preparation of peritoneal wash cell suspensions
Mice were sacrificed and 5 ml of sterile incomplete RPMI 1640 medium were injected 
into the peritoneal cavity. The abdomen of the mouse was gently massaged and the 
medium plus the peritoneal wash cells were harvested. The cell suspension was washed 
twice with 10% FCS RPMI 1640 medium and treated with Tris-NH^Cl if necessary. 
The final pellet of peritoneal wash cells were resuspended in 1 ml of 10% FCS RPMI 
1640 medium for determination of cell number and viability.
Determination of cell number and viability
The viability of cell preparations was measured by the trypan blue dye exclusion test. A 
dilution of 1:10 or 1:100 of cells in PBS (pH 7.2) was prepared and further diluted 1:1 
with a solution of 0.2% w/v trypan blue (Gurr, BDH Ltd) in PBS (pH 7.2). The 
suspension was mixed and incubated at room temperature for 2-3 minutes and then 
examined by phase contrast under oil immersion (xlOOO) on a light microscope. Viable 
cells remained clear, whereas dead cells were unable to exclude the dye and stained blue. 
The proportion of live to dead cells gave the percentage viability. At least 100 cells were 
counted.
To determine cell numbers, a 20jil aliquot of the 1:10 or 1:100 dilution of the cell 
suspension was pipetted into a haemocytometer (ARH) and the cells were counted under 
phase contrast (x400) on a light microscope. The calculation gave a total number cells 
per ml and from this the correct number of cells required for the experimental procedure 
was determined.
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In vivo depletion of Kupffer cells
Kupffer cells were depleted in mice by adaptation of the method described by Claasen 
and van Rooijen (1986). The liposomes were prepared by David Taylor (Department of 
Biochemistry, University of Glasgow). Briefly, 45mg phosphatidyl choline, 5 mg 
cholesterol, lOmg dicetyl phosphate and 5mg galactose ceramide (all from Sigma) were 
dissolved in 5ml chloroform (BDH) and 5ml methanol (Fisons Ltd). The solvent was 
removed by rotary evaporation under low vacuum at 37°C. The lipid film formed was 
once more removed by rotary evaporation under low vacuum at 37®C. The lipid film 
was then resuspended in 5ml PBS containing 945mg dichloromethylene diphosphonate 
(clodronate, Boehringer Mannheim) and rotated gently for 2 hours at 37®C. The 
suspension was then sonicated in a water bath sonicator (Ultrasonics Ltd) for 3 minutes 
and left at room temperature for 2 hours. This allowed liposome formation. The 
liposomes were washed by diluting to 36ml with PBS, centrifuged at 100,000g at 160C 
for 30 minutes. The supernatant was discarded and the liposomes were resuspended in 
20ml PBS. The concentration of liposome-entrapped clodronate was determined by the 
protocol described by Claasen and van Rooijen (1986). It was determined by David 
Taylor, that a regime of Sjig total lipid per gram body mass in a 200pl total volume 
given intravenously every 7 days, depleted the phagocytic activity of the liver most 
efficiently whilst the spleen remained unaffected.
Proliferative assays
Cell suspensions were prepared as described and adjusted to a final concentration of 
IxlO^/ml in 10% FCS RPMI 1640 medium. lOOpl of cel Is/well were aliquoted into 96 
well flat bottomed plate (Nunc) with lOOpl of either a crude P. chabaudi antigen 
(250|ig/ml), a normal RBC antigen (250jig/ml) and Con A (Ipg/m l, from stock 
solution of 1 mg/ml. Sigma). Control cultures were unstimulated. The plate was
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incubated at 37°C, 5% CO2  for 72 hours. Each well was pulsed with IpCi (37kBq) of 
^H-methyl-thymidine (ImCi/ml, specific activity 5Ci/mmol, Amersham) in a 10|il 
volume of 10% FCS RPMI 1640 medium and the plate was incubated for a further 18 
hours at 37°C. The wells were harvested with a semi-automatic cell harvester (Titertek, 
Flow) onto glass fibre filter paper (FG/A Whatman) and air-dried. Each filter disc, 
corresponding to a specific well, was transferred to plastic beta vials (LKB) and 2 ml 
non-aqueous scintillation fluid (Optiscint safe, LKB) added. Lids were placed on the 
insert tubes which were placed inside outer plastic scintillation vials. The beta activity 
present in each sample was detected during 1 minute using a scintillation counter (LKB 
Wallac 1219 Rackbeta) and the counts per minute (cpm) calculated using the Ultroterm 
III software package. All samples were set up in triplicate to enable an arithmetic mean 
of the cpm, representative of the proliferative response, to be calculated.
Preparation of parasitised and normal red blood cell lysates
For in vitro stimulation of cell suspensions soluble crude P. chabaudi antigens were 
prepared. P. chabaudi infected mice were kept under a reversed light-dark cycle 
(12hours of light between 1900-0700) conditions, and therefore schizogony, which 
under normal light condition would occur at around 0100 hour, occurred between 1100- 
1300. Mice at peak parasitaemia were sacrificed and bled as described before 
schizogony occurred. Erythrocytes containing mainly late ring stages were washed twice 
in 5% FCS RPMI 1640 medium at 250g for 5 minutes. The erythrocytes were 
resuspended to a 10% haematocrit and cultured in a petri dish containing complete 
malaria medium with the human serum replaced by FCS to at a final concentration of 
10%. Once the parasites had reached the schizont stage, monitored every 30 minutes by 
examination of Giemsa’s stained thin blood smears, the cells were washed in 5% FCS 
RPMI 1640 medium at 250g for 5 minutes and resuspended to the original volume in 
sterile PBS (pH 7.2). The suspension was filtered through a sterile Whatman CFl 1 
powdered cellulose paper column to remove leukocytes (B eu tier et al., 1976). The
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filtrate was washed in 5% FCS RPMI 1640 medium at 250g for 5 minutes and then 
resuspended in PBS (pH 7.2). 1ml of cell suspension was mixed with 1 ml of NaH2 P0 4  
and centrifuged at 9000g for 2 minutes. The supernatant was discarded and the process 
was repeated with 2 volumes of parasitised erythrocytes to 10 volumes NaH2 P 0 4  and 
centrifuged at 9000g for 5 minutes. The supernatant was discarded and the pellet was 
diluted in PBS. The cell suspension was freeze-thawed three times. Each cycle of 
freeze-thawing entailed snap freezing the preparation by plunging into liquid N2  then 
immediately defrosting the suspension in a 37°C waterbath (Gallencamp). The disrupted 
parasitised erythrocytes were centrifuged at 1500g for 10 minutes and the supernatant 
was collected. This was termed the pRBC lysate antigen and was stored at -20°C until 
required.
Non-infected blood was used to prepare the normal RBC (nRBC) lysate antigen. The 
procedure was as for the preparation of the pRBC lysate excluding the culturing of the 
parasitised erythrocytes.
Determination of total protein concentration
The total protein concentration of both the pRBC and nRBC lysate was determined by 
an adaptation of the method described by Smith et al., (1985). Standards of known 
protein concentrations were prepared by diluting 2 mg/ml stock BSA standard (Pierce 
Chemical Co.) in PBS to give a range from 1-25 |ig/ml. Dilutions of the unknown 
protein lysates were prepared in PBS (1:100,1:1000, 1:10000). lOOjil/well of standards 
and samples were pipetted into a 96 well plate. lOOjil of Coomassie Protein Assay 
Reagent (Pierce) was added to each well. The plate was read at 570 nm on a MRX plate 
reader and the protein concentration was determined by plotting the results against the 
curve of the protein standards using Biolinx software (Dynatech).
Cytological analysis of cell suspensions
Cell suspensions were prepared as described and adjusted to a final volume of 10^ 
cells/ml in 10% FCS RPMI 1640 medium. 500|il of the cell suspension was aliquoted 
into the sample chamber. A microscope slide with a filter card covering the slide except 
for two circular areas (6 mm diameter, Shandon) was placed against the sample chamber 
and placed in a Shandon cytofuge. The samples were centrifuged at 4000g for 10 
minutes. A smear of the cells was formed on the microscope slide in the uncovered 
areas. The slide was air-dried, fixed in methanol and stained with Giemsa's stain. The 
cells were counted under oil immersion (xlOOO). At least 500 cells per slide were 
counted.
Determination of serum amyloid P production
Sera was harvested as described and assayed for the production of serum amyloid P 
(SAP). SAP standards were prepared in 1% bovine serum albumin (BSA) in PBS to 
cover a range of 1.5-50pg/ml (original stock SAP was lOOpg/ml, Calbiochem) and 
stored at -20^C until required. The negative control was 1% BSA/PBS alone. Samples 
and standards were diluted 1:100 in coating buffer (pH 9.6) and lOOjil/well was 
aliquoted onto an Immunlon 2 96 well plate (Dynatech). The plate was covered and 
incubated overnight at room temperature with continuous gentle shaking. The excess 
samples and standards were decanted and the non-specific binding sites were blocked 
with 10% Marvel/PBS and incubated at room temperature for one hour under constant 
agitation. The excess blocking agent was discarded and the plate was washed three times 
with PBS/Tween (0.05%). For each wash, wells were filled with PBS/Tween and 
allowed to stand for 3 minutes prior to the PBS/Tween being discarded. After the final 
wash, the plate was pounded onto paper towels. lOOpl of a 1:4000 dilution of rabbit 
anti-murine SAP antibody (Calbiochem) in 1% BSA/PBS/Tween were added to each 
well and incubated at room temperature for 90 minutes. Excess antibody was decanted
59
and the plate was washed 3 times as before. 150)il of TMB substrate (KPL) was added 
to each well and the plate was covered in tinfoil and incubated for 15 minutes at room 
temperature. The reaction was then stopped by the addition of 50|il of sulphuric acid 
(H2SO4) to each well. The absorbance was read at 450 nm on a MRX plate reader 
(Dynatech) and concentrations of unknown samples were calculated against a plot of the 
standard curve using Biolinx software (Dynatech).
Isolation of SAP from immune sera
SAP was isolated from immune sera by an adaptation of the technique used by Siripont, 
Tebo and Mortensen, (1988). Immune sera were pooled from P. chabaudi infected mice 
at day 11 post infection (approximately when peak production of SAP occurred). The 
pooled serum was passed through a column containing a 5 ml packed gel of o- 
phosphorylethanolamine-agarose (Sigma) which was equilibrated with 0.02M Tris- 
buffered (pH 7.4) saline containing 5 mM Ca^^. Bound SAP was eluted with Tris- 
buffered saline containing 5mM EDTA. The fractions collected were analysed for SAP 
content by the direct quantitative ELISA utilised to monitor SAP levels in serum. The 
fraction containing the eluted SAP was dialysed against PBS to ensure it was suitable 
for in vitro use. The sample containing the eluted SAP was aliquoted into standard 
dialysis tubing and placed in a beaker containing a 1:10 dilution of PBS (pH 7.2). The 
PBS was changed after several hours and the beaker was covered and incubated at 4°C 
overnight under constant stirring. The sample was then assayed for SAP content by the 
direct quantitative ELISA described.
The effect of SAP on the growth of malaria parasites in vitro
To determine if SAP had direct activity against malaria parasites, P. falciparum  and P. 
chabaudi were cultured in the presence of SAP (100-5000 fig/ml) isolated from immune 
serum by the technique described and chloroquine (0.1-10 pg/ml) was used as a control.
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The effect on the growth of either parasite was determined by the uptake of tritiated 
hypoxanthine. For P. falciparum, the cultures were incubated for 48 hours at 37®C 
under the conditions previously described and the radioactive tracer was added 
(IpCi/well). The plate was incubated for a further 18 hours and harvested as previously 
described. The effect on growth was determined as before and expressed as counts per 
minute.
The effect of SAP on the proliferative response of splenocytes
To determine if SAP had an effect on the proliferative response of splenocytes, isolated 
SAP (lOOOpg/ml) was added to cultures of splenocytes (5x10^ cells/ml), prepared as 
before from a naive mouse, at the same time as stimulation with Con A or LPS (both at 
5pg/ml). The cultures were incubated at 37®C for 72 hours and tritiated thymidine 
(IpCi/well) was added. The cultures were incubated for a further 18 hours and 
harvested as before. The effect on growth was determined as described previously and 
plotted as counts per minute.
The effect of NO on the growth of malaria parasites in vitro
The effect of NO on the development of malaria parasites in vitro was determined using 
s-nitroso-acetyl penicillamine (SNAP) (Calbiochem), a NO donor. P. falciparum  was 
obtained from the continuous cultures previously described. The parasitaemia used was 
0.5% and lOOpl of parasites at 5% haematocrit was pipetted into each well of a sterile 96 
well plate (Costar). SNAP was freshly prepared in complete malaria medium to give a 
range of concentrations from 45-363|iM. Controls included complete malaria medium, 
D-penicillamine (to control for SNAP) and sodium nitrite (to control for nitrite 
production), both at the same range of concentrations as SNAP. The cultures were 
incubated at 37°C under the conditions already described for the maintenance of P. 
falciparum  cultures. Growth of the parasite was measured by the uptake of tritiated
hypoxanthine (specific activity 28 Ci/mmol, stock ImCi/ml, Amersham) added at 
l|iCi/well in a lOpI volume (in complete malaria medium). The wells were harvested, at 
the indicated time after the addition of the radioactive tracer (see Chapter 8), using the 
semi-automatic cell harvester (Titertek, Flow) previously described. The cpm were 
determined as before and an arithmetic mean growth calculated.
For the experiments using the murine malarias P. chabaiidi or P. berghei, the parasites 
were obtained from infected mice as described and diluted to the required parasitaemia 
using normal mouse red blood cells. The assay was performed as described for P. 
falciparum except that the duration of the experiment was for 24 hours.
Determination of the effect of chloroquine on NO production by 
macrophages in vitro
An in vitro assay was designed to examine the effect of chloroquine on nitric oxide (NO) 
production by macrophages in vitro. Three types of macrophages were used. The 
macrophage-like cell line J774 was continuously cultured under standard cell culture 
conditions (5% CO2 , 37°C) in 10% FCS RPMI 1640 medium until required. The 
splenic macrophages and peritoneal wash cells were obtained from naive mice as 
described previously. Chloroquine (Chloroquine diphosphate salt, Sigma) standard 
solutions containing 1, 10, 100 or lOOOpM chloroquine in 10% FCS RPMI 1640 
medium were prepared and stored at -20°C until required. The cells were aliquoted into 
24 well plates (Greiner) at a concentration of 5x10^ cells/ml in 1 ml of 10% FCS RPMI 
1640 medium. The cells were treated with chloroquine at the concentrations indicated at 
-24, -2, 0, +2 and 4-6  (or +24) hours with respect to stimulation of the cells with IFNg 
(100 U/ml, stock: 200000 U/ml , Sigma) and LPS (25 ng/ml, stock: 1 mg/ml. Sigma). 
The cultures were incubated for 48 hours at 5% CO2 , 37°C and then the culture 
supernatants were assayed for nitrite concentration as an indication of NO production.
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Determination of NO production
The level of NO production in vitro was determined by the measurement of the end 
product nitrite using the Griess reaction described by Migliorini et al., (1991). Nitrite 
standards were prepared by diluting a 10 “ mM stock solution of sodium nitrite in 10% 
FCS RPMI 1640 medium to give a range of 5-300p.M nitrite. 60 |il of culture 
supernatant or standard was added to 60 pi of Griess solution (1:1 mix of 0.1% a- 
napthylamine, Sigma and 1% sulphanilamide in 5% phosphoric acid, Sigma) in a 
individual well of a 96 well plate (Corning). The plate was incubated for 10 minutes at 
room temperature and read at 540 nm on a MRX plate reader. The concentration of 
nitrite for the unkown samples was calculated against a plot of the standard curve using 
Biolinx software (Dynatech).
Statistical analysis
Results are expressed as means±lSDM and group data were compared using a 
Student's t -test. A significant result was considered to be when the value of p< 0.05.
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Chapter Three
The liver: a possible site of a protective immune response 
against the asexual erythrocytic stage of P. chabaudi
infection.
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Introduction
The presence of immunocompetent cells in the liver has been reported in parasitic, viral 
and bacterial infections (Khan and Vanderberg, 1992, Koziel et al., 1992, Goossens, 
Jouin and Milon, 1991). Recruitment of peripheral blood mononuclear phagocytes to the 
liver during Listeria monocytogenes infection (North, 1970) has shown the importance 
of this non-lymphoid organ. This process of recruitment during L. monocytogenes 
infection has now been shown to fall into three distinct phases (Goossens, Jouin and 
Milon, 1991). There is an initial recruitment of lymphomeyloid cells which is followed 
by recruitment of myelomonocytic cells and then CD8+ T cells. The hypothesis that the 
liver is an important organ of the immune system, is gathering momentum. The 
anatomical position of the liver means it is in contact with several different 
immunological environments including the spleen, gut and lymphatic system and may be 
involved in a protective immune response to several different pathogens. The presence 
of immunocompetent cells in the liver may not only be due to recruitment from the 
peripheral blood, spleen or bone marrow, but may also be due to expansion of 
intrahepatic lymphomyeloid cells. Recently, the liver has been described as a meeting 
place for thymus-dependent circulating T cells and thymus-independent T cells which 
express NK cell markers (Crispe and Mehal, 1996). The two sets of cells are 
differentiated by expression markers. One subpopulation believed to derive from the 
circulating T cell pool is a mixture of CD8+, CD4+ and CD4" CD8' (double negative) 
cells while the other subpopulation of cells express an intermediate level of TCRap and 
also N K l.l. The population of T cells expressing N K l.l is not only restricted to the 
liver but is also found in the bone marrow and thymus (Watanabe et al., 1995), and the 
numbers of these cells have been shown to increase in response to IL-12 and TNFa 
(Crispe and Mehal, 1996). Therefore, an active immune response in the liver may 
involve not only recruitment of cells but expansion of intrahepatic lymphomyeloid cells.
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Immunity to the intrahepatic stages of malaria provides one of the best examples of a 
protective immune response in the liver to a pathogen (refer to Introduction for a review 
of immunity to pre-erythrocytic stages of malaria). Both CD4+ and CD8+ T cells have 
been shown to mediate the immune response to pre-erythrocytic stages of various 
malaria species (Renia et al., 1993, Suhrbier, 1991). The intrahepatic form of the 
parasite can be a target of antibodies, cytokines, phagocytic and cytotoxic cells (Mazier 
et al., 1988) and non-specific factors such as acute phase proteins (Mazier et a i,  1988). 
Strong immune responses can be induced to the pre-erythrocytic stages of malaria by 
vaccination with irradiated sporozoites (Hoffman and Franke, 1994). Cytological 
analysis of leukocytes isolated from livers following a sporozoite-induced P. yoelii 
malaria infection in mice revealed that after the clearance of the subsequent erythrocytic 
stage, CD4+ and CD8“^  T cells and B cells were the (pre)dominant cells present during a 
primary infection (Faure et al., 1994). Following challenge of mice with a second 
sporozoite inoculation one week after clearing the erythrocytic stage of infection, the 
composition of the leukocytes changed to CD3+CD4"CD8* cells and polymorphonuclear 
cells (Faure et a l, 1994).
The role of the liver in the immune response to the erythrocytic stage of malaria infection 
has largely been ignored. However, the extensively characterised response to the exo- 
erythrocytic stage has demonstrated there are several immune effector mechanisms 
present in the liver which have the potential to be directed against erythrocytic stage 
parasites. Dockrell and colleagues proposed an important role for the liver in the 
recovery from blood stage infection (Dockrell, De Souza and Playfair, 1980). Mice 
vaccinated with fixed parasitised RBCs of P. yoelii and Bordetella pertussis can clear a 
normally lethal challenge of P. yoelii and this is associated with an increase in the 
number of cells present in the liver and an increase in the uptake of parasitised 
erythrocytes by the liver (Dockrell, De Souza and Playfair, 1980, Playfair and De 
Souza, 1982). Activation of Kupffer cells has also been reported to occur during blood- 
stage infection (Dockrell, De Souza and Playfair, 1980) and these cells are involved in
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phagocytosis of parasitised erythrocytes but also may act as antigen presenting cells 
(Suss et a l, 1988). Increased retention or trapping of lymphocytes in the liver has been 
demonstrated around peak parasitaemia during P. chabaudi infection in mice 
(Kumararatne et al., 1987) and increased migration of leukocytes to the livers of mice 
vaccinated against P. yoelii with a crude P. yoelii parasitised erythrocyte lysate and 
Bordetella pertussis has been observed (Playfair et al., 1979). Concomitantly, there is a 
decrease in the retention of lymphocytes by spleens of P. chabaudi infected mice 
(Kumararatne et al., 1987) suggesting a redistribution of lymphocytes occurs at peak 
parasitaemia which results in an exclusion of lymphocytes from the spleen.
One characteristic of the P. chabaudi model is that mature parasitised erythrocytes stop 
circulating in the peripheral blood and cytoadhere to the endothelial linings of the 
sinusoids in the liver and also endothelial linings of the spleen (Cox, Semoff and 
Hommel, 1987). Sequestration is traditionally thought of as being a mechanism which 
the parasite undergoes to avoid splenic filtration which has been demonstrated during 
both lethal and non-lethal P. yoelii infection (Weiss, 1990) and involves splenic barrier 
cells. Therefore, it is unclear why late stage P. chabaudi parasitised erythrocytes would 
sequester to the spleen. It is unknown where in the spleen the parasitised erythrocyte 
cytoadheres to and hence the parasitised erythrocyte may avoid splenic clearance by 
undergoing schizogony before reaching the splenic barrier cells. However, 
cytoadherence of the parasitised erythrocyte to endothelial cells may induce a localised 
immune response, with the presence of parasite-derived antigens on the surface of the 
parasitised erythrocyte being a possible target. During schizogony, merozoites, toxins 
and cell debris are released into the bloodstream. The merozoite form of the parasite may 
be the most vulnerable to immune attack because it is extracellular. The release of 
parasite derived toxins and cellular debris following schizogony may provide a strong 
antigenic stimulus thereby inducing an intense localised response. The observation that 
there is an increase in the numbers of lymphomyeloid cells present in the liver around 
peak parasitaemia compared with a reduction in the numbers present in the spleen
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(Kum araratne et a l ,  1987) suggests different immune responses may be 
compartmentalised to each of these sites. This was investigated by firstly isolating 
lymphomyeloid cells from livers of mice during the acute phase of P. chabaudi 
infection. Adoptive transfer studies were performed to determine if the lymphomyeloid 
cells isolated from the liver could confer protection to a P. chabaudi challenge. The 
degree of protection mediated by these cells was compared with splenocytes isolated at 
the same time in the acute phase of infection. Preliminary investigations into the role of 
Kupffer cells by depletion in vivo using liposome-encapsulated clodronate further 
defined the importance of the liver during the asexual blood-stage of a malaria infection.
Results
Isolation of lymphomyeloid cells from livers of P. chabaudi infected 
mice
Lymphomyeloid (LM) cells were isolated from livers of P. chabaudi infected mice by 
the protocol described in Materials and Methods. NIH mice were infected with 1x10^ 
pRBC of P. chabaudi and two mice were killed at each of the time points indicated. The 
number of LM cells harvested from each liver was determined and a mean value was 
calculated. Peak numbers of LM cells were isolated at day 10 post infection with a mean 
value of 20x10^ cells per liver (Figure 3.1): this was two days after the peak of the 
parasitaemia.
Adoptive transfer of isolated LM cells
Adoptive transfer studies were performed to determine if LM cells, isolated from the 
livers of infected mice could confer protection against a P. chabaudi challenge. LM cells 
were isolated, as before, from donor NIH mice infected with 1x10$ pRBCs of P. 
chabaudi, at day 11 post infection. Simultaneously, non-adherent splenocytes and
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Figure 3.1. Extraction of lymphomyeloid cells (LM) from the livers of 
P. chabaudi infected mice. Mice were infected with 1x10^ pRBCs of P. 
chabaudi. Two mice were sacrificed at each timepoint and the mean number 
of cells per liver (xlO^) calculated.
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peripheral blood mononuclear (PBMN) cells were harvested by standard isolation 
techniques (described in Material and Methods) from the same donor mice. Splenocytes 
were also harvested from naive NIH mice, to enable the study to include cells whieh had 
no prior exposure to malaria infection. Recipient NIH mice were sub-lethally irradiated 
(400 Rads) 24 hours before the transfer of cells. Groups of six mice received either 
3x10^ LM cells, 3x10^ PBMN cells, 1x10^ immune splenocytes or 1x10^ naive 
splenocytes. The mice were subsequently infected with 1x10^ pRBCs of P. chabaudi. 
The group of mice receiving the LM cells were significantly protected at peak 
parasitaemia when compared with control groups (Figure 3.2). No mortality was 
observed in any of the recipient groups. At peak parasitaemia, the control groups had 
similar values although the mice receiving the PBMN cells had an earlier peak of 
parasitaemia and subsequently cleared the primary parasitaemia first. No differences 
were observed between the groups after the primary parasitaemia, with the parasitaemia 
remaining sub-patent during the time observed (Figure 3.2). Attempts were made to 
expand the adoptive transfer studies to include LM cells from the livers of non-infected 
mice but repeat experiments failed to demonstrate any protective effect mediated by the 
adoptive transfer of, not only the immune LM cells but the immune splenic cells. On two 
occasions the challenge infection did not establish within the recipient mice. Hence, the 
data obtained for the adoptive transfer of immune LM cells isolated form the livers of P. 
chabaudi infected mice has to be considered as preliminary data. Further repeats of the 
adoptive transfer studies are planned.
The effect of Kupffer cell depletion on the course of P. chabaudi 
infection
A preliminary experiment was performed to investigate the role of the Kupffer cell 
during the asexual-blood stage of P. chabaudi infection. Kupffer cells were depleted by 
treatment of NIH mice with liposome-encapsulated clodronate before infection with 
1x10^ pRBCs of P. chabaudi and once every 7 days thereafter for the duration of the
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Figure 3.2.1. Adoptive transfer of liver LM cells, isolated at day LI of a 
P. c/iabaudiinfection, to irradiated recipients, significantly reduced the peak 
of the primary parasitaemia (p<0.04) to an homologous challenge compared 
with the transfer of immune splenocytes isolated concomitantly. Each group
of recipients consisted of six mice and were challenged with IxKP pRBCs 
of P. chabaiidi. The mean log parasitaemia A) and mean percentage 
parasitaemia B) are presented.
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infection to prevent Kupffer cell replenishment (Refer to Materials and Methods). 
Control NIH mice were infected with 10^ pRBCS and given no treatment. The mice 
depleted of Kupffer cells had a significantly exacerbated peak of parasitaemia compared 
with the control group (p values for day 9, 10 11 and 12 post infection were all < 0.03). 
No significant differences were observed during the recrudescence parasitaemia between 
the two groups (Figure 3.3).
D iscussion
The demonstration that there is an increase in the number of LM cells present in the liver 
at a point where the primary parasitaemia of a P. chabaudi infection is going into 
remission, confirms earlier observations (Kumararatne et a i, 1987). The present study, 
unlike others (Playfair and De Souza, 1982, Kumararatne et a i,  1987) does not involve 
administration of radiolabelled cells and tracking of the homing patterns of these cells 
during infection and hence, identifies that the liver is a site of a possible immune 
response to the acute phase of a P. chabaudi infection. It is not clear if the increase in the 
number of cells isolated from the liver is a consequence of increased recruitment or an 
expansion of an intrahepatic LM cell population. Peak numbers of cells were isolated 
one or two days after the peak of the primary parasitaemia suggesting that these cells 
might be involved in the immune response at this time of infection. Adoptive transfer of 
LM cells isolated from the liver at this time conferred protection to irradiated, naive 
recipient mice against an homologous challenge. The protection observed was 
significantly greater than that mediated by splenocytes from the same time of infection 
(day 11 post infection). The LM cells significantly reduced the peak of the primary 
parasitaemia compared to the control groups indicating that the protection conferred 
resulted in an increase in anti-parasite effector mechanisms. During a preliminary 
experiment, LM cells isolated from livers at day 11 post infection were able, upon 
adoptive transfer, to delay mortality observed in irradiated, naive recipient mice, 
following a P. chabaudi challenge (data not shown). The cause of death in all groups of
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Figure 3.2.2. Adoptive transfer of liver LM cells, isolated at day 11 of a 
P. chabaudi infection, to irradiated recipients, significantly reduced the 
peak of the primary parasitaemia (p<0.04) to an homologous challenge 
compared with the transfer of PBMN cells isolated concomitantly. Each 
group of recipients consisted of six mice and were challenged with 1x10^ 
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parasitaemia B) are presented.
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this preliminary experiment appeared to be due to the fulminating parasitaemia, 
suggesting the liver LM cells were capable of suppressing parasite growth for a period 
but were able only to delay the time of death.
Previous studies have shown an increase in numbers of cells present in the liver 
(Kumararatne et a l, 1987) and associated this increase with protection (Dockrell, De 
Souza and Playfair, 1980) but the adoptive transfer studies reported here demonstrate 
the LM cells present in the liver during the acute phase of P. chabaudi infection are 
involved in a protective immune response against the blood-stage of infection. It has 
been recently suggested that the liver is a site where T cells migrate too in order to 
apoptose (Crispe and Mehal, 1996). The LM cells isolated from the liver are unlikely to 
be undergoing apoptosis because the adoptive transfer studies demonstrate that they are 
capable of mediating a protective immune response.
To understand what type of effector mechanism may be mediated by the LM cells 
present in the liver which possibly results in parasite destruction, it is important to know 
the types of cells which participate in this response. Lymphomyeloid cells isolated from 
the liver have been shown to contain unusual lymphocytes. The y5 T cell subset, which 
have been reported to expand during malaria infection (van der Heyde et a i ,  1993b), 
appear to be a minor ingredient of the liver LM cells along with B cells, although this 
may be dependent upon the isolation technique (Crispe and Mehal, 1996). It is mainly T 
cells that have been characterised in cells isolated from the liver. A mixture of CD8+, 
CD4+ and CD4" CD8" T cells along with a subset termed N K l.l T cells, which express 
TCRaP at an intermediate level and IL-2 receptor along with the natural killer 1.1 cell 
marker, have been shown to be present in the intrahepatic T cell pool (Ohteki and 
MacDonald, 1994, Crispe and Mehal, 1996). The N K l.l T cells have an unusual 
distribution with a high frequency of cells present in the liver, bone marrow and thymus 
suggesting that they may exert their functions in specialised locations (Vicari and 
Zlotnik, 1996). The morphology of these cells indicates that they are
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Figure 3.2.3. Adoptive transfer of liver LM cells, isolated at day LI of a 
P. chabaudi infection, to irradiated recipients, significantly reduced the peak 
of the primary parasitaemia (p<0.04) to an homologous challenge compared 
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intermediate between T cells and NK cells (Watanabe et a l, 1995). NK 1.1 T cells have 
been shown to produce both IL-4 and IFNy (Arase, Arase and Saito, 1996) and can 
differentiate into cytotoxic effector cells upon activation with IL-2, with the ability to kill 
targets of NK cells (Koyasu, 1994). The function of this subset of T cells is unclear but 
because of their cytokine secretion profile and potential cytotoxic ability, they may be 
involved in not only directing the CD4+ T helper cell mediated responses through IFNy 
or IL-4 secretion but may also participate in parasite destruction within the liver.
Cytofluorometric analysis of the isolated LM cells during the acute phase of P. chabaudi 
infection, would enable identification of the eells present within this population and 
could be compared with changes in the lymphocyte subsets in the spleen. This would 
give a direct comparison between the lymphocyte populations within the liver and 
spleen, identifying the immune responses which are functional in both these organs 
during a primary P. chabaudi infection and perhaps reveal why LM cells from the liver 
confer significantly better protection than splenocytes upon adoptive transfer to recipient 
mice receiving an homologous challenge of P. chabaudi. However, it must be noted that 
at day 11 post infection, when the cells were isolated from both the spleen and liver, it 
has been reported that there is an exclusion of lymphocytes from the spleen and 
increased retention of lymphocytes in the liver (Kumararatne et al., 1987), perhaps 
reflecting a change in the site of the protective immune response at this time point in the 
infection. Liver LM cells have been previously characterised by cytofluorometric 
analysis following infection of mice with P. yoelii sporozoites (Faure et al., 1994). The 
majority of cells identified were lymphoid, with a rapid increase in CD4+, CD8+ and 
CD4" CD8" T cells plus B cells (Faure et al., 1994). The increase in cell numbers in the 
livers was persistent throughout the subsequent blood stage infection following 
inoculation with sporozoites of P. yoelii. Cytological analysis of the same LM cells 
revealed that polymorphonuclear (PMN) cells and macrophage/monocytes were also 
present in high numbers (Faure et al., 1994). Liver LM cells isolated from mice during a 
primary P. chabaudi infection and analysed cytologically, were found to have an
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increase in lymphoid, monocyte and PMN cell populations (see Chapter 6 and 7). The 
absence of this increase, most notably in the monocyte and PMN cells, observed in 
IFNy receptor and IL-4 gene deficient mice was associated with an exacerbation of the 
primary parasitaemia (see Chapter 6 and 7). Therefore, the recruitment of monocytes 
and PMN cells appears to be crucial to the protective effector mechanisms in the liver 
during the acute phase of P. chabaudi infection.
It has been estimated that more than half the circulating monocytes are destined to 
become the resident macrophages in the liver, known as Kupffer cells (Crofton, 
Diesselhoff-den Dulk and Van Furth, 1978). These cells can phagocytose parasitised 
erythrocytes (Shear, Nussenzweig and Bianco, 1979) and may act as antigen-presenting 
cells (Faure et al., 1994). Hence, Kupffer cells appear to have a pivotal role in the 
immune response in the liver. Antigen presentation to T cells will result in an expansion 
of intrahepatic T cells or enhanced recruitment which will stimulate effector cells present 
in the liver, including Kupffer cells, to secrete various inflammatory cytokines and toxic 
molecules such as NO, associated with activated macrophages. When Kupffer cells 
were depleted in vivo, a significant exacerbation of the primary peak of parasitaemia was 
observed. This demonstrates the importance of Kupffer cells during the acute phase of 
infection but also illustrates that control of the primary parasitaemia includes effector 
mechanisms which are Kupffer cell independent. It must be noted however, that this 
observation is preliminary and requires further investigation.
Malaria is a very dynamic, systemic infection which induces the production of various 
inflammatory cytokines (Bate, Taverne and Playfair, 1988, Kwiatkowski et a l,  1990). 
Associated with the production of these cytokines, such as IL-1 and TN Fa, is the 
activation of endothelial cells and the up-regulation of adhesion molecules (Schofield et 
a l, 1996). The presence of the parasite induces this inflammatory environment but both 
the parasite and the immune system utilise it, either in the process of parasite 
sequestration or the recruitment of immunocompetent cells to various sites. In the P.
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chabaudi model, a major site of sequestration, as already mentioned, is the liver (Cox, 
Semoff and Hommel, 1987). This process is linked to antigenic variation and the 
establishment of chronic infection (Gilks, Walliker and Newbold, 1990) but it is unclear 
if sequestration is required to induce the recruitment of LM cells to the liver. The 
cytoadherence of the mature parasitised erythrocyte, in an environment which has the 
potential to mediate a protective immune response, provides a good opportunity for anti­
parasite effector mechanisms. Analysis of LM cells present in the liver during infection 
with a non-sequestering clone of P. chabaudi would determine if sequestration is 
necessary to induce the increase in the numbers of LM cells present and the proposed 
protective effector mechanism occurring in the liver during a primary P. chabaudi 
infection.
The liver is potentially a site of parasite destruction during the acute phase of a P. 
chabaudi infection. An increase in the numbers of LM cells present in the liver coincides 
with the peak of the primary parasitaemia and these cells were able to confer protection 
to an homologous challenge. The importance of the liver was further defined by the 
observation that depletion of Kupffer cells resulted in an exacerbation of the primary 
patent parasitaemia. Identification of the cell types present in the isolated LM cells would 
elucidate the type of immune response which potentially is involved in parasite 
destruction during the asexual erythrocytic stage of P. chabaudi infection. Further 
investigations of the LM cells present in the liver during a P. chabaudi infection are 
planned. Cytofluorometric analysis is already underway with the aim of identifying the 
composition of the LM cells through the expression of surface molecules. Initially the 
work has focused on lymphoid cells, where both B and T cells have been identified, 
although this work will be expanded to include CD3+CD4"CD8" T cells and NK cells. 
As already mentioned, repeat studies of the adoptive transfer experiments are planned, 
including LM cells isolated from the liver of naive mice as a further control.
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Chapter Four
The role of serum amyloid P during blood-stage malaria
infection .
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Introduction
A rapid inflammatory response is an essential part of the host’s non-specific response to 
injury or microbial infection. This is characterised by fever and an increase in the 
synthesis in the liver of serum proteins termed acute phase reactants (APR). The major 
APR in humans is C-Reactive protein (CRP), originally named for its calcium dependent 
binding to the C-polysaccharide of pneumococcal bacteria (Volanakis and Kaplan, 
1971). In mice, CRP is present at very low concentrations in the serum and has not yet 
been identified as an APR in mice (Pepys et al., 1978, Le, Muller and Mortensen, 
1982). Serum amyloid P (SAP) is the main APR in mice (Pepys et al., 1979) and is a 
molecular homologue of CRP (Pepys et al., 1978, Levo, Frangione and Franklin, 
1977). Both CRP and SAP are pentraxins (Osmand et a l ,  1977), with both coding 
genes found on chromosome 1 in humans and mice (Steel and Whitehead, 1994). The 
biological activity of these APRs is related to non-specific host defence mechanisms with 
both CRP and SAP having similar properties. However, the role of CRP has been better 
characterised. CRP can act as an opsonin for bacteria and immune complexes (Steel and 
Whitehead, 1994) mediated through the ability of CRP to bind to Fc receptors 
(Mortensen and Dusckiewicz, 1977), and activate the classical pathway of complement 
(Osmand et a l, 1975). SAP is the circulating precursor to amyloid P component which 
is a constituent of amyloid deposits (Benson et a i, 1976). Like CRP, SAP can enhance 
macrophage mediated phagocytosis via binding to glycoprotein receptors (Siripont, Tebo 
and Mortensen, 1988) and can activate the classical complement pathway via binding to 
C lq  (Ying et al., 1993). SAP has also been shown to regulate antibody responses in 
vitro (Sarlo and Mortensen, 1987). Both CRP and SAP have the capacity to bind 
chromatin, histones and DNA (Steel and Whitehead, 1994) and it has been suggested 
that the binding to and subsequent clearance of nuclear material which is released from 
necrotic tissue during inflammation would prevent the development of nuclear antigen 
specific autoimmunity (Steel and Whitehead, 1994).
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An increased rate of APR synthesis can occur following various inflammatory stimuli. 
Rapid increases in hepatic SAP mRNA in mice following an intraperitoneal injection of 
thioglycollate have been reported (Zahedi and Whitehead, 1989). IL-1 and IL-6 have 
been shown to stimulate the production of SAP by mouse hepatocytes in vitro (Lin et 
al., 1990). Administration of recombinant IL-1 and TN Fa induces SAP production in 
vivo (Mortensen et al., 1988). Hence, APRs are synthesised rapidly following 
inflammatory stimuli, which is important during an infection, when the non-specific 
immune response controls the initial stages of infection allowing the development of 
acquired, specific effector mechanisms.
Although mice do not synthesise CRP as part of their acute phase response, passively 
administered human CRP has been shown to protect mice from lethal infection with 
Streptococcus pneumoniae (Mold et al., 1981). Transgenic mice, expressing human 
CRP, have increased protection to S. pneumoniae (Szalai, Briles and Volanakis, 1995). 
Elevated levels of SAP have been observed in the serum of mice infected with 
Nippostrongyls braziliensis (LaMontague et a i, 1984) and Schistosoma mansoni (Pepys 
et a l, 1979). Trypanosomia cruzi infection in mice induces an increase in SAP levels 
(Luz, van Leuven and Araujo-Jorge, 1994, Truyens et al., 1994) and is associated with 
a delay in mortality following a lethal infection (Truyens et al., 1994).
The exo-erythrocytic stage of malaria infection involves a developmental phase within 
the liver which induces a strong inflammatory response inducing the required stimuli for 
the production of APRs. CRP has been shown to bind to the surface membrane of P. 
falciparum  and P. yoelii sporozoites probably via a phosphorylcholine-binding site 
(Mazier et a l, 1988). Addition of purified CRP to hepatocyte monolayers in vitro, at the 
time of inoculation with P. yoelii sporozoites inhibited parasite schizogony (Pied et a l,
1989). This effect was abrogated by the pre-treatment of cultures with anti-CRP 
antibodies (Pied et al., 1989). Time-course experiments revealed that CRP-mediated
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inhibition occurred at the early phase of infection (Mazier et a l, 1988). It is thought that 
CRP inhibits sporozoite penetration of the hepatocyte by masking recognition sites 
involved in the sporozoite-hepatocyte interaction (Nussler et al., 1991c). CRP mediated 
inhibition was also observed after sporozoite penetration (Nussler et al., 1991c). It is 
possible that CRP bound to sporozoites, penetrates the hepatocyte and subsequently 
prevents trophozoite division (Nussler et a l, 1991b). Induction of raised CRP levels in 
rats by injection with turpentine oil, protected against a challenge with P. yoelii 
sporozoites (Pied et a l, 1989). The susceptibility to P. berghei infection of two species 
of rat has been attributed to differences in the acute phase response induced by infection 
(Vreden et a l ,  1995). Furthermore, sporozoites incubated in acute phase serum had 
reduced infectivity but this was abolished by the treatment of the cultures with anti-CRP 
antibodies (Pied et a l ,  1989). The inhibition of the exo-erythrocytic stage of 
development may also involve indirect CRP mediated mechanisms such as the activation 
of complement or macrophages resulting in opsonisation of the parasite.
Raised serum levels of CRP have been observed in P. falciparum  infected individuals 
(Gillespie et a l, 1991) and correlate with severity of disease. CRP has been shown to 
bind to merozoites (Pied et a l,  1989), probably in a similar manner to the calcium 
dependent binding to sporozoites. However, the role of APRs in the immune response 
induced by blood-stage malaria infection is unclear. This study investigated the 
production of SAP, the main APR of mice during the course of experimental 
erythrocytic malaria infection. In vitro assays were performed to analyse if SAP had any 
direct anti-parasite effect.
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Results
SAP production during experimental blood-stage malaria infection
Levels of SAP in the serum of mice infected with P. chabaudi, P. berghei and P. vinckei 
petteri. were assayed by the technique described (Materials and Methods). Each group 
consisted of six mice and were infected with 1x10^ pRBCs of the respective parasite 
species. Semm samples were collected by tail bleeds from 3 mice of each experimental 
group and two mice from a non-infected control group. Each individual sample was 
assayed in triplicate and the mean value of SAP was calculated for each group. Elevated 
SAP levels were observed during the course of infection for all three malaria species 
compared to serum taken from non-infected controls (Figures 4.1, 4.2 and 4.3). Peak 
production of SAP during P. chabaudi and P. vinckei infection, occurred one or two 
days after the peak of the primary parasitaemia (Figures 4.1 and 4.2). SAP production 
during a lethal infection of P. berghei was elevated (Figure 4.3) and remained relatively 
high (compared to control levels) until the time of death (mortality data not shown).
The effect of SAP on the growth of P. falciparum in vitro
SAP was isolated from serum harvested from mice on day 11 of a P. chabaudi infection 
by the technique described (Materials and Methods). P. falciparum at 0.5% parasitaemia 
and 1.5% haematocrit was cultured in the presence of isolated SAP (100-5000 pg/ml) or 
chloroquine (0.1-10 pg/ml). The effect of either treatment on parasite growth was 
determined by the uptake of tritiated hypoxanthine. The addition of SAP, at 5 mg/ml, a 
concentration observed physiologically during a P. chabaudi infection, resulted in a 
significant decrease in tritiated hypoxanthine incorporation indicating an inhibitory effect 
of SAP on parasite growth (Figure 4.4).
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Figure 4.1. SAP was assayed in the serum of mice infected with 1x10  ^
pRBCs of P. chabaudi Serum was collected from 3 mice at each timepoint 
and each serum sample was assayed in triplicate. Control mice were 
non-infected and serum was collected from two mice at each timepoint and 
assayed in triplicate. Each data point is the mean of all the results obtained 
for each group. Peak production of SAP occurred one day after the peak of 
the primary parasitaemia.
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The effect of SAP on the growth of P. chabaudi in vitro
P. chabaudi was harvested from an infected mouse and cultured at 0.5% parasitaemia 
and 1.5% haematocrit in the presence of isolated SAP (100-5000 pg/ml) or chloroquine 
(0.1-10 p-g/ml). The effect of both treatments on the growth of P. chabaudi in vitro over 
a 24 hour period was determined by tritiated hypoxanthine incorporation. No effect on 
parasite growth was observed following the addition of SAP to P. chabaudi cultures 
(Figure 4.5).
The effect of SAP on proliferative responses of splenocytes
Splenocytes were harvested from naive mice and cultured at 5x10^ cells/ml. The cells 
were stimulated with either Concanavalin A or LPS (both 5 pg/ml) and concomitantly 
treated with SAP (1 mg/ml). The effect of SAP on the proliferative response by 
splenocytes to both stimulants was determined by tritiated thymidine incorporation. 
Treatment of splenocytes with SAP was found to inhibit the proliferative response to the 
T cell mitogen, Concanavalin A (Figure 4.6). However, it was observed that the 
proliferative response to LPS was enhanced in the presence of SAP (Figure 4.6).
D iscussion
The data reported here demonstrates that experimental infection of mice with blood-stage 
malaria induces elevated production of SAP, the main APR in mice. During P. chabaudi 
and P. vinckei infection, both non-lethal infections in NIH mice, the peak production of 
SAP occurred one or two days after the peak of the primary patent parasitaemia. P. 
berghei infection in NIH mice has a lethal outcome, with death occurring approximately 
19 to 20 days after infection. SAP levels were elevated in the serum of P. berghei 
infected mice and remained relatively high com pared to the control
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Figure 4.2. SAP was assayed in the serum of mice infected with 1x10  ^
pRBCs of P. vinckei petleri. Serum was collected from 3 mice at each 
timepoint and each serum sample was assayed in triplicate. Control mice 
were non-infected and serum was collected from two mice at each timepoint 
and assayed in triplicate. Each data point is the mean of all the results 
obtained for each group. Peak production of SAP occurred one day after the 
peak of the primary parasitaemia.
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group. It is unclear if the stimulus for inducing the increased rate of SAP synthesis is 
derived from the presence of the parasite and/or the inflammatory environment created 
by the response of the host to infection. During P. berghei infection, the parasitaemia 
remains at a high level from day 6 onwards until the time of death, resulting in sustained 
production of SAP probably due to the stimulation of inflammatory mediators during the 
course of infection.
During the course of P. chabaudi and P. vinckei infections, SAP production is elevated 
throughout, with similar concentrations at peak production of SAP. As already 
discussed (see Chapter 3), mature asexual erythrocytic stages of P. chabaudi withdraw 
from the circulation and cytoadhere to endothelial linings of tissues such as the liver. 
Hepatocytes are the main source of SAP synthesis (Koj, 1974) and it was thought that 
perhaps the sequestration of the parasite to the liver, resulting in a localised immune 
response, may induce SAP production. However, it appears sequestration does not 
significantly enhance the production of SAP because P. vinckei does not undergo 
sequestration but the level of SAP production during a P. vinckei infection is similar to 
that induced by a P. chabaudi infection. P. falciparum  infection in humans results in 
elevated CRP levels (Gillespie et al., 1991) and taken with the observations made from 
the three rodent malarial infections reported here, demonstrate that blood-stage malaria 
infection induces a systemic acute phase response.
The actual biological role of APR during blood-stage malaria infection is unclear. 
Isolation of SAP from immune serum allowed the investigation of any direct anti­
parasite effect. The addition of murine SAP, at a concentration which is found in the 
serum of mice at peak parasitaemia, to P. falciparum  cultures, inhibited parasite 
development. However, no effect on the growth of P. chabaudi in vitro was observed in 
terms of the uptake of tritiated hypoxanthine. The lack of growth inhibition mediated by 
SAP against P. chabaudi, although disappointing, may actually give an insight into the 
mechanism of inhibition of P. falciparum  growth. The normal culture conditions for
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Figure 4.3. SAP was assayed in the scrum of mice infected with 1x10  ^
pRBCs of P. berghei. Serum was collected from 3 mice at each timepoint 
and each serum sample was assayed in triplicate. Control mice were 
non-infected and serum was collected from two mice at each timepoint and 
assayed in triplicate. Each data point is the mean of all the results obtained 
for each group. SAP was elevated in the serum of mice infected with 
P. berghei until the time of death.
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p. falciparum, are not ideal for the growth of P. chabaudi in vitro. P. chabaudi has been 
shown to have a preference for young erythrocytes and the best growth rate has been 
obtained using 10% rat serum instead of foetal calf serum which was used in this study 
(McNally, O'Donovan and Dalton, 1992). Furthermore, it has been reported that 
although schizogony does occur in P. chabaudi in vitro cultures, only a small proportion 
of merozoites re-invade and produce new rings (Sohal and Amot, 1993). The growth 
rate of P. chabaudi was determined by tritiated hypoxanthine incorporation in this study 
but it has been shown that most of the uptake of this tracer occurs during the early phase 
of development and in fact the rate of incorporation decreases as schizogony commences 
(Newbold et al., 1982, Sohal and Arnot, 1993). Therefore, if SAP mediated growth 
inhibition occurs during schizogony and release of merozoites, this would not be 
reflected by the determination of tritiated hypoxanthine uptake because the incorporation 
of the tracer would occur earlier in the parasites growth cycle. P. falciparum  completes 
its life cycle under in vitro conditions and readily goes through schizogony allowing 
continuous culture (growth of P. falciparum in vitro is asynchronous). Hence, the 
inhibition of SAP may occur during schizogony when SAP has easier access to the cell. 
Even though SAP, at 230kDa, is a large glycoprotein it may enter the erythrocyte via 
endocytosis or a parasitophorous duct (J. Kusel, personal communication). The other 
possibility is that SAP may interfere with the invasion of the merozoite into the 
erythrocyte. CRP has been shown to bind to merozoites (Pied et al., 1989) and can 
interfere with the sporozoite invasion of hepatocytes by masking important binding sites. 
SAP may prevent merozoite invasion of erythrocytes by either binding to the merozoite, 
probably in a calcium dependent manner or by masking important receptors on the 
erythrocyte because SAP has been shown to bind to complement coated erythrocytes 
(Hutchcraft er «/., 1981).
During P. chabaudi infection (and P. falciparum infection), the parasites undergo deep 
tissue schizogony in the liver. The merozoites released may be vulnerable to a high local 
concentration of SAP which may inhibit re-invasion of erythrocytes by merozoites. The
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Figure 4.4. The effect of SAP on the growth of P. falciparum in vitro. 
SAP was isolated from the serum of P. chabaudi infected mice was added 
to in vitro cultures of P. falciparum at the concentrations shown. 
Chloroquine (CLQ) was used as a control indicating parasite killing. SAP at 
5mg/ml,which is a concentration found in the serum of mice at peak 
parasitaemia, significantly 'mbihiicàP. falciparum growth (p< 0.0003),
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possible direct inhibition of parasite growth mediated by SAP requires further 
investigation. Induction of the acute phase response and hence, elevated APR levels 
prior to infection with P. chabaudi, would determine if SAP is involved in controlling 
the primary parasitaemia but it would be difficult to elucidate if this was a direct or 
indirect mechanism mediated by SAP.
SAP may be involved in the response to P. chabaudi infection indirectly through the 
activation of several different protective mechanisms of the immune system. 
Macrophages have an important role in the immune response to malaria infection through 
their ability to present antigen, phagocytose parasitised erythrocytes and secrete various 
inflammatory mediators. SAP has been reported to activate macrophages, enhancing IL- 
1 production (Sarlo and Mortensen, 1985) and increasing the bactericidal activity of 
elicited, inflammatory macrophages (Singh et a l, 1986). Therefore, elevated production 
of SAP during malaria infection may inhibit the growth of the parasite throughout the 
activation of macrophage-mediated responses. The interaction between macrophages and 
the synthesis of APR is important because the macrophage is the major source of the 
inflammatory mediators such as lL-1 and lL-6 which induce the production of APR. 
Hence, activated macrophages will secrete products which induce APR synthesis, which 
in turn further activate macrophages creating a response which depends upon the 
constant stimulation of macrophages. Depletion of macrophages during a primary P. 
chabaudi infection (Chapter 3) demonstrated that the macrophage appears to be important 
in controlling the primary patent parasitaemia which is when the peak production of SAP 
occurs. It would be interesting to repeat the depletion of macrophages during the course 
of a P. chabaudi infection and monitor the effect this has on the production of SAP. The 
effect of Kupffer cell depletion on macrophage-derived molecules such as NO, would 
also have to be examined.
Acute phase reactants have been shown to modulate neutrophil function (Butcha et al., 
1987) with enhanced chemotaxis and phagocytosis by neutrophils following in vitro
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Figure 4.5. The effect of SAP on the growth of P. chabaudi in vitro . 
Isolated SAP was added tom vZ/rc? cultures of P. chabaudi freshly obtained 
from an infected mouse, at the concentrations shown. Chloroquine (Clq) 
was used as a control of parasite killing. SAP had no effect on the growth 
of P. chabaudi in vitro
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stimulation with CRP. Neutrophil activation has been reported during severe malaria 
infection (Mohamed et al., 1996) and neutrophils can kill P. falciparum in vitro by a 
phagocytic mechanism (Celada, Cruchaud and Perrin, 1984). Hence, APR modulation 
of neutrophil function during a malaria infection may result in increased parasite killing 
through phagocytosis.
The evidence for an important role for complement in immunity to blood-stage malaria 
infection is conflicting. During acute phase infections complement levels have been 
reported to decrease (Greenwood and Brueton, 1974) and in vitro studies have 
demonstrated monocyte- and neutrophil-mediated phagocytosis of P. falciparum  
parasitised erythrocytes is independent of complement (Celada, Cruchaud and Perrin, 
1984). However, another study reported that phagocytosis of P. falciparum in vitro was 
facilitated by complement (Schwarzer et al., 1992) and required the presence of 
complement (Salmon et al., 1986). SAP can activate complement by binding to C lq 
(Ying et a i, 1993) and it has also been shown to bind to C4-binding protein (De Beer et 
a l,  1981) and C5b6 (Barbashov, Wang and Nicholson-Weller, 1997). The production 
of APR may be involved in the protective immune response through the activation of the 
complement cascade which may be involved in the development of protective immunity 
to the erythrocytic stages of malaria infection.
One of the main mechanisms through which SAP could influence the response to malaria 
infection is by exerting an immunomodulatory effect on various cells of the immune 
system. The studies reported here indicate that SAP has the ability to modulate the 
responses of both T cells and B cells because the proliferative response of splenocytes to 
the T cell mitogen, Concanavalin A, was inhibited following treatment with SAP. 
Furthermore, the proliferation of splenocytes in response to LPS stimulation was 
enhanced following the addition of SAP. These observations confirm earlier reports 
investigating the effect of SAP on T cells (Levo and Wollner, 1985, Li et al., 1984) 
where SAP was found to inhibit T cell responses to Concanavalin A and the
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Figure 4.6. The effect of SAP on the proliferative responses of 
splenocytes. Isolated SAP (Img/ml) was added to splenocytes harvested 
from naive mice. The cultures were stimulated with Concanavalin A (ConA)
or LPS (both at 5pg/ml). SAP inhibited the proliferative response to Con A 
(p< 0.001) but actually enhanced the response of splenocytes to LPS (p< 
0.004).
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proliferative responses of human peripheral blood m ononuclear cells to 
phytohaemagglutinin. These observations suggest that APR may exert an 
immunosuppressive effect on T cell responses. Splenocytes isolated from mice at peak 
parasitaemia of a P. chabaudi infection, display a suppressed response to T cell mitogens 
(Bernadette et a i, 1996). This coincides with peak production of SAP and suggests that 
the elevated levels of SAP may suppress T cell responses perhaps as a regulatory 
mechanism to dampen inflammatory responses which may be involved in the pathology 
associated with severe infection.
The immunosuppressive effect exerted on T cells by SAP, may not extend to B cells 
because addition of SAP to splenocytes, enhances the proliferative response to the B cell 
stimulant, LPS. Furthermore, SAP has been shown to suppress antibody responses in 
vitro to T cell dependent antigens (Sarlo and Mortensen, 1987). Another possible link 
between antibody production and SAP comes from the studies reported later (Chapter 5) 
on P. chabaudi infection of IL-6 gene deficient mice. As already mentioned, IL-6 is one 
of the main inducers of APR production (Heinrich, Castell and Andus, 1990) and 
subsequently, IL-6 deficient mice have an impaired acute phase response (Kopf et a l, 
1994). During the course of a P. chabaudi infection, the normal production of SAP is 
absent and this correlates with an extension of the primary parasitaemia and a reduced 
humoral response to the infection in the IL-6 deficient mice. Therefore, it is possible that 
the absence of SAP production and subsequent loss of its immunosuppressive effect, 
may result in a delay in reaching the required level of humoral response which is 
necessary for parasite clearance after the peak of the primary parasitaemia. However, it 
must be noted that the IL-6 deficient mice still cleared the P. chabaudi infection 
indicating that the role of SAP, if any, during immunity to this experimental infection is 
a minor one.
The work presented here demonstrates that experimental infection of mice results in the 
systemic production of APR, namely SAP and that this acute phase protein may have a
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direct inhibitory effect on the development of malaria parasites. SAP also has the 
potential to be an important immunoregulatory molecule which may influence the 
immune response to malaria infection.
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Chapter Five
Course of P. chabaudi infection in IL-6 defîcient mice.
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Introduction
IL-6, a glycoprotein of 20-30 kDa, is a pleiotropic cytokine produced by many cell 
types including monocytes/macrophages, endothelial cells, T cells and B cells (Akira, 
Taga and Kashimoto, 1993). Although it is the major stimulus of acute phase 
production (Gauldie et al, 1987, Andus et al, 1987), IL-6 is also important for the 
growth of B cells (Akira, Taga and Kashimoto, 1993) and can act on mitogen- 
activated B cells to induce IgM, IgG and IgA production without stimulating B cell 
proliferation (Muraguchi et al, 1988, Beagley et al, 1989). T cell activation, growth 
and differentiation are all regulated partially by IL-6, including the proliferation of 
peripheral T cells and differentiation of CTLs (Takai et al, 1988, Okada et al, 1988, 
Renauld, Vink and van Snick, 1989). IL-6 may achieve these activities by converting 
T cells to an IL-2 responsive state through the upregulation of IL-2 receptor expression 
and inducing IL-2 production by T cells (Noma et al, 1987, Le et al, 1988, Garman et 
a l,  1987, Houssiau et al, 1988). Hence, IL-6 can induce IL-2 secretion and 
proliferation of T cells directly, bypassing the requirement of expression of co­
stimulatory molecules by antigen presenting cells (Kasahara et al, 1990, Lorre et al,
1990). It is a possibility that IL-6 may be a co-stimulatory factor when a macrophage 
is acting as an antigen presenting cell. Macrophage phagocytosis and expression of a 
number of macrophage differentiation antigens can be enhanced by IL-6 (Akira, Taga 
and Kashimoto, 1993, Shabo e ta l ,  1988, Lotem, Shabo and Sachs, 1989). In general, 
cells require stimulation to produce IL-6. LPS and IFN-y can induce IL-6 production 
by monocytes (Helfgott et al, 1987, Leeuwenberg et al, 1990). EL-1 and TNF can 
also induce IL-6 production (Kohase et al, 1986, Van Damme et al, 1987) but IL-6 
cannot induce IL-1 or TNF production. Indeed, IL-6 can suppress endotoxin induced 
EL-1 and TNF production by macrophages (Aderka, Le and Vilcek, 1989, Schindler et 
al, 1990). Signal transduction pathways for the expression of IL-6 appear to involve 
protein kinase C and adenylate cyclase following induction by IL-1 or TNF (Zhang,
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Lin and Vilcek, 1988, Sehgal, Walther and Tamm, 1987). Dexamethasone and other 
glucocorticoids can markedly suppress the production of IL-6 (Helfgott et a l, 1987): 
suppression occurs at both transcriptional and post-transcriptional levels.
IL-6 is involved in haematopoiesis, the inflammatory response, bone metabolism and 
can exert an influence on neuronal cells (Akira, Taga and Kashimoto, 1993). The 
activity of NK cells can be enhanced by IL-6 stimulation (Luger et a l, 1989). IL-6 
induced production of acute phase proteins (APP) by hepatocytes is well established 
(Gauldie et a l, 1987, Andus et a l, 1987). The actual biological function of many of 
the acute phase proteins remains unclear. Several cytokines can synergise with IL-6 to 
induce acute phase protein production, including IL-1, IL-11, TN F-a and TGF-P 
(Akira, Taka and Kashimoto, 1993). IL-6 is also involved in the control of body 
temperature. It can act directly on the anterior hypothalamus altering the 
thermoregulatory set-point probably via the induction of PGEg sy n th es is  
(Kwiatkowski, 1995). This has obvious importance during a malarial infection where 
TNF, IL-1 and IL-6 are attributed with mediating/regulating the fever associated with 
schizont rupture. Although IL-6 appears to be a pro-inflammatory cytokine, anti­
inflammatory activities have also been reported. IL-6 has been shown to inhibit TNF 
production and may have a role in a negative feedback mechanism which can inhibit 
endotoxin initiated, cytokine mediated acute inflammation (Ulich et a l, 1991).
Elevated levels of IL-6 have been detected in the serum of patients presenting with 
severe P. falciparum infection (Kern et a l, 1989). The levels correlate with parasite 
density and high serum TNF levels (Kern et a l, 1989). Soluble IL-6 receptor levels 
were raised in children with severe P. falciparum  and appear to be a sensitive marker 
of cerebral malaria in conjunction with IL-6 serum levels (Jakobsen et a l, 1994). It 
has been suggested that elevated IL-6 levels may be related to 
hypergammaglobulinaemia observed in malaria (Grau et a l, 1990). The ability of IL-6
1 0 0
to inhibit hepatic gluconeogenesis (Hill, Stith and McCallum, 1990) may contribute to 
the hypoglycaemia observed during malarial infection (Clark et al, 1981).
Whilst research concerning the cause of fever during a malaria infection has centred 
on the TNF inducing abilities of parasitised erythrocytes or supernatants from in vitro 
cultures (Taverne et al, 1990a, Taverne et al, 1990b), it has been shown that the same 
crude extracts can also induce IL-6 production by monocytes (Jakobsen et al, 1993). 
In vitro experiments have illustrated that IL-6 can inhibit the development of exo- 
erythrocytic stages of parasites directly or indirectly (Pied et al, 1992, Nussler et al, 
1991b). This has also been shown in vivo in rats infected with P. berghei (Vreden et 
al, 1995). IL-6 levels were raised in rats resistant to P. berghei infection compared 
with a susceptible strain of rat.
A protective role for IL-6 during experimental human malaria has been suggested. 
Immunized volunteers, receiving irradiated P. falciparum sporozoites, were protected 
from a subsequent P. falciparum challenge (Harpaz et al, 1992). IL-6 was the only 
cytokine measured where a significant rise from background levels was observed. 
IFN-y, CRP, soluble CD8 and soluble IL-2 receptor were all raised in non-vaccinated 
individuals who all developed parasitaemia following a P. falciparum sporozoite 
challenge. It is interesting to note the absence of detectable CRP levels in the protected 
individuals suggesting that IL-6 may be involved at local level during first exposure to 
the infection but when individuals are vaccinated and then challenged the role of IL-6 
may be to generate a specific humoral response. Serum analysis of individuals during 
the vaccination process may give an indication of the mechanisms which result in 
mediating protection against a live sporozoite challenge and elucidate the role of IL-6 
during both responses.
Mice deficient in IL-6 production develop and breed normally (Kopf et al, 1994). The 
numbers of thymocytes and peripheral T cells are reduced when compared with
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controls but they were shown to have normal expression levels of characteristic T cell 
markers (Kopf et al, 1994). B cell functions in the IL-6 deficient mice were deficient 
in response to infection with vesicular stomatitis virus (Kopf e ta l ,  1994). IgG 
production and mucosal IgA responses were reduced in IL-6 deficient mice but IgM 
responses were normal. Reduced generation and activity of cytotoxic T cells were 
demonstrated by inefficient control of vaccinia virus by IL-6 deficient mice (Kopf et 
al, 1994). IL-6 deficient mice are more susceptible, than intact control mice, to 
Listeria monocytogenes (Kopf et al, 1994, Dalrymple et al, 1995), Candida albicans 
(Romani et al, 1996), Escherichia coli infection (Dalrymple et al, 1996), and have 
impaired resistance to the development of toxoplasmic encephalitis (Suzuki et al, 
1997). However, efficient immunity to Leishmania major infection develops in IL-6 
deficient mice (Moskowitz, Brown and Reiner, 1997) demonstrating that IL-6 
deficient mice mount an effective CD4+ Thl T cell response which mediates 
protective immunity to L. major infection (Locksley et al., 1993) through the 
activation of macrophages to produce NO (Liew et al,  1990). The IL-6 deficient mice 
produce comparable levels of IFNy in lymph nodes to that of control mice following L. 
major infection (Moskowitz, Brown and Reiner, 1997) but reduced IFNy production 
in the brains of T. gondii infected IL-6 deficient mice was observed (Suzuki et al, 
1997). This suggests that IL-6 may have different functions depending upon the site of 
the inflammatory response. Impaired recruitment of inflammatory cells to the brains of 
T. gondii infected IL-6 deficient mice may be a consequence of reduced IFNy 
production due to the absence of IL-6 (Suzuki et al, 1997).
One of the main detrimental effects of the absence of IL-6 during the response to an 
infection is a reduced peripheral blood neutrophilia. This has been observed following 
infection with E. coli (Dalrymple et al, 1996), C. albicans (Romani et al, 1996), L. 
monocytogenes (Dalrymple et al, 1995) and has been proposed as a possible 
deficiency in the inflammatory response to T. gondii (Suzuki et al, 1997). However, 
the inefficient neutrophilia resulting from the absence of IL-6 appears to be
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inconsequential to the control of L. major infection (Moskowitz, Brown and Reiner, 
1997).
As already mentioned above, IL-6 is involved in the immune response to the 
intrahepatic stages of malaria (Pied et al., 1992). Elevated levels of IL-6 have been 
observed in P. falciparum infected individuals but the actual role of IL-6, if any, 
during the erythrocytic stages of infection, is unclear. Hence, IL-6 deficient mice were 
used to investigate the role of IL-6 in immunity to P. chabaudi infection.
Results
The course of P, chabaudi infection in IL-6 deficient mice
Inbred IL-6 deficient mice on a 129SVJ background and inbred intact control mice 
(129SVJ) were infected with either 1x10^ pRBCs or 2x10^ pRBCs of P. chabaudi AS. 
Each group consisted of six mice and the parasitaemia was observed daily by 
microscopic examination of Giemsa's stained thin blood smears collected from the tail. 
IL-6 deficient mice receiving 1x10^ pRBCs of P. chabaudi consistently had a lower 
peak parasitaemia compared with control mice (Figure 5.1), although the difference 
was never statistically significant. A small but significant extension to the primary 
patent parasitaemia was observed in the IL-6 deficient mice (Figure 5.1). Infection of 
the IL-6 deficient mice with the higher challenge dose of 2x10^ pRBCs of P. chabaudi 
(Figure 5.2), abrogated the suppression of the peak parasitaemia observed following 
infection with the lower dose of 1x10^ pRBCs, but the significant extension of the 
primary patent parasitaemia remained in the IL-6 deficient mice (Figure 5.2). The 
appearance of recrudescent parasites in both the IL-6 deficient mice and control mice 
was inconsistent.
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Figure 5.1. The course of infection in IL-6 deficient mice (IL-6 -/-
129SVJ) and control mice (129SVJ) following inoculation with 1x10 ^ 
pRBCs of P. chabaudi. The parasitaemia is the mean of six mice.
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Total IgG production in IL-6 deficient mice during P. chabaudi infection
Total IgGl and IgG2a production was determined in the serum of IL-6 deficient mice 
during P. chabaudi infection. Both IL-6 deficient mice and intact control mice 
received either 1x10^ pRBCs or 2x10^ pRBCs of P. chabaudi AS. Three mice in each 
group were sacrificed at various time points and serum was collected, pooled and 
assayed for the production of total IgGl and IgG2a by the protocol described (see 
Materials and Methods). Following infection with either 1x10^ pRBCs (Figure 5.3) or 
2x10^ pRBCs (Figure 5.4) of P. chabaudi, production of both total IgGl and IgG2a 
was delayed and reduced compared to control mice.
The production of parasite-specific IgG in IL-6 deficient mice during P. chabaudi 
infection
Parasite-specific IgG production in the serum of IL-6 deficient mice and control mice 
was determined following infection with 1x10^ pRBCs or 2x10^ pRBCs of P. 
chabaudi AS by the indirect fluorescent antibody test (IFAT) described in Materials 
and Methods. Serum was collected from 3 mice via the tail vein at the time points 
indicated and assayed for the production of parasite-specific IgG. No significant 
differences were observed between the two groups in terms of parasite-specific IgG 
produced in the serum following infection with either 1x10^ pRBCs or 2x10^ pRBCs 
of P. chabaudi (Tables 1 and 2).
Ex vivo analysis of the response of splenocytes taken from IL-6 deficient mice 
during P. chabaudi infection
IL-6 deficient mice and intact control mice were infected with 1x10^ pRBCs of P. 
chabaudi AS. Three mice from each group were sacrificed at the various time points 
indicated. Splenocytes were harvested and pooled from the three individual mice of
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Figure 5.2. The course of infection in IL-6 deficient mice (IL-6 -/-
129SVJ) and control mice (129SVJ) following infection with 2x10 ^ 
pRBCs of P. chabaudi. The parasitaemia is the mean of six mice.
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each group in vitro at 5x10^ cells/ml and stimulated with Concanavalin A (Con A) or 
LPS (both at l|Xg/ml). The proliferative response of the splenocytes was determined by 
the incorporation of tritiated thymidine. Splenocytes taken from non-infected IL-6 
deficient mice and control mice had similar proliferative responses to Con A and LPS 
stimulation (Figure 5.5). Splenocytes from IL-6 deficient mice at days 4 and 8 post 
infection had a greater proliferative response to both Con A and LPS compared with 
splenocytes from control mice (Figure 5.5). On day 15 post infection splenocytes from 
the control mice had an enhanced proliferative response to Con A compared to 
splenocytes from IL-6 deficient mice. Both groups displayed a suppressed response to 
Con A stimulation on day 11 post infection (Figure 5.5). No parasite-specific 
proliferation was observed for splenocytes from either the IL-6 deficient mice or 
control mice (data not shown).
Cytological analysis of cells present in the spleen and liver of IL-6 deficient mice 
during P. chabaudi infection
Cytological analysis was performed on leukocytes extracted from the spleen and liver 
of both IL-6 deficient mice and control mice during P. chabaudi infection. IL-6 
deficient mice and control mice were infected with 1x10^ pRBCs of P. chabaudi. 
Three mice were sacrificed at the time points indicated, the leukocytes were extracted 
from the liver and spleen of individual mice and then pooled to give leukocytes 
extracted from either the liver or spleen for each group. Cytological analysis was 
performed as described in Materials and Methods and the results expressed as number 
of cells present per spleen or liver. It was observed that there was a delay in reaching 
peak numbers of lymphoid cells in the spleens of IL-6 deficient mice (Figure 5.6) but 
the monocyte and polymorphonuclear (PMN) cell numbers were similar in both 
groups. The data obtained from the liver is incomplete and therefore no definite 
conclusions can be made but there appears to be a trend of reduced monocyte and
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Figure 5.3. Total IgGl, A) and total lgG2a, B) production were 
determined in the serum of lL-6 deficient mice and control mice following
inoculation with IxlO^pRBCS of P. chabaudi. SQXum from three mice was 
analysed individually for both groups, in triplicate and the mean ± SD 
antibody level was calculated.
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PMN cells present in the liver during the early phase of infection (Figure 5.6) in the 
IL-6 deficient mice.
SAP production in IL-6 deficient mice during P. chabaudi infection
SAP production was determined in the serum of IL-6 deficient mice and control mice 
following infection with either 1x10^ pRBCs or 2x10^ pRBCs of P. chabaudi. Serum 
was collected from three mice via the tail vein at the time points indicated and assayed 
for SAP production individually. SAP production in the IL-6 deficient mice following 
infection with either dose of P. chabaudi did not rise significantly above background 
levels (Figure 5.7). In the control mice peak production of SAP coincided with the 
peak of the primary parasitaemia (Figure 5.7).
Discussion
The role of IL-6 during P. chabaudi infection appears to be a minor one. Infection of 
mice deficient in IL-6 production with 1x10^ pRBCs of P. chabaudi, consistently 
resulted in a lower peak parasitaemia when compared with wild type mice. Therefore, 
this result suggests that IL-6 is not involved in the control of the primary patent 
parasitaemia but may have a regulatory or negative role to play. The removal of IL-6 
production from the repertoire of the immune response creates an imbalance in the 
cytokine network, resulting in B cell and T cell deficiencies and impaired acute phase 
protein production (Kopf et a l, 1994). The lower peak parasitaemia observed in the 
IL-6 deficient mice suggests that there is an increase in parasite killing. IL-6 is capable 
of down-regulating TNF production by monocytes and hence could result in a 
suppression of inflammatory responses mediated by macrophages in response to 
malarial antigens. The absence of IL-6 in vivo during P. chabaudi infection may result 
in an increase in synthesis of macrophage products which have been linked with 
parasite killing. The increased proliferative response of splenocytes from IL-6
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Figure 5.4. Total IgGl, A) and total IgG2a, B) production were 
determined in the serum of lL-6 deficient mice and control mice following
inoculation with 2x10^ pRBCS of P. chabaudi. Serum from three mice 
was analysed individually for both groups, in triplicate and the mean ± SD 
antibody level was calculated.
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deficient mice suggests greater T cell activation which may be responsible for the 
increased stimulation of macrophages to produce inflammatory products such as TNF, 
NO and IL-12 which have been implicated in the control of the primary patent 
parasitaemia (Stevenson et a l, 1995). The IL-6 deficient mice do not suffer from 
endotoxic shock, unlike IL-10 deficient mice which succumb to overproduction of 
inflammatory mediators following P. chabaudi infection (Linke et a l, 1995). Hence 
IL-6 is not the main down-regulator of the macrophage mediated inflammatory 
response, indeed evidence suggests that IL-10 may fulfil this role (Moore et a l, 1993). 
Depletion of macrophages during P. chabaudi infection results in an exacerbation of 
the primary peak parasitaemia (see Chapter 3). This illustrates that the macrophage has 
an important function in the control of the peak parasitaemia confirming that down- 
regulation of macrophage mediated inflammatory responses will result in an increase 
in the number of parasites at peak parasitaemia. Therefore it is feasible to suggest that 
the removal of the negative feedback mechanism mediated by IL-6 may result in an 
increase in the production of inflammatory products like TNF, IL-1 and NO by 
macrophages, leading to an increase in parasite killing. However the increase in 
parasite killing does not significantly reduce the peak of the primary parasitaemia 
which implies that the importance of the proposed negative feedback mechanism 
mediated by IL-6 is minor and probably secondary to IL-10 mediated suppression of 
inflammatory responses.
Another possible explanation of the lower peak parasitaemia observed in the IL-6 
deficient mice could be related to the ability of IL-6 to alter body temperature 
(Kwiatkowski, 1995). Fever is a well documented symptom of a malarial infection. It 
has been suggested that although fever is distressing to the infected individual, the 
change in body temperature may interfere with parasite development because malarial 
parasites have optimal temperatures for growth (Kwiatkowski, 1989). During malaria 
infection in mice, the body temperature actually decreases and it is unclear how this 
process actually occurs. Fever in humans has been correlated with schizont rupture and
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Days post 
infection
Group
IL-6 -/- 129SVJ 129SVJ
0
4 - -
7 - -
10 100 100
14 500 500
17 1000 1000
20 1000 1000
24 1000 1000
31 1000 1000
38 1000 1000
45 1000 1000
Table 1. Parasite-specific IgG production in IL-6 deficient mice and control mice 
following inoculation with 1x10^ pRBCs of P. chabaudi. Serum from three mice was 
pooled and the level of parasite-specific IgG was determined by indirect fluorescence. 
Results are the mean of three samples and are expressed as the reciprocal of antibody 
titre.
Days post Group
infection
IL-6 -/- 129SVJ 129SVJ
0
4 - -
7 - -
10 - 500
14 100 500
17 1000 500
20 500 500
24 1000 1000
31 500 500
38 1000 500
45 1000 1000
Table 2. Parasite-specific IgG production in IL-6 deficient mice and control mice 
following inoculation with 2x10^ pRBCs of P. chabaudi. Serum from three mice was 
pooled and the level of parasite-specific IgG was determined by indirect fluorescence. 
Results are the mean of three samples and are expressed as the reciprocal of antibody 
titre.
Note: Range of samples analysed was 1:50 - 1:1000.
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the production of endogenous pyrogens, TNF, DL-1, and IL-6 (Kwiatkowski, 1995). It 
is possible that the removal of IL-6 production during P. chabaudi infection results in 
the temperature of IL-6 deficient mice being different to that of the normal intact 
control mice. This may mean that the body temperature of the IL-6 deficient mice is 
not optimal for the growth of the parasite and results in a slightly decreased peak 
parasitaemia.
Immunity to P. chabaudi in mice is regarded as a sequential Thl/Th2 mediated 
response. Following a challenge with 1x10^ pRBCs, IL-6 deficient mice had a slower 
rate of parasite clearance when compared with controls. To analyse if this slower 
clearance of the patent parasitaemia could be attributed to a delay in the switch from 
Thl to Th2 T cell mediated responses, the mice were challenged with 1x10^ and 
2x10^ pRBCs. It was possible that the IL-6 deficient mice receiving the 1x10^ pRBCs, 
had a reduced parasite load at peak parasitaemia compared with controls. Hence, there 
was less stimulation of effector mechanisms which would result in a slower clearance 
of parasites. This theory was shown to be incorrect because the IL-6 deficient mice, 
when challenged with 2x10^ pRBCs had approximately the same peak parasitaemia as 
control mice. Therefore the antigen load and stimulation of the effector mechanisms 
involved in the clearance of parasites was the same in both groups of mice but the IL-6 
deficient mice still had a slower rate of clearance of the primary patent parasitaemia.
Increasing the challenge of inoculation appears to have abrogated the reduction in the 
peak parasitaemia observed in the IL-6 deficient mice. The beneficial effect during the 
peak parasitaemia attributed to the absence of IL-6 production may be lost due to the 
increased growth rate of the parasite and a greater antigen load. The resultant increase 
in the production of inflammatory products may stimulate compensatory, down- 
regulating mechanisms, hence reducing the rate of parasite killing. The increase in the 
parasite challenge and consequently parasite growth rate, overrides the mechanism 
which results in a reduction in the peak parasitaemia when IL-6 production is absent.
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Figure 5.5. The proliferative response of splenoeytes from lL-6 
deficient miee and control mice harvested following inoculation with
1x10^ pRBCs of P. chabaudi. Three miee from both groups were sacrificed 
and the splenoeytes were pooled within each group and stimulated with 
either A) Concanavalin A or B) LPS. Each data point is the mean ± SD for 
an experiment performed in triplicate.
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The extension of the primary parasitaemia observed in the IL-6 deficient mice is 
associated with a delay and reduction of total IgGl and IgG2a and an absence of acute 
phase protein production. The role of IL-6 in the maturation of B cells is well 
established and a deficiency in this process may explain the slower rate of parasite 
clearance as both IgGl and IgG2a have been shown to be involved in immunity during 
a malarial infection (Troye-Blomberg, Berzins and Perlmann, 1994, Akanmori, Waki 
and Suzuki, 1994). However, there appears to be no significant reduction in the levels 
of parasite specific IgG produced in the IL-6 deficient mice during P. chabaudi 
infection although this data is subjective and requires further confirmation through the 
production of parasite-specific Ig isotypes. There is a reduced proliferative response of 
splenoeytes taken from IL-6 deficient mice at a time which coincides with the 
extension of the primary parasitaemia. It is possible that the reduced activation of T 
cells at this time may result in a reduction of the CD4+ Th2 T cell mediated assistance 
required to stimulate the production of the appropriate humoral response. Further 
investigation into the cytokine profiles of T cells at this time of infection would 
elucidate any deficiency in this process.
Administration of recombinant IL-6 to mice has been shown to boost anti-plasmodial 
IgG subtype production and suppress the secondary phase of P. chabaudi infection 
(Akanmori, Kawai and Suzuki, 1996). However, the absence of IL-6 does not 
conversely exacerbate the parasitaemia of P. chabaudi infection or reduce the 
production of parasite-specific IgG. Akanmori and colleagues (1996) proposed that IL- 
6 mediates the protective humoral response mounted during the secondary phase of P. 
chabaudi infection but in the studies performed here, the influence of IL-6, albeit a 
minor one, appears to be during the acute phase of infection. Inconsistent observations 
concerning the appearance of recrudescent parasites prevents any conclusions being 
made about the effect IL-6 absence has on the secondary phase of P. chabaudi 
infection.
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Figure 5.6. Cytological analysis of cells present in the spleen of IL-6
deficient mice and control mice following inoculation with 1x10 ^ pRBCs 
of P. chabaudi. Three mice from each group were sacrificed at each 
timepomt and the cells harvested were pooled and centrifuged. 500 cells 
were counted on each Geimsa's stained cytospin smear. Each data point is 
calculated from one smear and the number of A) lymphoid, B) monocyte 
and C) polymorphonuclear (PMN) cells, are expressed per spleen.
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Acute phase protein production, indicated by the measurement of SAP, was impaired 
during P. chabaudi infection in the IL-6 deficient mice. This demonstrates that the 
stimulation of the production of acute phase reactants is mainly via IL-6. Malaria 
infection cannot override this deficiency, nor can it stimulate the production of these 
inflammatory products either directly or through a compensatory mechanism. An 
interesting point is that the peak of SAP production in the control mice occurs just 
after the clearance of the primary parasitaemia. The possibility exists that the absence 
of the production of SAP at this time in the IL-6 deficient mice may contribute to the 
decreased rate of parasite clearance. This could be through a direct inhibition of the 
growth of the parasite, as SAP is known to bind to erythrocytes, the host cell for 
Plasmodium parasites during the asexual cycle in mammals. The other option is that 
SAP production may be an important stimulatory step in the process leading to 
effective parasite clearance (see Chapter 4).
Further work is required on this experimental model to determine the compensatory 
mechanisms which result from the absence of IL-6 production. An imbalance in the 
cytokine network is created but it is unclear if there is a cytokine which can replace the 
functions of IL-6 or if overproduction of several cytokines compensates for the IL-6 
deficiency. Analysis of the response of splenoeytes during the peak parasitaemia and 
the remission of the primary patent parasitaemia to specific and non-specific antigens 
may reveal why the deficiency in the cytokine network results in a lower peak 
parasitaemia and reduced rate of parasite clearance observed in the IL-6 deficient 
mice.
IL-6 is a pleiotropic cytokine involved in many different areas of the immune 
response, bridging specific and non-specific protective mechanisms. It is possible that 
the diverse functions of IL-6 may contribute to the minor detrimental effect observed 
in IL-6 deficient mice during P. chabaudi infection. Efficient compensatory 
mechanisms are probably already functional in an immunocompetent host but in fact
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Figure 5.7. Cytological analysis of cells present in the liver of IL-6
deficient mice and control mice following inoculation with 1x10^ pRBCs 
of P. chabaudi. Three mice from each group were sacrificed at each 
timepomt and the cells harvested were ptx)led and centrifuged. 500 cells 
were counted on each Geimsa's stained cytospin smear. Each data point is 
calculated from one smear and the number of A) lymphoid, B) monocyte 
and C) polymorphonuclear (PMN) cells, are expressed per liver.
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synergise with IL-6 to stimulate the required response under normal conditions. 
Therefore, the absence of IL-6 would result in an over-expression of the synergistic 
mechanisms which may explain the minor role for IL-6 observed in the experiments 
performed here. IL-6 deficient mice can mount efficient immunity to L. major 
infection (Moskowitz, Brown and Reiner, 1997) even though the macrophage, a major 
source of IL-6, has a pivotal role during leishmaniasis. However, the absence of IL-6 
results in increased susceptibility to L. monocytogenes (Kopf et a l, 1994) and E. coli 
infection (Dalrymple et al, 1996). The determining factor in the outcome of different 
infections in IL-6 deficient mice will be the influence IL-6 exerts on the definitive 
microbicidal mechanism. NO production is known to be the effector molecule of anti- 
parasitic activity during leishmaniasis (Liew et a l ,  1990), whereas, the identity of the 
microbicidal mechanism during malaria infection remains elusive. However, it is clear 
that the process is complex and involves innate and acquired immune responses. 
Hence, the outcome of a malaria infection may not be significantly altered by the loss 
of IL-6 production.
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Figure 5.8. The production of SAP in IL-6 deficient mice and control 
mice following infection with either A) 1x10^ pRBCS or B) 2x10^ pRBCs 
of P. chabaudi. Serum from three mice in each group was analysed for SAP 
levels in triplicate and the mean ± SD was calculated.
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Chapter Six
The course of P. chabaudi infection in IL-4 deficient mice
1 2 1
Introduction
IL-4 is a 19 kDa glycoprotein, which has pleiotropic effects on various components of 
the immune response. The gene for IL-4 is found on chromosome 5 (human) or 
chromosome 11 (mouse) and is part of a cytokine complex which includes genes for IL- 
3, IL-5 and GM-CSF (Paul, 1991). IL-4 can influence several types of cells including B 
cells, T cells, monocyte/macrophages and mast cells and mediates its function by 
binding to a receptor expressed on the target cell. The receptor is a 140 kDa 
transmembrane protein (Mosley et a l, 1989, Idzerda et al., 1990) which is known to 
activate at least two distinctive pathways following interaction with IL-4 (Kaplan et al., 
1996). One involves the activation of Stat 6 (signal transducer and activator of 
transcription 6), which appears to be the critical pathway for mediating IL-4 induced 
responses in lymphocytes (Kaplan et al., 1996). The second pathway involves the 
phosphorylation of an insulin receptor substrate termed 4 PS which associates with 
phosphatidylinositol 3-kinase (Keegan etal., 1994).
IL-4, originally identified by its ability to induce B cell differentiation (Howard et al., 
1982) is essential for Ig class switching to IgGl production (Snapper and Paul, 1987a 
and 1987b) and is essential for the induction of IgE production (Snapper, Finkleman and 
Paul, 1988). Transgenic mice, which overexpress IL-4, have elevated levels of both IgE 
and IgG l (Tepper et a l ,  1990). IL-4 stimulation of B cells results in increased 
expression of MHC class II (Noelle et a i, 1984), IL-4 receptor (Ohara and Paul, 1988) 
and CD23, which is a low affinity IgE receptor (Conrad et a i,  1987). The influence of 
IL-4 extends beyond B cell functions. Increased expression of la antigen and MHC class 
I and II induced by IL-4 stimulation, can result in the enhancement of the ability of 
macrophages to present antigen (Zlotnik et al., 1987, Stuart et al., 1988). IL-4 has been 
shown to enhance the proliferation of precursors of cytotoxic T cells and differentiation 
into CTL (Widner and Grabstein, 1987, Trenn et a l, 1988) and it has been proposed
1 2 2
that IL-4 may have a role in the development of the T cell repertoire within the thymus 
(Tepper a/., 1990).
One of the principal functions of IL-4 is the polarisation of the CD4+ T helper subsets. 
Th 1 CD4+ T cells secrete IFNy and TNpp whereas Th2 CD4+ T cells produce IL-4, IL- 
5 and XL-10 (Mosmann et al., 1986). The different subsets have been the focus of 
extensive research into their involvement in various mechanisms of the immune system 
and host defence responses. However, evidence is emerging that there is not such a clear 
definition of Thl and Th2 subsets, with some T cells secreting both sets of cytokines 
(Romagnani, 1996). The microenvironment can influence the polarisation of the CD4+ T 
cell response, with the presence of IL-4 early in the development being a potent stimulus 
for Th2 differentiation. Potential sources of rapid IL-4 production include a subset of 
CD4+ NK 1.1 cells or naive Th CD4+ T cells (Romagnani, 1997). As the activation of 
T cells increases, the production of IL-4 by naive Th cells would increase and reach a 
threshold level, polarising the differentiation of CD4+ T cells to the Th2 phenotype 
because IL-4 is capable of dominating the effeets of the other cytokines produced by 
naive Th cells (Romagnani, 1997).
The polarisation of the CD4+ Th subsets has been extensively investigated during 
infectious diseases, with IFNy and IL-4 reflecting the involvement of Thl and Th2 
mediated responses respectively. Hence, the role of IL-4 (and Th2 mediated responses) 
during infectious diseases has been analysed by anti-IL-4 treatment, addition of 
recombinant IL-4, detection of mRNA expression or protein secretion and more recently 
by the generation of IL-4 gene deficient mice.
Susceptibility to L. major infection in mice is associated with IL-4 production rather than 
IFN y (Reiner and Locksley, 1995). Depletion of IL-4 in susceptible mice by 
administration of anti-IL-4 antibody results in resistance to L. major (Sadick et al., 
1990). In contrast, IL-4 mediates a protective response to the gastrointestinal nematodes
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Heligmosomoides poly gyrus (Urban et a l ,  1991) and Trichuris muris (Else et a l ,
1994). Mouse strains which produce Th2 associated cytokines including IL-4 are 
resistant to T. muris infection whereas mice which produce T hl cytokines are 
susceptible (Else and Grencis, 1991, Else et a l, 1994). Treatment of susceptible mice 
with IL-4, induces Th2 mediated responses, preventing the establishment of a chronic T. 
muris infection and can also cure an established T. muris infection (Else et a l, 1994). 
Furthermore, IL-4 treatment of immunodeficient mice can cure established 
Nippostrongylus brazliensis infection (Urban e ta l,  1995).
The generation of IL-4 deficient mice has confirmed the results of studies where the role 
of IL-4 was examined previously by depletion of IL-4 by antibodies or addition of 
exogenous IL-4. The early production of IL-4 in Balb/c mice predisposes a susceptible 
phenotype to L. major infection and hence IL-4 deficient mice upon infection with L. 
major were found to be resistant with reduced Th2 responses (Kopf et a l ,  1996). 
Infection of IL-4 deficient mice with L. mexicana demonstrated that IL-4 is involved in 
down-regulating a protective Thl response as observed during L. major infection 
(Satoskar, Bluethmann and Alexander, 1995). IL-4 deficient mice are more susceptible 
than control mice during the initial phase of a T. gondii infection, where there is a rapid 
proliferation of tachyzoites, but have decreased pathology associated with chronic 
infection (Roberts et a l, 1996). Hence, IL-4 appears to have a protective role during the 
initial phase of a T. gondii infection, probably through down-regulation of inflammatory 
responses but the long-term effects of IL-4 are detrimental on the outcome of the 
development of protective mechanisms to bradyzoites, which encyst in tissues and 
initiate the chronic phase of infection. Immunocompetent mice can mount a protective 
immune response to a secondary H. polygyrus infection following drug cure of a 
primary infection (Urban et a l, 1992), unlike IL-4 deficient mice which are unable to 
reduce fecundity and expel adult worms during a secondary infection (Kopf et a l ,
1995).
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EL-4 and IL-5 are produced during Schistosoma mansoni infection in mice but only after 
an initial IFNy mediated Thl response (Paul, 1991). The sequential involvement of T hl/ 
Th2 mediated responses is also apparent in experimental malaria infection of mice with 
P. chabaudi. During a primary infection with P. chabaudi, Thl and Th2 cells appear 
sequentially during the course of infection (Langhorne et al., 1989) and CD4+ T cell 
clones isolated from mice at day 16 post infection and after clearance of a secondary P. 
chabaudi infection, which were of a Thl and Th2 subset respectively, were able to 
confer protection to an homologous challenge (Taylor-Robinson and Phillips, 1994b). 
These results imply that control of the acute phase of P. chabaudi infection is mediated 
by Thl responses, essentially antibody-independent mechanisms and that this is 
superceded by antibody-dependent Th2 mediated response which is important for 
parasite elimination. Early production of IL-4 correlates with susceptibility to a P. 
chabaudi infection (Jacobs, Radzioch and Stevenson, 1995), plus IL-4 appears to have 
no role in the protective response of mice to P. vinckei vinckei infection (Perlmann et 
al., 1995). Furthermore, IL-4 does not appear to be involved in anti-sporozoite 
immunity (White, Jarboe and Krzych, 1994) even though antibody-dependent 
mechanisms are thought to participate in a protective response (Nussenzweig et al., 
1967). Hence, IL-4 deficient mice have been used to examine the role of IL-4 and 
consequently Th2 mediated responses during experimental blood-stage malaria infection 
(von der Weid et al., 1994b, van der Hey de et al., 1997). Th2 associated cytokines (IL- 
5, IL-9 and IL-10 ) are reduced in the IL-4 deficient mice following N. braziliensis 
infection (Kopf et al., 1993) and IgE responses to the same nematode infection are also 
absent (Kuhn, Rajewsky and Muller, 1991).
IL-4 deficient mice have been used to investigate the role of IL-4 and IL-4 driven Th2 
responses to experimental malaria infection. The outcome of the previous investigations 
using IL-4 deficient mice infected with either P. chabaudi chabaudi AS, P. chabaudi 
adami or P. yoelii was that the absence of IL-4 has no significant exacerbating effect on 
the course of infection (von der Weid et al., 1994b, van der Heyde et al., 1997). In the
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studies described here infection of IL-4 deficient mice on three different backgrounds, 
one outbred (B6xl29) and two inbred (129SV and Balb/c) strains, with P. chabaudi 
chabaudi AS was performed in order to dissect the roles of Thl and Th2 mediated 
responses and complement the investigation of the outcome of malaria infection in mice 
lacking the receptor for the Th 1 associated cytokine, IFNy (see Chapter 7).
Results
The course of P. chabaudi infection in IL-4 deHcient mice
IL-4 deficient mice and corresponding intact control mice were infected with 1x10^ 
pRBCs of P. chabaudi AS. Mice of three different backgrounds with the disruption of 
the IL-4 gene were used, one outbred (B6xl29SV) and two inbred strains (129SV and 
Balb/c). Each group consisted of six mice and the parasitaemia was observed daily by 
microscopic examination of Giemsa's stained thin blood smears collected from the tail. 
P. chabaudi infection of IL-4 deficient B6xl29 mice resulted in a significant 
exacerbation at peak parasitaemia [p<0.04 at day 10 post infection] (Figure 6.1). The 
same result was observed following P. chabaudi infection of IL-4 deficient 129SV 
[p<0.002 at day 12 post infection] and Balb/c mice [p<0.0004 at day 9 post infection] 
(Figures 6.2 and 6.3 respectively). Clearance of the primary patent parasitaemia 
occurred at a similar rate in the IL-4 deficient mice (all three backgrounds) and the 
control mice. Recrudescent parasites appeared only in the IL-4 deficient 129SV mice 
(Figure 6.2). No data was obtained on the recrudescence parasitaemia for IL-4 deficient 
Balb/c mice because the course of infection was followed only for 20 days.
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Total IgG and IgE production in IL-4 deficient mice during P. chabaudi
infection
Total IgGl, Ig02a and IgE production was determined in the serum of IL-4 deficient 
mice during P. chabaudi infection. IL-4 deficient 129SV mice and control 129SV mice 
received 1x10^ pRBCs of P. chabaudi. Three mice in each group were sacrificed at 
various time points and serum was collected, pooled and assayed for the production of 
total IgGl, IgG2a or IgE by the protocol described (see Materials and Methods). Total 
IgGl was reduced in IL-4 deficient 129SV mice compared with control 129SV mice 
during the early phase of the primary parasitaemia (Figure 6.4). The level of total IgG2a 
production in the IL-4 129SV deficient mice was similar to that in the serum of control 
129SV mice (Figure 6.4). Neither IL-4 deficient 129SV mice nor control 129SV mice 
produced significant levels of total IgE (Figure 6.4).
The production of parasite-specific IgG in IL-4 deficient mice during P. 
chabaudi infection
Parasite-specific IgG production in the serum of IL-4 deficient 129SV mice and control 
129SV mice was determined following infection with 1x10^ pRBCs of P. chabaudi AS 
by the indirect fluorescent antibody test (IFAT) described in Materials and Methods. 
Three mice from each group were sacrificed at the time points indicated and serum was 
collected, pooled and assayed for the production of parasite-specific IgG. No significant 
differences were observed between the two groups in terms of parasite-specific IgG 
produced in the serum during P. chabaudi infection (Table 3).
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Ex vivo analysis of the response of splenoeytes taken from IL-4 deficient 
mice during P. chabaudi infection
IL-4 deficient 129SV mice and intact control 129SV mice were infected with 1x10^ 
pRBCs of P. chabaudi AS. Three mice from each group were sacrificed at the various 
time points indicated. Splenoeytes were harvested and pooled from the three individual 
mice of each group, cultured in vitro at 5x10^ cells/ml and stimulated with Con A 
(Ip-g/ml). The proliferative response of the splenoeytes was determined by the 
incorporation of tritiated thymidine. Splenoeytes from non-infected IL-4 deficient 129SV 
mice and control 129SV mice had similar proliferative responses to Con A stimulation 
(Figure 6.5). Splenoeytes from both groups had similar responses to Con A stimulation 
during the course of P. chabaudi infection except for day 6 post infection where 
splenoeytes from IL-4 deficient 129SV mice had a reduced proliferative response 
[p<0.002] (Figure 6.5).
Cytological analysis of cells present in the spleen and liver of IL-4 
deficient mice during P. chabaudi infection
Cytological analysis was performed on leukocytes extracted from the spleen and liver of 
both IL-4 deficient 129SV mice and control 129SV mice following infection with 1x10^ 
pRBCs of P. chabaudi. Three mice from each group were sacrificed at the time points 
indicated, the leukocytes were extracted from the liver and spleen of individual mice and 
then pooled to give leukocytes extracted from either the liver or spleen for each group. 
Cytological analysis was performed as described in Materials and Methods and the 
results expressed as the number of cells present per spleen or liver. A small reduction in 
the numbers of lymphoid cells present in the spleen of IL-4 deficient 129SV mice was 
observed but both groups had similar numbers of monocytes and PMN cells present in 
the spleen (Figure 6.7). There was a reduction in the numbers of lymphoid, monocyte
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and PMN cells present in the liver of IL-4 deficient 129SV mice during P. chabaudi
infection (Figure 6.8).
Discussion
IL-4 deficient mice can control and clear a primary infection of P. chabaudi with similar 
efficiency to that of controls. However, a small but significant exacerbation of the peak 
of the primary patent parasitaemia was observed in the IL-4 deficient mice. This result 
was consistently observed in IL-4 deficient mice on three different backgrounds. The 
work reported here confirms previous studies (von der Weid et al., 1994, van der Heyde 
et a l, 1997) in that the presence of IL-4 is not essential for the efficient elimination of a 
patent erythrocytic stage malarial infection in mice.
The sequential involvement of Thl and Th2 associated cytokines and the related cell 
mediated immunity (antibody-independent) and antibody-dependent immunity during P. 
chabaudi infection is well documented (Langhorne et al., 1989, Taylor-Robinson and 
Phillips, 1992). The importance of IL-4 in the development of Th2 cells dictates that the 
absence of this Th2 associated cytokine during a P. chabaudi infection might result in a 
deficiency in the clearance of the parasites, a mechanism attributed to antibody mediated 
immunity (Meding and Langhorne, 1991, Stevenson and Tam, 1993). However, the 
studies presented here and elsewhere (von der Weid et al., 1994b, van der Heyde et a i, 
1997), using IL-4 deficient mice, contradict the proposed role for IL-4 in mediating Th2 
associated effector mechanisms thought to be involved in the elimination of blood-stage 
infection. Infection of IL-4 deficient mice with P. yoelii, resulted in no difference 
compared to control mice (van der Heyde et a l,  1997) even though immunity to P. 
yoelii is traditionally thought to be mainly antibody-dependent (Weinbaum, Evans and 
Tigelaar, 1976). Furthermore, in the studies reported here, an exacerbation of the 
primary patent parasitaemia was observed in the IL-4 deficient mice despite this phase of 
the P. chabaudi infection being thought to be predominately a Th 1 and IFNy mediated
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response (Langhorne et a i ,  1989, Taylor-Robinson and Phillips, 1992). Previously, 
infection of IL-4 deficient mice resulted in a sustained Thl response indicated by 
prolonged IFNy production and elevated XL-12 levels (von der Weid et a i ,  1994b). 
Analysis of cytokine production in the present studies, by splenoeytes in vitro, in the 
serum or mRNA expression, would indicate if there was a similar sustained Thl 
response. The exacerbation of the peak parasitaemia observed in the absence of IL-4 
suggests that the acute phase of P. chabaudi is not solely under the control of Thl 
mediated responses. However, the assumption that IL-4, although the main cytokine 
involved in the development of Th2 CD4^ T cells, is essential for Th2 mediated 
responses is now regarded unlikely, von der Weid and colleagues (1994b) demonstrated 
that despite the absence of IL-4 during P. chabaudi infection, other Th2 associated 
cytokines (IL-5, IL-6, IL-10) were still produced and that CD4^ T cells from the IL-4 
deficient mice were only delayed in their switch from the Thl to Th2 phenotype.
Infection of IL-4 deficient mice with P. chabaudi in the studies reported here and 
elsewhere (von der Weid et al., 1994b) demonstrate the importance of the humoral 
response to malaria infection because even in the absence of IL-4, compensatory 
mechanisms ensure that a protective humoral response is still induced albeit either 
reduced or delayed. Total IgGl levels were reduced in IL-4 deficient mice confirming 
previous reports (von der Weid et a l, 1994b) and a reduction in parasite-specific IgGl 
has also been documented (von der Weid et at., 1994b). These observations are not 
surprising because of the importance of IL-4 in class switching to IgGl production 
(Snapper and Paul, 1987a). It is interesting that IL-4 deficient mice did not have a low 
grade persistent parasitaemia which is observed in B cell deficient mice following a P. 
chabaudi infection (Taylor-Robinson and Phillips, 1994a). A sustained Thl mediated 
response, indicated by IFNy and IL-12 production (Taylor-Robinson and Phillips, 
1994a) and by the frequency of Thl CD4"  ^T cells following limited dilution analysis 
(von der Weid and Langhorne, 1993) was observed in P. chabaudi infected B cell 
deficient mice. Concomitantly, a reduction in IL-4 was observed (von der Weid and
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Days post 
infection
Group 
IL-4 -/- 129SV 129SV
0 - -
6 100 -
10 100 100
13 1000 1000
15 500 1000
22 1000 1000
Table 3. Parasite-specific IgG production in IL-4 deficient 129SV mice and control 
129SV mice following inoculation with 1x10^ pRBCs of P. chabaudi. Serum from three 
mice was pooled and the level of parasite-specific IgG was determined by indirect 
fluorescence. Results are the mean of three samples and are expressed as the reciprocal of 
antibody titre.
Note: Range of samples analysed was 1: 50 - 1: 1000.
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Langhorne, 1993, Taylor-Robinson and Phillips, 1994a) and is probably a result of the 
loss of B cells as antigen presenting cells which may influence the development of CD4^ 
T cells towards Th2 differentiation and subsequently IL-4 production (Gajewski et a l, 
1991). A loss of B cell production of IL-10, a cytokine which can suppress Thl 
development (Moore et a l, 1993), would also result in a reduction of IL-4 production 
because the response would now have a Thl bias. However, the persistent patent 
parasitaemia observed in B cell deficient mice does not appear to be a consequence of the 
reduced Th2 associated cytokine production but is more likely due to the loss of the 
protective humoral response. IL-4 deficient mice efficiently clear a P. yoelii infection 
which is thought to induce antibody-dependent immunity (van der Heyde et al., 1997). 
Furthermore, P. chabaudi infection of IL-4 deficient mice results in a similar sustained 
Thl response as seen in the B cell deficient mice (von der Weid et al., 1994b) but there 
is a humoral response still induced in the IL-4 deficient mice and subsequently the IL-4 
deficient mice can efficiently control the infection unlike B cell deficient mice. These 
observations suggest that parasite elimination following the acute phase of a primary P. 
chabaudi infection, requires B cell production of parasite-specific antibodies whereas the 
involvement of IL-4 and Th2 mediated responses is not synomonous with antibody- 
dependent immunity. Evidence for this hypothesis is provided by the observation of an 
exacerbated P. yoelii infection in IFNy deficient mice (van der Heyde et al., 1997), 
which suggests that IFNy can contribute to antibody-dependent immunity. Hence, the 
chronic parasitaemia observed in B cell deficient mice can be attributed to the absence of 
the humoral response and not the failure to switch from Thl to Th2 mediated responses.
The reason why IL-4 deficient mice in this study have an exacerbated peak of the 
primary parasitaemia is unclear. It is most likely that the reduction in the humoral 
response, indicated by reduced levels of total IgG may contribute to this observation. 
Another possibility is that the alteration in the balance of cytokine interactions which 
regulate Thl/Th2 development caused by the absence of IL-4 may result in reduced anti­
parasite immunity at this time of infection. IL-4 mediated induction of IgGl has been
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shown to be involved in the protection mediated by a Th2 CD4^ T cell clone to CD4^ T 
cell depleted mice upon challenge with P. chabaudi (Taylor-Robinson et a l, 1993). The 
reduction of IgGl in IL-4 deficient mice during the course of P. chabaudi infection may 
lead to a decrease in antibody-dependent cellular cytotoxicity (ADCC) which has been 
proposed to inhibit P. falciparum  growth in vitro (Brown and Smalley, 1980, Brown, 
Greenwood and Terry, 1986). An increase in ADCC has been reported in P. chabaudi 
infected mice (McDonald and Phillips, 1978a) and hence, the exacerbated peak of 
parasitaemia may be due to decreased IgGl mediated ADCC.
IL-4 does exert effects on the immune system outwith Th2 T cell development and 
stimulation of IgGl production. The stimulation of endothelial cells by IL-4, resulting in 
the enhanced adhesion of lymphocytes could explain, in part, the reduced numbers of 
lymphoid cells present in the liver of IL-4 deficient mice at peak parasitaemia. As 
previously discussed (see Chapter 3), lymphomyeloid cells present in the liver may be 
involved in a protective immune response at this point of a P. chabaudi infection. Hence, 
in the absence of IL-4, the reduced numbers of lymphomyeloid cells present in the liver 
may contribute to the exacerbated peak of parasitaemia observed in P. chabaudi infected 
IL-4 deficient mice.
The infection of IL-4 deficient mice with P. chabaudi demonstrates that either the 
requirement for IL-4 induction of Th2 mediated antibody-dependent immunity during a 
primary infection is of less importance than previously thought or that significant 
mechanisms compensate for the loss of IL-4 function. IL-10 or IL-13, alone or in 
combination, may replace IL-4 function and induce the required protective immunity 
during a malaria infection. However, no significant detrimental effect on the outcome of 
a P. chabaudi infection has been observed in mice deficient of Th2 associated cytokines 
(van der Hey de et a l ,  1997, see Chapter 5), promoting the hypothesis that Thl 
associated cytokine mediated antibody-dependent immunity may be sufficient to control 
a primary P. chabaudi infection and that the contribution of IL-4 and Th2 associated
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cytokines is of secondary importance. Further analysis of both the profile of cytokine 
production and the humoral response, in particular the production of parasite-specific 
antibody isotypes is necessary to elucidate the contribution of IL-4 to immunity to 
experimental malaria infection and the compensatory mechanisms replacing the function 
of IL-4.
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Chapter Seven
The course of P. chabaudi infection in IFNyR deficient mice
142
Introduction
IFNy was first identified as an antiviral agent in the supernatants of leukocytes cultures 
stimulated by PHA (Wheelock, 1965). Subsequently, IFNy has been shown to 
orchestrate a wide range of cellular responses which demonstrates the importance of 
IFNy in the regulation of the immune system and the control of infectious disease. The 
main sources of IFNy are activated Thl CD4+ T cells (Mosmann and Coffman, 1989), 
activated NK cells (Perussia, 1991) and CD8+ cytotoxic T cells of the type 1 cytokine 
phenotype (Sad, Marcotte and Mosmann, 1995). Cross-linking of the T cell receptor is 
the major stimulus of IFNy production by T cells (Ullman et a l ,  1990). IFNy 
production by NK cells is stimulated by TNFa and IL-12 (Trinchieri, 1995) and can 
also be autostimulated by IFNy itself (Hardy and Sawada, 1989). Biologically active 
IFNy is a 34 kDa homodimer (Greenland, Wenner and Schreiber, 1992, Fountoulakis et 
al., 1992) which interacts with a specific cell receptor ubiquitously expressed on all 
nucleated ceils (Valente et at., 1992). The IFNy receptor (IFNyR) consists of two 
subunits, a 90 kDa a  chain (Farrar and Schreiber, 1993) and a 314 amino acid (60-65 
kDa) p chain (Bach, Aguet and Schreiber, 1997). Each chain of the IFNyR is associated 
with a specific Janus kinase [JAK] (Igarashi et a l, 1994). The IFNy homodimer binds 
to 2 a  chains of the IFNyR, resulting in a  chain dimérisation (Fountoulakis et a l, 1992) 
and consequent association of the p chains which leads to activation of the JAKs 
(Boehm et a l, 1997). This induces binding of ST AT l a  (signal transducer and activator 
of transcription la )  to the receptor complex (Greenland et at., 1994, Heim et a l,  1995). 
S T A T la  homodimers are formed following phosphorylation of the bound ST A Tla 
(Greenland et a l,  1995). The STA Tla homodimers (also known as Gamma Activated 
Factor, GAF) translocate to the nucleus and bind to gamma activated sites and initiate 
transcription (Boehm et a l,  1997). Through this signaling pathway, IFNy can initiate 
transcription of a number of genes bearing suitable gamma activated sites in their 
promoter regions. Currently there are over 200 known IFNy-regulated genes (Boehm et 
a i,  1997).
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The rapid response to IFNy induced transcription is due to the activation of the latent 
cytosolic transcription factor STA Tla and hence it does not require the synthesis of new 
transcription factors. However, some cellular responses to IFNy require the synthesis of 
IFNy induced transcription factors to initiate the transcription of the desired product 
(Boehm et al., 1997). These secondary transcription factors are termed interferon 
regulatory factors (IRF) (Boehm et a l,  1997). IRF-1 is induced by IFNy via a gamma 
activated site, participates in several IFNy specific cellular responses (Sims et a i,  1993, 
Coccia et a l,  1995) and is also induced by TNFa (Fujita et a l ,  1989). IRF-2 is 
antagonistic to IRF-1 and acts as a transcription inhibitor (Harada et al., 1989, Harada et 
al., 1994).
The major function of IFNy is immunoregulatory, where it is involved in the 
development of the CD4+ T cell response which determines the response to an antigen 
or pathogen. The dichotomy of the CD4+ T cell response is well established. EL-12 and 
IFNy are implicated in the decision to adopt a Thl phenotype whereas IL-4 induces Th2 
differentiation (Seder and Paul, 1994). The actual role of IFNy in this process appears to 
be secondary to IL-12 which has emerged as one of the main immunoregulatory 
molecules directing cell-mediated immunity (Trinchieri, 1995). Thl differentiation is 
maintained by a positive feedback loop in which IL-12 production from stimulated 
macrophages, induces IFNy production by naive CD4+ T cells resulting in the adoption 
of a Thl phenotype. IFNy from the Thl cells or IL-12 activated NK cells, induces EL-12 
production by macrophages providing a constant stimulus for the differentiation of the 
CD4+ T cell response to the Thl phenotype and links innate recognition of pathogens to 
acquired immunity. IFNy has been shown in vitro to enhance the Thl differentiating 
effects of IL-12 (Wenner e ta i ,  1996, Bradley, Dalton and Croft, 1996). It is possible 
that this phenomenon may be attributed to IFNy induced expression of the IL-12 
receptor on naive T cells (Boehm e ta i,  1997). The costimulatory ligands B7-1 and B7- 
2 are thought to have a role in the induction of T cell responses (Lenchow, Walunas and
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Bluestone, 1996). Both are upregulated by IFNy (Freedman et al., 1991, Hathcock et 
al., 1994) but they may have differential effects on Th cell development with B7-1 
favouring Thl and B7-2 favouring Th2 cell development (Freeman et al., 1995, 
Kuchroo et a l, 1995).
One feature of the Thl/Th2 paradigm is the antagonistic effect mediated by IFNy on Th2 
development and associated functions. Conversely, IL-4 is antagonistic to IFNy 
mediated responses. IFNy can inhibit the growth of Th2 CD4+ T cell clones in vitro 
(Gajewski and Fitch, 1988, Maggi et al., 1992) but it is unclear if IFNy can suppress 
IL-4 gene transcription during the establishment of Thl development. The antagonistic 
effects of IFNy and IL-4 are present throughout Thl/Th2 mediated responses. IFNy is 
the main switch factor regulating IgG2a switching in the mouse (Snapper and Paul, 
1987a) and IL-4 induces IgGl and IgE class switching (Vitetta et a i, 1985, Coffman et 
al., 1986) with both cytokines antagonising the class switching mediated by the 
reciprocal cytokine. The expression of FcyRI on macrophages is upregulated by IFNy 
stimulation and results in an increase in Ig02a mediated opsonisation (Boehm et al., 
1997). EL-4 induction of FceRII (CD23) on basophils and mast cells is down regulated 
by IFNy (Boehm et a i,  1997).
IFNy is a critical mediator of early immune responses during the acute phases of various 
infections. The generation of mice with a disruption of the gene for IFNy or the IFNyR 
has enabled the confirmation of the importance of IFNy induced cellular responses to 
viral, bacterial and parasitic infections. IFN'jR deficient mice are susceptible to vaccinia 
virus (Huang et al., 1993) and mycobacterial infection (Kamijo et al., 1993) 
demonstrating the requirement for IFNy mediated functions in controlling infectious 
pathogens. The primary responses to L  monocytogenes infection are IFNy dependent 
(Huang et a i, 1993) and early IFNy production is associated with resistance to L. major 
infection (Heinzel et al., 1991). Hence, IFNy is a critical mediator of enhanced
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microbicidal activity to acute infection mainly through the activation of macrophages to 
increase antigen presentation or the secretion of antimicrobial products such as NO.
The role of IFNy during experimental malaria infection has been extensively studied. 
The intrahepatocytic development of P. berghei in vitro was inhibited upon the addition 
of recombinant human IFNy (Schofield et a i,  1987a). IFNy is produced prior to the 
peak parasitaemia of P. chabaudi infection (Slade and Langhome, 1989). Treatment of 
mice infected with P. yoelii with recombinant IFNy increases resistance to infection 
(Shear et al., 1989). The addition of recombinant IFNy to co-cultures of P. falciparum  
and human monocyte-derived macrophages increases the appearance of crisis forms of 
P. falciparum in vitro (Ockenhouse, Shulman and Shear, 1984). Control of the acute 
phase of P. chabaudi infection is Thl mediated and partly IFNy dependent (Meding et 
a i, 1990). Mice resistant to P. chabaudi infection have been shown to produce an early 
IFNy response whereas susceptible mice have an early IL-4 response (Stevenson and 
Tam, 1993). However, anti-IFNy treatment during P. chabaudi infection does not 
abrogate protective immunity suggesting that IFNy independent mechanisms are also 
involved in the control of the acute phase of infection (Stevenson e ta i,  1990).
IF N ^  deficient mice displayed no significant increased susceptibility to P. yoelii and P. 
chabaudi adami infection (Tsuji et a l, 1995). However, IFNy deficient mice have been 
shown to be more susceptible to P. yoelii and P. chabaudi adami (van der Hey de et a l, 
1997), illustrating that the response of the two types of deficient mice perhaps cannot be 
directly compared. Recently, IFNyR deficient mice were shown to be more susceptible 
to P. chabaudi chabaudi infection displaying a high mortality rate and an increased 
leukocytosis compared to control mice (Favre et a l, 1997, published while these studies 
were in progress). No significant differences were observed between the two groups 
during the primary parasitaemia, but, IFNyR deficient mice developed a pronounced 
secondary parasitaemia. Hence, IFNy dependent cellular responses are crucial to the 
development of protective immunity during a P. chabaudi infection. The studies reported
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here aim to elucidate why the absence of the IF N ^  results in an increased susceptibility 
to P. chabaudi infection.
Results
The course of P. chabaudi infection in IFNyR deficient mice
IFNyR deficient 129SVEV mice and intact control 129SVEV mice were infected with 
either 1x10^ pRBCs or 1x10^ pRBCs of P. chabaudi AS. Each group consisted of at 
least six mice and the parasitaemia was observed daily by microscopic examination of 
Giemsa's stained thin blood smears collected from the tail. Infection of IFNyR deficient 
mice with both 1x10^ pRBCs and 1x10^ pRBCs of P. chabaudi resulted in a significant 
secondary peak of parasitaemia (no recrudescence parasitaemia was observed in the 
control mice) observed after 20 days post infection (Figures 7.1 and 7.2). There was no 
significant difference between the IFNyR deficient mice and control mice during the 
primary parasitaemia although there was a consistent trend in that the peak of the 
primary parasitaemia was greater in the IFNyR deficient mice. In control mice the 
infection became sub-patent (determined by microscopic examination) around 20 days 
post infection whereas in IFNyR deficient mice, clearance of the parasites to sub-patency 
did not occur until approximately day 40 post infection (Figures 7.1 and 7.2).
Survival in IFNyR deficient mice during P. chabaudi infection
P. chabaudi infection of IF N '^  deficient mice resulted in an increase in the mortality rate 
compared with control mice. 75% of IFNyR deficient mice succumbed to infection with 
1x10^ pRBCs of P. chabaudi (Figure 7.3) and 43% died following infection with 
IxlQ l pRBCs of P. chabaudi (Figure 7.4). No mortality was observed in the control 
mice with either dose of P. chabaudi infection (Figures 7.3 and 7.4).
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Figure 7.1. The course of infection in IFN yR deficient mice (IFNy -/-
129SVEV) and control 129SVEV mice following infection with 1x10^ 
pRBCs of P. chabaudi. The mean log parasitaemia A), and percentage 
parasitaemia B), of six mice are presented. The results are combined from 
three replicate experiments.
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Total IgG and IgE production in IFNyR deficient mice during P , 
chabaudi infection
Total IgGl, Ig02a and IgE production was determined in the serum of IFNyR deficient 
mice during P. chabaudi infection. IFNyR deficient mice and control mice received 
1x10^ pRBCs o f f .  chabaudi. Three mice in each group were sacrificed at various time 
points and serum was collected, pooled and assayed for the production of total IgGl, 
IgG2a or IgE (see Materials and Methods). Total IgGl levels in the serum of IFNyR 
deficient mice were similar to that of control mice (Figure 7.5A). There was a delay and 
a reduction in the total IgG2a response of IFNyR deficient mice to P. chabaudi infection 
compared to control mice (Figure 7.5B). IFNyR deficient mice produced a significant 
amount of total IgE in response to P. chabaudi infection whereas no significant levels of 
total IgE were observed in the serum of control mice (Figure 7.5C).
The production of parasite-specific IgG in IFNyR deficient mice during 
P. chabaudi infection
Parasite-specific IgG production in the serum of IFNyR deficient mice and control mice 
was determined following infection with 1x10^ pRBCs of P. chabaudi AS by IF AT 
described in Materials and Methods). Three mice from each group were sacrificed at the 
time points indicated and serum was collected, pooled and assayed for the production of 
parasite-specific IgG. The level of parasite-specific IgG in the serum of IFNyR deficient 
mice during P. chabaudi infection was reduced compared to control mice throughout the 
period of infection analysed (Table 4).
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Figure 7.2. The course of infection in IFN yR deficient mice (IFN/ -/-
129SVEV) and control 129SVEV mice following infection with 1x10  ^
pRBCs of P. chabaudi. The mean log parasitaemia A), and percentage 
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Ex vivo analysis of the response of splenocytes taken from IFNyR 
deficient mice during P. chabaudi infection
IFNyR deficient mice and control mice were infected with 1x10^ pRBCs of P. chabaudi 
AS. Three mice from each group were sacrificed at the various time points indicated. 
Splenocytes were harvested and pooled from the three individual mice of each group, 
cultured in vitro at 5x10^ cells/ml and stimulated with Con A (l|Xg/ml). The proliferative 
response of the splenocytes was determined by the incorporation of tritiated thymidine. 
Splenocytes from IFNyR deficient mice had a greater proliferative response to Con A 
than splenocytes from control mice on day 0 post infection [p<0.002] (Figure 7.6). On 
days 6, 10 and 15 post infection, splenocytes from IFNyR deficient mice had a 
significantly increased proliferative response compared with splenocytes from control 
mice to Con A stimulation [p<0.002] (Figure 7.6). Splenocytes taken from control mice 
had a significantly greater proliferative response to Con A than splenocytes from IFNyR 
deficient mice on day 13 post infection [p<0.001] (Figure 7.6). No parasite-specific 
proliferative response was observed following stimulation of splenocytes with a pRBC 
lysate of P. chabaudi (data not shown).
Cytological analysis of cells present in the spleen or liver of IFNyR 
deficient mice during P. chabaudi infection
Cytological analysis was performed on leukocytes extracted from the spleen and liver of 
both IFNyR deficient mice and control mice following infection with 1x10^ pRBCs of 
P. chabaudi. Three mice from each group were sacrificed at the time points indicated, 
the leukocytes extracted from the liver and spleen of individual mice and then pooled to 
give leukocytes extracted from either the liver or spleen for each group. Cytological 
analysis was performed as described in Materials and Methods and the results expressed 
as the number of cells present per spleen or liver. There was a reduction in the number 
of lymphoid cells present in the spleen of IFNyR deficient mice but both
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Figure 7.3. Survival of IFNyR deficient mice and control mice following
infection with 1x10 ^ pRBCs of P. chabaudi. Each group consisted of at 
least six mice and the results are combined from three replicate experiments.
152
groups had similar numbers of monocytes and PMN cells present in the spleen (Figure 
7.7). In the liver, a reduction in lymphoid, monocyte and PMN cells present was 
observed in IFNyR deficient mice compared to control mice during P. chabaudi infection 
(Figure 7.8).
Discussion
The data presented in this study demonstrate that IFNyR deficient mice are more 
susceptible to P. chabaudi infection. A high mortality rate in the IFNyR deficient mice 
was observed whereas there were no deaths in the control groups. The acute phase of 
the P. chabaudi infection was controlled by both IFNyR deficient mice and control mice 
with a similar efficiency. However, the infection never became sub-patent in the IFNyR 
deficient mice and this was followed by a pronounced secondary parasitaemia unlike the 
control mice where no recrudescence occurred during the period of infection observed. 
These observations confirm previous results (Favre et a l,  1997, van der Heyde et a l, 
1997) illustrating the importance of IFNy dependent cellular responses to malaria 
infection.
The use of IFNyR deficient and IFNy deficient mice has extended the studies of IFNy 
mediated response to malaria infection whereas in previous studies this took the form of 
either deletion of IFNy by antibody treatment or addition of exogenous IFNy (Meding et 
al., 1990, Stevenson et al., 1990). Anti-IFNy treatment of mice resulted in a 
significantly higher primary peak parasitaemia of P. chabaudi infection Meding et a l, 
(1990), and Stevenson et a l,  (1990). However, Jacobs and colleagues (1996) did not 
observe significant differences in the course of the parasitaemia of a P. chabaudi 
infection. The results obtained in this study and elsewhere (Favre et a l ,  1997) 
demonstrate that the absence of the IFNyR results in a pronounced secondary peak of 
parasitaemia which is different to other published observations (Tsuji et a l, 1995) in 
which IFNyR deficient mice had only a moderately prolonged parasitaemia and no
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mortality associated with infection. These discrepancies could have several explanations. 
Different genetic backgrounds of the IFNyR deficient mice and infection with different 
murine malaria parasite species may contribute to the contradictory results obtained 
using IFNyR deficient mice. The degree of depletion of IFNy mediated function by 
treatment with antibodies may vary from study to study and is probably not as absolute 
as the gene disruption strategy. Conversely, IFNyR deficient mice may have developed 
mechanisms to compensate for the loss of IFNy function, thus making comparisons 
between studies more difficult.
The pronounced secondary peak of parasitaemia observed in the IFNyR deficient mice 
infected with P. chabaudi is in accord with a previous report (Favre et al., 1997) and is 
similar to the outcome of infection of IFNy deficient mice with P. chabaudi adami in that 
clearance of infection is significantly delayed when compared to controls (van der Heyde 
etai., 1997). Mice treated with anti-IL-12 monoclonal antibodies have also been shown 
to have a pronounced secondary parasitaemia following P. chabaudi infection (Yap, 
Jacobs and Stevenson, 1994) which when taken together with the results reported here 
and previous studies (Favre et al., 1997, van der Heyde et a l ,  1997) supports the 
hypothesis that IL-12 mediated protection is partly dependent upon IFNy stimulated 
cellular responses (Stevenson e ta i,  1995).
The course of P. chabaudi infection in IFNyR deficient mice is similar to that observed 
in immunocompromised mice such as SCID or nude mice and mice depleted of CD4"*’ T 
cells or B cells. All of these mice demonstrate an element of control during the acute 
phase of the infection but the development of the acquired protective immunity is absent 
or delayed and a chronic parasitaemia develops (Stevenson, Tam and Rae, 1990 Meding 
and Langhorne, 1991, Podoba and Stevenson, 1991, Taylor-Robinson and Phillips, 
1994a). Hence, the outcome of experimental malaria infection in immunocompromised 
mice is similar to that of IFNyR deficient mice in that a high mortality rate and a 
pronounced secondary  parasitaem ia  are observed , a lthough  the
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IFNyR deficient mice are able to clear the infection by day 40 post infection in this study 
and by day 23 post infection in the studies performed by Favre et al. (1997). The 
importance of the sequential involvement of Thl and Th2 mediated responses in the 
development of protective immunity to P. chabaudi infection was confirmed by the 
studies using immunocompromised hosts. However, they also demonstrated the 
requirement for not only CD4+ T cells but B cells to confer efficient resolution of 
infection in reconstituted immunocompromised hosts (Meding and Langhorne, 1991, 
Taylor-Robinson and Phillips, 1993). Hence, Thl cells are important in the control of 
the acute phase of infection through the stimulation and amplification of non-specific 
inflammatory responses and Th2 cells and B cells are responsible for the total clearance 
of parasites. The mechanism of the switch between Thl and Th2 mediated responses 
during a primary P. chabaudi infection is unclear. It has been proposed that B cells are 
required for this switch in the CD4+ T cell response because of the development of a 
chronic parasitaemia in B cell deficient mice following the control of the acute phase of 
infection (Taylor-Robinson and Phillips, 1994a), Analysis of the CD4+ helper T cell 
profiles during a P. chabaudi infection of B cell deficient mice revealed that a persistent 
Thl response is present in these mice with a failure to switch to Th2 mediated 
responses. The role of B cells in antigen presentation is an important one which will 
influence the Thl/Th2 dichotomy during a P. chabaudi infection but it may be the 
production of the appropriate humoral response which is the main contributory factor to 
the development of the chronic parasitaemia observed in B cell deficient mice. It is 
feasible that the absence of IFNyR mediated function in B cells may prevent the desired 
humoral response being produced in the IFNyR deficient mice during a P. chabaudi 
infection. Analysis of the CD4+ T cell helper response during infection of IFNyR 
deficient mice with P. chabaudi would determine if there is a failure to switch from Thl 
to Th2 mediated responses or if there is an earlier appearance of Th2 and IL-4 mediated 
responses which has been associated with susceptibility to P. chabaudi infection 
(Stevenson and Tam, 1993). An indication may be given by the significant total IgE 
response observed in the serum of IFNyR deficient mice which may reflect an aberrant
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Days post 
infection
Group 
IFNyR -/- 129SVEV 129SVEV
0 - -
6 - -
10 50 100
13 100 1000
15 100 1000
22 N/A 1000
Table 4. Parasite-specific IgG production in IFNyR deficient 129SVEV mice and
control 129SVEV mice following inoculation with 1x10^ pRBCs of P. chabaudi. Serum 
from three mice was pooled and the level of parasite-specific IgG was determined by 
indirect fluorescence. Results are the mean of three samples and are expressed as the 
reciprocal of antibody titre.
Note: Range of samples analysed was 1:50 - 1:1000.
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Th2 response in these mice. Indeed, it may be that there is a requirement for the 
inhibitory interaction between IFNy and IL-4 to induce the sequential Thl/Th2 mediated 
responses. It must be noted, however, that IL-12 is now regarded as the main cytokine 
involved in Thl development and that IFNy is a product of Thl response which induces 
the cellular responses associated with Thl CD4+ T cell immunity (Manetti et al., 1993). 
IFNy dependent functions may have a pivotal role in the control of the switch between 
Thl and Th2 regulated responses and hence the IFNyR deficient mice may have a 
dysfunctional CD4+ T cell response because of the lack of IFNy dependent cellular 
responses.
There are several explanations why a P. chabaudi infection of IFNyR deficient mice 
does not become sub-patent at the same time as in control mice. Increased parasite 
survival may occur due to the absence of IFNy induced expression of adhesion 
molecules which could reduce not only the level of sequestration of mature pRBCs but 
reduce the recruitment of cells to the liver, which has been proposed as a site of a 
possible protective immune response (see Chapter 3). This is reflected in the reduced 
numbers of lymphoid, monocyte and PMN cells observed in the liver of P. chabaudi 
infected IFNyR deficient mice and may contribute to an increase in parasite survival. The 
IFNyR deficient mice do have an increased leukocytosis compared to control mice 
following a P. chabaudi infection (Favre et al., 1997 and personal observations) which 
may be a consequence of a disruption in the redistribution of immune cells to organs 
such as the liver or spleen.
The failure of IFNyR deficient mice to clear the infection as efficiently as control mice 
could, as already mentioned, be attributed to the deficiency in IFNy dependent humoral 
responses. In this study, there is a reduction in parasite-specific IgG production and 
total IgG2a levels in the IFNyR deficient mice. IgG2a has been proposed to have a 
protective role in experimental malaria infection (Waki et al., 1995). It is possible that 
during the acute phase of infection, the parasite-specific isotype produced is IgG2a, a
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Figure 7.6. The proliferative response of splencx:ytes harvested from 
IFNyR deficient mice and control 129SVEV mice following inoculation with
1x10 ^ pRBCs of P. chabaudi. Three mice from both groups were 
sacrificed and the splenocytes pooled within each group and stimulated with 
Con A. The proliferative response was determined by the uptake of tritiated 
thymidine and each data point is the mean ± SD for an experiment 
performed in triplicate.
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IFNy dependent isotype (Snapper and Paul, 1987), which could explain the lower level 
of parasite-specific antibody production and the failure to resolve a P. chabaudi infection 
efficiently. However, it must be noted that the IFNyR deficient mice do produce 
detectable levels of total IgG2a demonstrating an IFNy independent pathway of 
stimulation for IgG2a production.
The pleiotropic effects of IFNy mean that there are deficiencies in several functions of 
the immune system in IFNyR deficient mice which could contribute to the inefficient 
development of protective immunity to P. chabaudi infection. IFNy activation of 
macrophages and its influence on antigen presentation are processes which will be 
dysfunctional in the IFNyR deficient mice and will have a bearing on the outcome of a 
P. chabaudi infection. However, the possibility of compensatory mechanisms cannot be 
ignored and IFNy independent pathways of activation of macrophages and NK cells, 
together could contribute to the degree of protective immunity observed during P. 
chabaudi infection in IFNyR deficient mice.
It is unclear why there is a high mortality rate in the IFNyR deficient mice following 
infection with the normally self-resolving P. chabaudi. Mortality is not consistently 
linked with fulminating parasitaemia and occurs throughout the course of a primary 
infection. The extent of the anaemia in the IFNyR deficient mice following P. chabaudi 
infection was the same as control mice (Favre et al., 1997) and does not appear to 
contribute to the high mortality rate observed. It is unknown if there is an over­
production of other inflammatory mediators such as IL-1 or TNF to compensate for the 
lack of IFNy stimulated inflammatory responses. This would be similar to P. chabaudi 
infection of IL-10 mice which appear to succumb to an increase in pathology attributed 
to a combination of malaria toxins and an exacerbated inflammatory response (Linke et 
a l,  1996). However, recently IL-10 deficient mice were shown to survive and control 
both P. yoelii and P. chabaudi adami infection with a similar efficiency as control mice 
with no mortality observed (van der Heyde et al., 1997). The increase in the
1 6 1
sC
C
600X
c
«c.
V
500
4 0 0
3 00
200c_
E
100c
I
E
3
X. 255 15 2010
days post infection
B)
C)
40 0X
I
c.
3 0 0 -
ic
E
"o
E
3X
2 0 0 -
O
100 -
o
5 150 10 20 25
IFN yR -/- 129SV EV  
129SVEV
days post in leclion
80o
60  -
I
1
Z2
S: 2 0 -
I
E
3z
O
5 15 20 25100
days post in fection
F ig u r e  7.7. Cytological analysis of cells present in the spleen of IFNyR 
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proliferative response of splenocytes taken from P. chabaudi infected IFNyR deficient 
mice to Con A stimulation suggests that they may be primed to produce a greater 
response to infection but that this response is inappropriate because efficient control of 
the infection is not observed. Indeed it may be indicative of over-production of 
inflammatory mediators.
A significant quantity of total IgE was observed in the serum of IFNyR deficient mice 
during a P. chabaudi infection. IgE has recently been proposed as a pathogenic factor in 
P. falciparum  infection (Perlmann et al., 1997). Patients with cerebral malaria were 
shown to have significantly higher IgE levels compared to those with uncomplicated 
malaria (Perlmann et a i, 1994). The elevation of IgE may contribute to the pathology of 
severe disease without cerebral involvement and may be a pathogenic factor in P. 
falciparum  infection in general (Perlmann et a i,  1997). The proposed mechanism 
involved in IgE mediated pathology is the interaction of IgE with the low-affinity FceRII 
(CD23) receptor which is expressed on a variety of cells including 
monocytes/macrophages, eosinophils and B cells (Perlmann et al., 1997). This process 
can induce the production of cytokines such as TNF which has been shown to be 
involved in the pathogenesis of malaria infection (Grau et al., 1987, Clark, Rockett and 
Cowden, 1991). There does not appear to be a correlation between the level of parasite- 
specific IgE and pathogenicity but rather, it is the quantity of IgE that correlates with 
disease severity (Perlmann et al., 1994, Perlmann et a l,  1997). Hence although the 
quantity of parasite-specific IgE in the IFNyR deficient mice during a P. chabaudi 
infection is unknown, the significant total IgE response may contribute to the pathology 
observed (high mortality rate) through the cross-linking of CD23 receptors on effector 
cells such as monocytes, resulting in the over-production of inflammatory mediators. 
Measurement of the level of TNF and NO production would confirm if this is a 
mechanism which is a contributory factor in the high mortality rate observed in the 
EFN'^R deficient mice following a P. chabaudi infection.
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Figure 7.8. Cytological analysis of the cells present in the livers of
IFNyR deficient 129SVEV mice and control 129SVEV mice following
infection with 1x10^ pRBCs of P. chabaudi. Three mice from each group 
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expressed per liver.
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The infection of IFNyR deficient mice with P. chabaudi provides a model which may 
contribute to the understanding of the development of protective immunity to blood- 
stage malaria. Analysis of cytokine production by re-stimulation of splenocytes in vitro, 
tissue-specific mRNA expression and levels in the semm is planned and may identify if 
there is a bias to a Th2 response indicated by the significant IgE production or if it is an 
over-production of inflammatory cytokines such as IL-1, TNF and IL-6 that is 
detrimental to the host's response to infection.
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Chapter Eight
The effect of the nitric oxide donor, SNAP, on the growth of
malaria parasites in vitro.
1 6 6
Introduction
NO is produced when L-arginine is oxidised to produce one molecule each of L-citrulline 
and NO. This process is catalysed by the enzyme nitric oxide synthase (NOS). Three 
isoforms of NOS are expressed in mammals, two of which, NOSl and NOS3, are 
dependent on elevated intracellular Ca^+ (MacMicking, Xie and Nathan, 1997) and are 
expressed constitutively. The third isoform, N0S2, is independent of intracellular Ca^+ 
concentration and is termed inducible NOS (iNOS) (Xie et al., 1992, Green and Nacy, 
1993). NOSl and N0S3 are often termed cNOS and produce a low output of NO which 
mediates the physiological functions of NO. NOS2 (iNOS) produces a high output of 
NO which is stimulated during inflammation and infection. Production of NO by NOS 
requires the attachment of several molecules including haeme, tetrahydrobiopterin, 
calmodulin, flavin adenine dinucleotide (FAD) and flavin mononucleotide (FMN) 
(MacMicking, Xie and Nathan, 1997). The difference in NO output between cNOS and 
iNOS can be attributed first to the ability of iNOS to bind calmodulin tightly independent 
of intracellular Ca^+ concentration and secondly to the sustained response of iNOS to 
inflammatory stimuli (Green and Nacy, 1993, MacMicking, Xie and Nathan, 1997).
Activation of iNOS requires a priming agent and a secondary signal. IFNy, LPS, TNF 
and other cytokines have all been shown to induce iNOS expression and subsequent NO 
production (Weinberg, Chapman and Hibbs, 1978, Amber et al., 1988, Ding, Nathan 
and Stuehr, 1988, Drapier, Weitzerbin and Hibbs, 1988). Induction of iNOS by IFNy 
and LPS occurs at the level of transcription (Xie, Whisnant and Nathan, 1993, Martin, 
Nathan and Xie, 1994). The promoter region of the iNOS gene contains consensus 
sequences for the binding of transcription factors which are involved in the induction of 
several IFNy inducible genes (Harada et al., 1989, Xie, Whisnant and Nathan, 1993, 
Kamijo et a l,  1994, Martin, Nathan and Xie, 1994). Inhibition of iNOS expression by 
cytokines such as IL-4, IL-10 and TGF(3 (Ding et al., 1990, Gazzinelli et al., 1991, 
Cunha, Moncada and Liew, 1992, Oswald et al., 1992) is an important control
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mechanism which prevents inappropriate production of NO. Inducible NOS activity is 
also inhibited by NO (Assruey et a l, 1993), demonstrating an important self-regulatory 
feedback mechanism.
NO can interact with other free radicals to yield various intermediates which are usually 
short-lived molecules but can influence the biological function of NO (MacMicking, Xie 
and Nathan, 1997). The physiological function(s) of NO includes vasodilation, enzyme 
regulation and neurotransmission (Moncada, Palmer and Higgs, 1991). The role of NO 
in response to inflammation or infection has been the focus of extensive research. NO 
has been shown to have microbicidal activity against bacteria, protozoan and helminth 
parasites, fungi and tumour cells. The cytotoxic potential of NO, produced by activated 
macrophages was first observed in tumour immunology studies (Hibbs et al., 1988). 
The target of NO mediated inhibition of tumour cell growth was iron-sulphur complexes 
present in enzymes essential for mitochondrial respiration (Hibbs et al., 1988). 
Subsequently, NO was shown to inhibit DNA synthesis in tumour cells through 
inhibition of ribonucleotide reductase which is the rate-limiting step in DNA synthesis 
(Kwon, Stuehr and Nathan, 1991).
NO is considered to be one of the major cytotoxic mechanisms in host responses to 
protozoan infection. L. major actually invades the macrophage, a major source of NO, 
but the production of NO has been shown to be the main effector mechanism against L. 
major infection (Green et al., 1990, Liew et al., 1990). Control of T. gondii infection 
has been shown to involve NO during the chronic phase of infection (Gazzinelli et al., 
1993). Down-regulation of iNOS activity is thought to lead to re-activation of T. gondii 
infection. Killing of helminth parasites has been partially attributed to NO (James and 
Hibbs, 1990) possibly through inhibition of enzymes containing iron-sulphur 
complexes that are important in metabolic function. Clostridium and Eschericha coli 
have also been shown to be susceptible to NO mediated cytotoxicity (Kwon, Stuehr and 
Nathan, 1991, Green and Nacy, 1993).
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NO production was identified to be one of the main effector mechanisms in the 
distmction of intra-hepatic malaria parasites (Nussler et al. 1991a). IL-6, IL-1, TNF and 
IFNy have been shown to stimulate L-arginine dependent elimination of exo-erythrocytic 
stages of the parasite. Several cells in the liver have the potential to produce NO, such as 
endothelial cells, Kupffer cells and the hepatocytes themselves (Nussler et al., 1991a). 
The protective role of NO against the exo-erythrocytic stage is thus well established but 
no definitive role for NO during the blood stage of infection has been obtained. The 
demonstration of killing of P. falciparum in vitro by NO derivatives (Rockett et a l, 
1991) illustrated a possible direct, cytotoxic effect of NO against blood stage parasites. 
Exogenous TNFa, lymphotoxin and IL-1 can induce in vivo production of nitrite and 
nitrate in P. vinckei infected mice (Rockett et al., 1992). The authors suggest that this 
indicates a possible role for inflammatory cytokines and NO production in the pathology 
associated with severe malaria. However, they do not record if the increase in nitrite and 
nitrate levels following administration of the cytokines, results in any alterations in the 
course of the P. vinckei infection.
The role of NO in cerebral malaria is controversial. Cerebral malaria caused by P. 
falciparum  has conventionally been explained as resulting from blockage of the blood 
supply by parasitised erythrocytes which sequester in the cerebral microvasculature 
(Aikawa, 1988). The argument against this explanation is that those patients who 
recover from cerebral malaria but do not have the neurologic impairment associated with 
long term oxygen deprivation (Clark, Rockett and Cowden, 1992). Immunological 
analysis of the cause of coma during cerebral malaria infection has provided evidence for 
a NO-dependent pathology mechanism but also a protective role during the severe 
complications of malaria infection (see below).
In both experimental model and human infections, TNFa appears to play a pivotal role. 
Patients with cerebral malaria, demonstrate high levels of T N F a  in plasma
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(Kwiatkowski et a l, 1990, Grau et al, 1989b). Individuals homozygous for the TNF2 
allele, a variant of the TN Fa gene promoter region, have a greatly increased risk for 
death or severe neurologic sequelae due to cerebral malaria (McGuire et a l, 1994). In 
the P. berghei ANKA mouse model of cerebral malaria, treatment with anti-IFNy 
reduced the excessive overproduction of TN Fa and prevented the development of 
cerebral lesions (Grau et al, 1989a).
The mechanisms by which sequestered parasitised erythrocytes cause coma are unclear 
but the hypothesis is that the parasitised erythrocytes bind to specific receptors on 
endothelial cells via host adhesion molecules such as ICAM-1. Expression of adhesion 
molecules is increased during cerebral malaria as part of a systemic endothelial activation 
by inflammatory molecules. The adhesion of parasitised erythrocytes to endothelial cells 
in the microvasculature of the brain may stimulate local production of TNFa which in 
turn stimulates NO production. TNFa induced NO can then diffuse through the blood 
brain barrier and interfere with neurologic function possibly by stimulating guanylate 
cyclase in neurons. This would result in an increase in cyclic GMP levels leading to 
further stimulation of NO production, resulting in brain dysfunction (Asension et a l, 
1993). This may be due to the toxic properties of NO (Snyder, 1992) or through 
inhibition of NO synthase activity by NO (Griscavage et a l, 1993) hence, disrupting 
local neurotransmission in the brain. NO may also be responsible for the increase in 
intracranial pressure observed in cerebral malaria patients through an increase in 
vasodilation (Newton gf aZ., 1991).
Further evidence supporting the pathological role attributed to TNF induced NO 
production and up-regulated ICAM-1 expression is supplied by P. berghei ANKA 
infection of TNFa/p double deficient mice. These mice have a complete disruption of 
TNF signalling pathways and hence no TNF production. P. berghei ANKA infection in 
intact mice induces fatal cerebral malaria with death occurring within 5 to 8 days. The 
TNFa/p deficient mice are completely resistant to P. berghei ANKA induced cerebral
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malaria (Rudin et al, 1997a). Furthermore, systemic release of NO and up-regulation of 
ICAM-1 expression on endothelial cells were only observed in the control mice. TNF 
also appears to be involved in the recruitment of mononuclear cells and microvascular 
damage because vascular leakage and perivascular haemorrhage plus mononuclear cell 
adhesion to endothelial cells were absent in the TNFa/p deficient mice (Rudin et a l, 
1997a). The absence of adhesion by mononuclear cells could probably be attributed to 
the lack of ICAM-1 expression in the TNFcx/p deficient mice during infection.
In contrast to these results the role of NO in the development of experimental cerebral 
malaria has been shown to be minimal. L-NMMA treatment had no influence on the 
course of murine cerebral malaria development (Kremsner et a l, 1993, Asension et al, 
1993). Other data suggests that the production of NO during cerebral malaria may be 
beneficial rather than pathological. In vivo inhibition of NO production results in an 
increased leukocyte adherence to endothelial cells via CD11/CD18 integrins (Kubes, 
Suzuki and Granger, 1991). A nti-C D lla treatment abrogated the development of 
experimental cerebral malaria indicating that CDl 1/CD 18 mediated leukocyte adhesion is 
crucial in the pathogenesis of this experimental cerebral malaria (Falanga and Butcher 
1991, Grau et a l, 1991). NO has been shown to inhibit leukocyte-endothelial 
interactions. Neutrophil adhesion to endothelial cells is inhibited by NO (Niu, Ibbotson 
and Kubes, 1996) and NO has also been shown to suppress ICAM-1 expression on 
endothelial cells (Biffl et a l,  1996). Hence, NO may suppress the recruitment of 
leukocytes by down-regulating CDl 1/CD 18 mediated adhesion or the expression of 
other involved adhesion molecules.
The constriction of intracerebral arterioles occurs during human and experimental 
cerebral malaria (Polder, Jerusalem and Eling, 1991). Both NO and prostacyclin can 
induce vasodilation and inhibit platelet aggregation (Hyslop and De Nucci 1991). 
Administration of a prostacyclin analogue prevented the development of cerebral malaria 
suggesting that the vasodilatory property of NO may be protective during cerebral
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malaria. There is, therefore, strong evidence from experimental cerebral malaria to 
support a protective role for NO during malaria infection. However, results obtained 
from the experimental model of cerebral malaria cannot be readily extrapolated to human 
cerebral malaria because the pathology observed in the model result from the 
accumulation of leukocytes, rather than parasitised erythrocytes in the cerebral blood 
vessels. The role of NO during human cerebral malaria has been investigated. There 
have been several studies which have analysed NO end products, reactive nitrogen 
intermediates (RNI), in plasma of patients. Contradictory results, supporting both a 
pathological and a protective role for NO have emerged.
RNI levels in Tanzanian children were inversely related to disease severity, with levels 
highest in subclinical infections and lowest in fatal cerebral malaria. IL-10, a cytokine 
which can suppress NO production (Cunha, Moncada and Liew, 1992), increased with 
severity (Anstey et al, 1996). The suppression of NO synthesis in cerebral malaria may 
contribute to pathogenesis because NO may have a protective role during infection. 
Another study, proposing a protective role for NO was carried out on Gabonese 
patients. (Kremsner et al, 1996). High plasma RNI levels during severe malaria could 
be correlated with an accelerated cure. In contrast with these two studies, a study 
performed on cerebral malaria patients from Papa New Guinea suggests a pathological 
role for NO (Al-Yaman et a l, 1996). The RNI levels measured were compared to 
disease severity and clinical outcome, and correlated with the depth and duration of 
coma. Higher RNI levels were observed in patients with deeper coma and with longer 
duration of coma. Fatal outcomes were correlated with significantly higher RNI levels. 
The results suggest that NO is involved in the development of coma during cerebral 
malaria.
Immunosuppression during malaria infection is well documented (reviewed in Weidanz, 
1983). Malaria infected children have more severe gastro-intestinal and respiratory 
infections than normal children (Greenwood et a l, 1972). Malaria has also been
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reported to impair the efficacy of childhood vaccination against tetanus, typhoid and 
meningococcal disease (Williamson and Greenwood 1978). A poor proliferative 
response of lymphocytes to Con A and other mitogens parallels the degree of 
immunosuppression in both human (MacDermott et a l, 1980) and rodent infections 
(Correa, Narayanon and Miller 1980). During trypanosome infection T cell responses 
are suppressed. This phenomenon has been shown to be mediated via suppressor 
macrophages which down-regulate T cell proliferative responses through NO and 
prostaglandin dependent mechanisms (Schleifer and Mansfield, 1993). The addition of 
L-NMMA to splenocyte cultures from malaria infected mice, restored the proliferative 
response of the splenocytes to similar levels as controls (Rockett et a l ,  1994) 
suggesting that NO may mediate antigen-specific immunosuppression observed during 
malaria infection. NO mediated immunosuppression has also been observed in burn- 
injured rats (Bamberger et al, 1992) and an increase in NO synthase in pregnant rats is 
thought to mediate the immunosuppression observed during pregnancy (Conrad et a l,
1993). There are several different mechanisms through which NO may induce 
immunosuppression. NO appears to suppress T cell clonal expansion but not T cell 
effector cell maturation and cytokine secretion (Schleifer and Mansfield, 1993). Hence, 
the suppression mediated by NO may occur as a consequence of discrete signalling 
events. This could be achieved by down-regulation of IL-2 receptor expression, 
modification of the CD3/TCR complex or modulation of accessory molecules which are 
important for the expression of T cells. NO could also inactivate components of the 
mitochondrial respiratory chain (Stuehr and Nathan, 1989) resulting in a reduction in 
cellular metabolic energy levels or it may inactivate ribonucleotide reductase which is 
required for DNA synthesis and hence cell proliferation (Kwon, Stuehr and Nathan, 
1991).
The microbicidal activity of NO generated by a L-arginine dependent pathway has been 
extensively demonstrated during T. gondii (Adams et a l, 1990, Marietta et a l, 1988) 
and L. major infections (Green et a l, 1990, Liew et a l, 1990). As already mentioned
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NO has been shown to inhibit the intrahepatic development of malaria parasites 
(Schofield et a l, 1987a, Nussler et a l, 1991a). The role of NO during the blood stage 
of infection, as discussed is unclear. In P. chabaudi infection, a NO peak coincides with 
peak parasitaemia (Taylor-Robinson et a l, 1994a). The increase in NO production may 
be necessary for the host to control the acute infection because L-NMMA given to mice 
results in an exacerbation of the parasitaemia (Taylor-Robinson et a l, 1993). During P. 
chabaudi infection, Thl cells appear to control the primary parasitaemia with a switch to 
Th2 mediated immunity after the peak parasitaemia. It has been suggested that NO may 
be the molecule which induces the switch in immunity because it is capable of down- 
regulating Thl cell functions (Taylor-Robinson and Phillips 1994b, Taylor-Robinson et 
a l, 1994a).
There is no substantial evidence for NO having a direct cytotoxic effect on parasitised 
erythrocytes. In vitro experiments performed by Rockett and colleagues (1991) 
demonstrated that derivatives of NO can inhibit parasite growth. However, the levels of 
the derivatives they used may not reflect physiological levels of NO produced during a 
malaria infection. This chapter describes the effect of NO, generated by s-nitroso-acetyl- 
penicillamine (SNAP), on malaria parasites in vitro. The effect on various stages of P. 
falciparum was examined and also the effect of SNAP on the rodent malarial parasites, 
P. chabaudi and P. berghei. The hypothesis that haemoglobin may quench NO in the 
bloodstream (Sternberg e ta l ,  1994) and prevent any direct effect against the parasite 
was also investigated.
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Results
Generation of NO in vitro by SNAP
SNAP was freshly prepared in complete malaria medium (45-363 |liM, final 
concentration). Complete malaria medium alone was included as a control. All cultures 
were incubated at 37®C and supernatants were harvested at the time points indicated 
over a 72 hour period (Figure 8.1). Nitrite levels in the supernatant were measured by 
the Griess reaction as an indication of NO production by SNAP. The generation of NO 
by SNAP occurred over 24 hours for all the concentrations of SNAP analysed (Figure 
8 . 1).
Inhibition of P. falciparum  growth in the presence of SNAP
The effect of SNAP generated NO, on the growth of P. falciparum  was determined by 
culturing the parasites in the presence of the range of concentrations of SNAP indicated 
and observing the effect on the uptake of tritiated hypoxanthine by the parasite. Controls 
contained either medium alone or equivalent concentrations of DL penicillamine or 
sodium nitrite. Neither of these two substances, at the concentrations used, inhibited 
parasite growth and therefore all the control values have been combined. In figure 8.2A 
and 8.2B, the P. falciparum cultures were initiated with late (trophozoite) stages. SNAP 
was added at the start of the experiment or after 24 hours when the majority of the 
parasites had re-invaded new erythrocytes and were now ring stages. The tritiated 
hypoxanthine was added at the same time as the SNAP and the cultures were harvested 
24 hours later. SNAP at concentrations as low as 45|iM could inhibit the growth of P. 
falciparum  indicated by the reduction in the uptake of tritiated hypoxanthine compared 
with the controls. Cultures containing trophozoites (Figure 8.2A) appear to be more 
susceptible to the effect of SNAP than cultures containing mainly ring stages (Figure 
8 .2B) .  E x a m i n a t i o n  of  smears  t aken  f r om the  c u l t u r e s
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Figure 8.1. SNAP was freshly prepared and incubated at 3 7 % . Culture 
supernatants were harvested over a 72 hour period. Nitrite levels were 
measured by the Griess reaction as an indication of NO production by 
SNAP. Each data point is the mean ± SD combined from two replicate 
experiments.
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indicated that the higher eoncentrations of SNAP were killing parasites but that the lower 
concentrations of SNAP, parasites appeared to be developing more slowly than parasites 
from control cultures. This suggests that SNAP at lower concentrations may be having a 
cytostatic effect on the growth of parasites.
Cytostatic effect of NO, generated by SNAP, on the growth of 
P. falciparum
To investigate the possible cytostatic effect of low concentrations of SNAP on the 
growth of P. falciparum, SNAP at a concentration of 91|iM was added to cultures 
containing trophozoites. The tritiated hypoxanthine was then added at the times indicated 
on Figure 8.3. All the cultures were harvested at 31 hours after the addition of SNAP. 
As the amount of NO production declined (see Figure 8.1), the uptake of tritiated 
hypoxanthine increased to levels closer to controls. Smears from the cultures confirmed 
that during the period of NO generation by SNAP, the trophozoite stages were viable 
but not developing. However, at the end of the experiment, after NO production had 
ceased, the parasites had developed and some were undergoing division and re­
invasion.
A different approach to investigating the cytostatic role of NO generated by SNAP was 
to add 91|xM of SNAP to cultures containing trophozoites and add the tritiated 
hypoxanthine at the same time as the SNAP but harvest the cultures at the times 
indicated on Figure 8.4. SNAP had a greater inhibitory effect on the growth of the 
parasites during the early part of the experiment but as the duration of the experiment 
neared the cessation of NO generation by SNAP, a recovery in parasite growth was 
observed. This suggests a possible cytostatic role for NO rather than a cytotoxic effect 
on the growth of malaria parasites in vitro.
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Figure 8.2A. The effect of SNAP on the growth of trophozoite stages of 
P. falciparum in vitro . Cultures were initiated with trophozoite stages. 
SNAP and tritiated hypoxanthine were added at the start (0 hours) and the 
cultures were harvested 24 hours later. Incorporation of tritiated 
hypoxanthine is shown relative to controls. Each point is the mean ± SD of 
an experiment performed in triplicate.
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Figure 8.2B. The effect of SNAP on the growth of ring stages of 
P. falciparum in vitro. Cultures contained mainly ring stages. SNAP and 
tritiated hypoxanthine were added at 0 hours and the cultures were harvested 
24 hours later. Incorporation of tritiated hypoxanthine is shown relative to 
controls. Each point is the mean ± SD of an experiment performed in 
triplicate.
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The effect of NO generated by SNAP on the growth of the murine 
malaria parasites, P. chabaudi and P. berghei in vitro.
The effect of SNAP on the growth of P. chabaudi and P. berghei under in vitro culture 
conditions was investigated. Mice, infected with either parasite were bled on the day of 
the experiment. The parasitaemia of both parasites was adjusted to 1 % by the addition of 
non-infected erythrocytes and cultures at a 5 % haematocrit. SNAP was added to the 
cultures at the concentrations indicated on Figure 8.5 and 8.6. Tritiated hypoxanthine 
was added at the same time as SNAP and the cultures were harvested 24 hours later. 
Figure 8.5 shows the effect SNAP had on the growth of P. chabaudi in vitro. SNAP 
was able to inhibit P. chabaudi growth at 91|xM. The effect of the higher concentrations 
of SNAP, appears to be lessened when in culture with the murine parasite, P. chabaudi, 
compared to the results observed for the human parasite, P. falciparum. This 
observation is confirmed by the results obtained for the effect of SNAP on the growth of 
P. berghei in vitro (Figure 8.6). The protocol was designed exactly the same as the P. 
chabaudi experiment. SNAP had an inhibitory effect on the growth of P. berghei in vitro 
but only at 182pM and above, thus confirming the reduced effect of NO generated by 
SNAP on murine malaria parasites compared with the effect of NO on the growth of P. 
falciparum.
An increase in haemoglobin levels does not reduce the effect of NO 
generated by SNAP on the growth of malaria parasites in vitro,
NO can bind to the haeme group of haemoglobin (Hakim et al., 1996) and it is possible 
that this may dilute any effect against the intra-erythrocytic malaria parasite. This 
hypothesis was investigated by using P. chabaudi in vitro at various parasitaemia 
obtained by the addition of non-infected erythrocytes. SNAP and the tritiated 
hypoxanthine were added at the same time and the cultures were harvested 24 hours
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Figure 8.3. Cytostatic effect of NO on the growth of P. falciparum in 
vitro. SNAP at 9\pM  was added to trophozoite stages. Tritiated 
hypoxanthine was added at 0,6,  19 and 21 hours. The cultures were 
harvested at 31 hours. Incorporation of tritiated hypoxanthine is shown 
relative to controls. Each point is the mean ± SD of an experiment performed 
in triplicate.
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later. The parasites were cultured at 18%, 9%, 4.5% and 2.25% in the presence of 
SNAP. Inhibition of parasite growth was observed consistently at 91 pM SNAP and 
above with no decrease in the inhibitory effect of SNAP generated NO, as the number of 
non-infected erythrocytes increased (Figure 8.7). Therefore, the increase in the 
haemoglobin levels present in the cultures does not appear to suppress the inhibitory 
effect of NO, generated by SNAP, on the growth of malaria parasites.
Discussion
The in vitro experiments performed demonstrate that NO, generated by SNAP can 
inhibit the growth and development of malaria parasites. At concentrations of SNAP 
above 182pM, the growth of the asexual erythrocytic parasites was inhibited. However, 
at lower concentrations of SNAP, the trophozoite stage of the parasite life cycle, 
appeared more sensitive to the inhibitory effect of the NO donor, SNAP, than earlier 
ring stages. The effect of NO on the growth of malaria parasites in vitro, was observed 
not only on the human malaria parasite, P. falciparum  but also the murine malaria 
species, P. chabaudi and P. berghei. Hence, these results suggest that NO may inhibit 
the growth and development of the malaria parasite within the erythrocyte.
NO, generated by SNAP, has been shown to kill Trypanosoma cruzi trypomastigotes in 
vitro  (Vespa, Cunha and Silva, 1994) and L. major (Assreuy et a l,  1994), 
demonstrating the importance of NO during certain parasitic infections. Interestingly, 
NO does not have a protective role during T. brucei infection (Sternberg et a l, 1994). 
Indeed, the immunosuppression observed during T. brucei infection is mediated by NO 
and inhibition of NO production results in a reduced parasitaemia (Sternberg et a l,
1994). This illustrates how NO can have a varied influence on the immune response to 
infections. NO has been proposed to mediate the pathology observed during cerebral 
malaria (Clark, Rockett and Cowden, 1991) and also immunosuppression (Rockett et 
al, 1994). The results presented in this study, propose a protective role for NO against 
the asexual erythrocytic stage of malaria. Previous work demonstrated killing of P.
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Figure 8.4. The recovery of parasite growth as the production of NO 
declines. SNAP at 91//M was added to trophozoite stages. Tritiated 
hypoaxanthine was added at 0 hours. The cultures were harvested at 5.15, 
16.25, 29.15 and 39.15 hours. Incorporation of tritiated hypoxanthine is 
shown relative to controls. Each point is the mean ± SD of an experiment 
performed in triplicate.
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falciparum in vitro by NO derivatives (Rockett e ta l, 1991). Nitrosothiol derivatives of 
cysteine and glutathione were found to be the most effective compounds used. Nitrite 
was also reported to kill parasites in vitro (Rockett et a l, 1991), however, nitrite was 
found to have no inhibitory effect at levels equivalent to SNAP in the studies reported 
here. These contradictory results may be explained by the fact that Rockett and 
colleagues (1991) observed killing of P. falciparum  by sodium nitrite at 30 times the 
concentration used in the experiments undertaken in this study.
In vivo studies have failed to define the role of NO during the asexual erythrocytic stage 
of malaria infection. P. chabaudi infected mice, receiving NMMA treatment, 
demonstrated a marked increase in parasitaemia (Taylor-Robinson et a l, 1993). 
Previous studies, using NMMA and aminoguanidine as NO synthase inhibitors, did not 
demonstrate any increase in the parasitaemia during P. chabaudi infeetion but did report 
an exacerbation in susceptibility to infection (Rockett et a l, 1994, Jacobs, Radzioch 
and Stevenson, 1995, Amante and Good, 1997). Different protocols may account for 
the conflicting results because Taylor-Robinson et a l ,  (1993) were using 
thymectomised mice and transfer of T cell clones while the other studies were using 
immunocompetent mice. Therefore, NO may be protective by a mechanism other than 
being parasiticidal. Mice pre-treated with NMMA, infected with P. vinckei and treated 
with chloroquine plus IFNy exhibited higher mortality and more pronounced liver and 
kidney lesions (Kremnser et a l, 1992). This suggests that NO may act as a tissue- 
protective molecule during malaria infection either by inactivating tissue damage by 
oxygen radicals or inhibiting leukocyte adhesion to endothelium and preventing hypoxic 
tissue damage (Jacobs, Radzioch and Stevenson, 1995). Further evidence for this 
hypothesis comes from human malaria infection. Patients infected with P. falciparum or 
P. vivax have increased plasma levels of RNI (Nussler et a l, 1994). Also, the duration 
of coma due to cerebral malaria is shorter in children with relatively high NO plasma 
levels (Cot gr aZ., 1994).
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Figure 8.5. The effect of NO, generated by SNAP, on the growth of 
P. chabaudi in vitro. SNAP and tritiated hypoxanthine were added at 0 
hours. The cultures were harvested 24 hours later. Incorporation of tritiated 
hypoxanthine is shown relative to controls. Each point is the mean ± SD of 
triplicates and is data combined from two replicate experiments.
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Although, NO has been shown to be cytotoxic to L. major (Liew et a l, 1990) and T. 
gondii (Adams et a l, 1990) in vivo, there is insufficient evidence to confirm a direct 
cytotoxic effect of NO on malaria parasites in vivo. However, NO may act on the 
intraerythrocytic parasite in a cytostatic manner. As NO production by SNAP ceased, it 
was observed that the parasites resumed growth suggesting a cytostatic effect rather than 
cytotoxic. To elucidate how NO could be exerting a cytostatic effect on the growth of the 
malaria parasite, the mechanisms involved in the development of the intraerythrocytic 
phase of the complex life cycle have to be examined. An important process which is a 
likely candidate for interference by NO, is the reduction of ribonucleotide diphosphates 
to deoxyribonucleotide triphosphates which are needed for DNA synthesis. This 
reaction is catalysed by the enzyme, ribonucleotide reductase (RR) which is a target of 
macrophage derived NO cytotoxicity to tumour cells (Kwon, Stuehr and Nathan, 1991). 
RR is the rate-limiting step in DNA synthesis, depends on thiols and a non-haeme iron 
in its reaction centre (Stubbe, 1990) which maintain a key trosyl radical (Ochiai et a l, 
1990). Thus, RR is a candidate for inactivation by NO. Activated macrophages and 
hydroxyurea, a pharmacological inhibitor of RR, were both shown to have a similar 
cytostatic effect on DNA synthesis in tumour cells (Kwon, Stuehr and Nathan, 1991, 
Lepoivre et a l, 1991). Iron chelation treatment of P. falciparum  infected erythrocytes 
interferes with iron-dependent metabolism of malaria parasites and inhibits their 
development (Lytton et a l, 1994). The mechanism of this inhibition is to block DNA 
synthesis catalysed by RR. The iron chelators block integration of iron into newly 
synthesised R2 subunits rather than removal of iron from fully assembled RR protein. A 
similar inhibition of parasite growth was observed using hydroxyurea (Rubin et a l,
1993). Parasites were able to recover from iron chelation after removal of the drug 
depending upon the treatment regime and drug properties (Lytton et a l, 1994). These 
observations mirror the results obtained for NO mediated inhibition of malaria parasites 
in vitro. As the generation of NO by SNAP neared completion, the parasites were able 
to recover which is similar to the recovery of parasite growth following iron chelation 
treatment.
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Figure 8.6. The effect of NO, generated by SNAP, on the growth of P. 
berghei in vitro. SNAP and tritiated hypoxanthine were added at 0 hours. 
The cultures were harvested 24 hours later. Incorporation of tritiated 
hypoxanthine is shown relative to controls. Each point is the mean ± SD of 
triplicates and is data combined from two replicate experiments.
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Mature parasites, trophozoites and schizonts are more susceptible to both NO and iron 
chelators probably because peak RR activity is found at this stage of parasite 
development (Rubin et a i, 1993). Hence, lower RR activity in the ring stages may 
account for the increased resistance to NO and iron chelation treatment. Another factor 
influencing the effect of NO and iron chelators is access to the parasite. This is 
dependent upon the permeability of the erythrocyte membrane and the stage of the 
intraerythrocytic parasite. The parasite causes alterations in the erythrocytic membrane to 
facilitate the movement of nutrients and waste products. A tubovesicular membrane 
network extending from the parasite vacuole membrane probably has a central role in 
this process (Deitsch and Wellems, 1996). As the parasite matures, changes in the 
permeability of the erythrocyte membrane occur, allowing access to small molecular 
weight molecules to the parasite possibly via the parasitophorous duct which is an 
extension of the tubovesicular membrane and allows transfer of molecules between the 
parasite and extracellular environment (Deitsch and Wellems, 1996). Therefore, 
susceptibility of trophozoites to NO, compared with ring stages, is because NO has 
easier access to the parasite and that peak activity of RR, one of the main candidate 
targets, occurs during mature parasites. There are other possible targets for NO mediated 
inhibition of parasite growth such as mitochondria respiratory functions which are 
catalysed by iron containing enzymes. The cytostatic inhibition of parasite growth by 
NO may result in the asynchronous growth observed at peak parasitaemia during an 
infection.
An important observation made during these studies was that an increase in the levels of 
haemoglobin did not quench the effect of NO on the growth of the parasite. It had been 
proposed that erythrocytes would act as a sink for NO because of the scavenging activity 
of haemoglobin (Sternberg et ai, 1994), thus preventing any anti-parasite effect of NO 
in the bloodstream. However, increasing the levels of haemoglobin was found not
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to diminish NO mediated inhibition of P. chabaudi growth in vitro. As the parasite 
develops within the erythrocyte, it degrades haemoglobin to yield amino acids which are 
a nutrient source for the developing parasite. The trophozoite stage digests the majority 
of the haemoglobin (Goldberg and Slater, 1992). Hence, NO may be able to inhibit the 
growth of the intraerythrocytic parasite because the scavenging capacity of haemoglobin 
is lost due to degradation by the parasite.
These results demonstrate that NO can inhibit the growth and development of malaria 
parasites in both a cytotoxic and cytostatic manner. Trophozoite stages are more 
susceptible to NO than ring stages possibly because of increased permeability of the 
erythrocyte membrane allowing increased access to the mature parasite for NO. The 
actual mechanism of inhibition mediated by NO is unclear. The potential of NO to 
inactivate RR and subsequently DNA synthesis offers one explanation of how NO may 
inhibit parasite growth and development. Analysis of various metabolic processes 
during parasite growth will confirm how NO inhibition is mediated. Measurement of 
DNA synthesis during the in vitro experiments in conjunction with observing the effect 
of the RR inhibitor, hydroxyurea would determine if this enzyme is susceptible to NO 
mediated inactivation. ATP levels would indicate if the mitochondria respiratory function 
was affected by the presence of NO.
The in vitro experiments suggest that in vivo, high localised concentrations of NO may 
be able to either kill intraerythrocytic parasites or more likely, inhibit their development. 
The mature stage parasites were more susceptible to NO, suggesting the parasite may be 
vulnerable in vivo during sequestration. This process involves the trophozoite/schizont 
infected erythrocytes adhering to endothelial linings of capillaries. The systemic 
inflammatory response induced by infection could stimulate a high, local production of 
NO by cells such as endothelial cells resulting in inhibition of parasite development. A 
cytotoxic effect would result in parasite death but a cytostatic effect may be important in
1 8 9
aiding the effector mechanism of the immune system to respond to the non-circulating 
parasitised erythrocyte.
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Chapter Nine
The effect of chloroquine on nitric oxide production by
macrophages
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Introduction
The spread of P. falciparum  resistance to current antimalarial drugs and the slow 
progress towards an effective vaccine have the emphasised the need for new 
antimalarials. Advances have been made in the understanding of the mode of action of 
some antimalarials. However, the interaction between chemotherapy and protective 
immune responses to malaria infection is unclear and a better understanding will be 
important in future control programmes which may combine vaccination with 
chemotherapy.
Some antimalarials are known to be immunosuppressive. Indeed, chloroquine is used in 
the treatment of autoimmune disorders because of its anti-inflammatory properties (Hurst 
et al., 1986). The actual mechanism(s) of immunosuppression by antimalarials is 
unclear. Chloroquine has been shown to suppress the proliferation of lymphocytes (Trist 
and Weatherall, 1981, Salmeron and Lipsky, 1983) and this activity appears to be dose 
related, since only high concentrations of chloroquine profoundly suppressed the 
proliferation of mitogen and antigen stimulated lymphocytes (Bygberg and Flachs,
1986). Chloroquine, mefloquine and quinine, at high concentrations can inhibit IL-2 
production (Bygberg et a i ,  1987) which will affect subsequent T cell responses. 
Neutrophil chemotaxis can be inhibited by concentrations of the antimalarial achieved in 
the blood during malaria prophylaxis but no effect was observed on the bactericidal 
activity of these cells (Kharazmi et aL, 1983, Kharazmi and Eriksen, 1986). The 
immunosuppressive effect of chloroquine on leukocytes has only been demonstrated 
with high concentrations, suggesting that chemotherapy may not influence the immune 
response significantly. Furthermore, antimalarial prophylaxis does not appear to alter 
immune responses to commonly used vaccines (Bjorkman, 1988) but the effect on 
protective immune responses to malaria remains is still to be investigated.
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Chloroquine has been shown to reduce antibody titres to rabies vaccination (Taylor, 
Wasi and Bernard, 1984, Pappaioanou et a l,  1986). However, a normal prophylactic 
dose of chloroquine, did not affect cellular responses to typhoid vaccination (Bygberg 
and Flachs, 1986) and chloroquine did not have any affect on antibody production in 
rabbits following typhoid vaccination (Thompson and Bartholomew, 1964).
The uptake or digestion of haemoglobin by the parasite is thought to be the metabolic 
process altered by chloroquine (Foley and Tilley, 1997). Chloroquine is a weak base 
which can traverse the membrane of the parasitised erythrocyte and moves down the pH 
gradient to accumulate in the acidic food vacuole (Fitch et a l, 1974). A high intracellular 
concentration of chloroquine inhibits haem polymerisation resulting in a build up of 
haem which is toxic to the parasite (Vander Jagt, Hunsaker and Campos, 1986). The 
immunomodulatory properties of chloroquine derive from its ability to influence 
antigenic presentation. This can come about because chloroquine can accumulate in 
vesicles such as lysosome and endosomes, causing an elevation in pH which influences 
the assembly of antigenic peptides with the class IIMHC complex (Fox, 1995).
Macrophages are important antigen presenting cells and have a pivotal role in the 
immune system because they are involved in the induction of the immune response and 
subsequent effector mechanisms. Chloroquine has been shown to have suppressive 
effects on macrophages additional to its influence on antigen presentation. Production of 
T N F a  and IL-6 by macrophages is inhibited by chloroquine (Picot et al., 1993). 
Chloroquine has also been shown to inhibit IL-1 production by monocytes (Krogstad 
and Schlessinger, 1987). These observations indicate that chloroquine could have the 
potential to alter the production of inflammatory mediators by macrophages which could 
be important during a malarial infection. Overproduction of TN Fa and NO, both 
macrophage products, has been implicated in the development of cerebral malaria (Clark, 
Rockett and Cowden, 1991). Mice infected with P. chabaudi produce a sharp peak of 
NO at peak parasitaemia (Taylor-Robinson et al., 1993). However, in mice treated with
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chloroquine 24-48 hours prior to peak parasitaemia, the production of NO was ablated 
(Phillips, Mathers and Taylor-Robinson, 1994). Investigations were carried out to 
examine if chloroquine inhibited NO production by macrophages.
Results
Chloroquine mediated inhibition of NO production by J774 cells
Cells of the murine macrophage-like cell line, J774, were cultured at 5xl0^cells/ml and 
treated with chloroquine (1-lOOOpM final concentration) at 24 and 2 hours before, the 
same time as and 2 and 6 hours after stimulation with IFNy (lOOU/ml) and LPS 
(25ng/ml). Nitrite in the culture supernatant was measured by the Griess reaction as an 
indication of NO production. 100 and lOOOpM chloroquine inhibited NO production, 
both before and after stimulation (100|iM: -24 hours, p<0.04; -2 hours, p<0.004; 0 
hours, p<0.005, lOOOmM: -24 hours, p<0.05; -2 hours, p<0.002; 0 hours, p<0.006; 
4-2 hours, p<0.01; 4-6 hours, p<0.003). No inhibition of NO was observed for 
concentrations of chloroquine at 10|iM or below. lOOOpM chloroquine inhibited NO 
production by J774 cells at all the timepoints but the effect of lOOjiM chloroquine 
appeared to decrease when treatment was delayed until after stimulation.
Chloroquine induced inhibition of NO production by murine splenic 
macrophages
Splenic macrophages were obtained from of naive mice and cultured at 5x10^ cells/ml. 
Chloroquine treatment was identical to the protocol described above and the cells were 
again similarly stimulated with IFNy and LPS. NO production by the splenic 
macrophages was inhibited by 100 and lOOOpM chloroquine, similar to the result
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obtained for the J774 cells (lOOjiM: -24 hours, p<0.0001; 0 hours, p<0.0001; +2 
hours, p<0.01; lOOOmM: -24 hours, p<0.0002; -2 hours, p<0.00006; 0 hours, 
p<0.00006: +2 hours, p<0.00003; +24 hours, p<0.0001). 10|xM chloroquine and 
below did not inhibit NO production by splenic macrophages.
NO production by murine peritoneal was cells is inhibited by 
chloroquine.
Peritoneal wash cells were obtained from naive mice and cultured at 5x10^ cells/ml. The 
cells were treated with 100|iM chloroquine 24 hours prior to and the same time as 
stimulation with IFNy and LPS. NO production by the murine peritoneal wash cells was 
significantly inhibited at both timepoints (-24 hours, p<0.00001; 0 hours, p<0.00002).
Discussion
The results performed in this study, demonstrate that chloroquine at a concentration 
lOOjiM can alter the production of effector molecules by stimulated macrophages. In 
earlier studies, chloroquine mediated inhibition of IL-1 (Krogstad and Schlessinger,
1987), TN Fa and IL-6 production (Picot et al., 1993) by macrophages has been 
demonstrated and this has now been extended to include NO. Chloroquine treatment of 
three types of macrophages, J774, murine splenic macrophages and murine peritoneal 
(adherent) wash cells resulted in an inhibition of NO production following stimulation 
with IFNy and LPS. Inhibition of NO production was observed with chloroquine 
treatment of the cells both prior to and after stimulation. However, with lOOjiM 
chloroquine treatment, a recovery of NO production was observed when treatment of the 
cells was after stimulation which was not observed in the cells treated with 1000}xM 
chloroquine.
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The production of NO by macrophages is a complex process. Stimulation of the 
macrophage is required to induce NOS transcription and the signal transduction pathway 
involves several different processes. Transcription factors such as NF-kB and IRF-1 
have binding sites in the promoter region of the iNOS gene (Martin, Nathan and Xie,
1994). LPS stimulation results in the binding of a NF-kB complex to the promoter 
region of iNOS (Xie, Kashiwabara and Nathan, 1994) but it may also enhance the 
production of transcription factors stimulated by IFNy (Xie, Whisnant and Nathan, 
1993). IFNy stimulation induces IRF-1 to bind to the appropriate binding site on the 
promoter sequence of the iNOS gene (Martin, Nathan and Xie, 1994). Macrophages 
from IRF-1 deficient mice did not express iNOS mRNA upon stimulation with IFNy and 
LPS (Kamijo et a l, 1994). The induction of IRF-1 by IFNy stimulation may be 
mediated by gamma activated factor (GAF) undergoing IFNy induced tyrosine 
phosphorylation which in turn induces translocation of GAF to the nucleus resulting in 
expression of the necessary transcription factors (Martin, Nathan and Xie, 1994). 
Approximately 22 transcription factor consensus sequences within the promoter region 
of iNOS have been identified (Xie, Whisnant and Nathan, 1993). These include 
consensus sequences for transcription factors involved in the induction of other genes by 
cytokines or bacterial products, such as the IFNy response element, the y-activated site 
and NF-kB binding sites (Xie, Whisnant and Nathan, 1993).
Inducible NOS only produces NO when homodimeric and attached to at least five other 
co-factor molecules: haem, tetrahydrobiopterin, calmodulin and the flavins, FAD and 
FMN (MacMicking etah, 1997). The binding of calmodulin can occur in the absence of 
elevated calcium levels unlike the constitutively expressed forms of NOS (Bastian and 
Hibbs, 1994). This allows iNOS to sustain production of NO because there is no 
requirement for elevated calcium.
Inhibition of iNOS activity by glucocorticoids has been demonstrated at transcription and 
post-transcriptional levels (Kunz et al., 1996). TGF(3l destabilises iNOS mRNA
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Figure 9.3, Chloroquine induced inhibition of NO production by murine 
(adherent) peritoneal wash cells. The cells were harvested from the
peritoneal cavity of naive mice and cultured at 5x10 ^ cells/ml. The cells 
were treated with lOO^M chloroquine 24 hours before or at the same time as
stimulation with IFN y and LPS. Control wells were cells plus medium 
alone. Each point is the mean ± SD for an experiment performed in 
triplicate.
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and accelerated its degradation (Vodovotz and Bogdan, 1994). Cytokines such as IL-4 
and IL-10 inhibit NO production by macrophages (Sands et al., 1994, Cunha, Moncada 
and Liew, 1992). From the experiments performed, it is unclear if chloroquine mediated 
inhibition of NO production occurs at the transcriptional or post-transcriptional level. 
Extraction of iNOS mRNA from the macrophage cultures treated with chloroquine 
would determine if the inhibtion mediated by chloroquine occurs at the transcriptional 
level. The inhibition is dose-dependent and at lOOpM the inhibition is not complete in 
relation to the treatment regime. TNF production by macrophages is also inhibited by 
choloroquine in a dose-dependent manner, through disruption of iron homeostasis (Picot 
et al., 1993). Recently a regulatory loop between iNOS induction and iron metabolism 
has been proposed (Weiss et a l,  1994). An increase in ferric ion concentration, 
decreased iNOS activity in response to LPS stimulation whereas iron chelation treatment 
of macrophages resulted in an increase in iNOS activity (Weiss et al., 1994). The 
changes in enzyme activity result from alterations in the transcription of iNOS mRNA. 
The stability of the mRNA is not significantly affected by the different treatments but the 
nuclear transcription of iNOS mRNA is increased following iron chelation and decreased 
by the presence of ferric ions (Weiss et al., 1994). Iron metabolism, therefore, has a 
regulatory role during the production of NO by iNOS. A regulatory element in the iNOS 
promoter region, responsive to iron chelation has recently been elucidated confirming the 
link between iron metabolism and iNOS expression (Melillo et al. 1997). Chloroquine 
has been shown to inhibit LPS-induced TN Fa production via disruption of iron 
homeostasis (Picot et al., 1993), hence, chloroquine inhibition of IFNy/LPS induced 
NO production by macrophages, may be mediated by disruption of the regulatory loop 
between iron metabolism and iNOS activity.
Chloroquine inhibition of cytokine secretion by macrophages has been shown to be not 
only related to disruption of iron metabolism (Picot et al., 1993). Chloroquine has also 
been shown to inhibit the activity of phospholipase A2 (PLA2) (Zidovetzki, Sherman 
and O'Brien, 1993, Nosal, Jancinova and Petrikova, 1995). This has important
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consequences on signal transduction pathways because PLA2 catalyses the production 
of arachadonic acid metabolites which can activate protein kinase C (PKC), which, 
through phosphorylation of proteins, initiates a cascade of kinase activation resulting in 
the induction of the required gene. Inhibitors of PKC activity has been shown to inhibit 
IFNy/LPS induced NO production (Severn, Wakelam and Liew, 1992). IL-4 mediated 
inhibition of NO production may occur through inhibition of phospholipase activity, 
reducing the generation of diacylglycerols subsequently inhibiting PKC activity (Severn, 
Wakelam and Liew, 1992). Upon activation, PKC is translocated to the cell membrane 
(Severn, Wakelam and Liew, 1992), however, the reduction of diacylglycerol 
stimulation of PKC by IL-4, results in an inhibition of iNOS gene transcription (Sands 
et al., 1994). Hence, chloroquine mediated inhibition of IFNy/LPS induced NO 
production, could possibly result from chloroquine suppression of PKC activation by 
products generated by phospholipase cleavage of phospholipids. Measurement of PKC 
activity would determine if chloroquine treatment of macrophages prevents NO 
production through inhibition of this pathway.
T N F a production has been shown to be important, in an autocrine fashion, in the 
induction of NO production (Jun et al., 1995). Anti-TNFa antibodies were shown to 
inhibit IFNy and taxol (an anti-cancer agent) induced NO production (Jun et al. 1995). 
The suppressive effect of IL-10 on NO production is exerted indirectly via its inhibition 
of TN Fa production (Oswald et al., 1992). Chloroquine inhibits TN Fa production 
(Picot et al., 1993), hence, the inhibition of NO production observed in this study may 
result from an inhibition of the autocrine pathway of stimulation involving TNFa. Both 
TNFa and NO have been implicated in the immunopathological damage associated with 
cerebral malaria (Clark, Rockett and Cowden, 1991). The spread of P. falciparum  
resistance to chloroquine means that it is rarely used in some areas. However, 
chloroquine may provide an inexpensive method of suppressing the pathology mediated 
by TN Fa and NO during cerebral malaria.
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The effect of chloroquine (or other antimalarial) chemotherapy or prophylaxis treatment 
on the generation of protective immunity to malaria infection is an area which remains 
poorly understood. There are several factors which can influence the interaction between 
antimalarial compound and immune response. These include: the immunosuppressive 
potential of antim alarials; the effect of antim alarials on m alaria-linked 
immunosuppression and immunopathology; the induction of immunity in relation to 
chemotherapy. The immunosuppressive effect of chemotherapy has already been briefly 
discussed but it is clear that antimalarials do have the potential to suppress the 
development of protective immune effector mechanisms although this may be dependent 
upon the dosage used in the chemotherapy (Bjorkman, 1988). Immunosuppressive 
effects tend to be observed with higher doses of antimalarial drugs. However, 
prophylactic doses of chloroquine (600mg base/week) have been shown to inhibit the 
phagocytosis of IgG coated sheep red blood cells by human monocytes (Osorio, Fonte 
and Finlay, 1992) demonstrating the immunosuppressive potential of antimalarials. The 
interaction between chemotherapy and the induction of immunity to malaria infection is 
an important issue. It is unclear if protection given by chemotherapy will reduce the level 
of acquired immunity gained by infection and re-infection. Semi-immune schoolchildren 
were given antimalarial treatment for one-two months in an endemic area of Tanzania 
(Pringle and Avery-Jones, 1966). Subsequent new clinical infections caused clinical 
symptoms and a parasitaemia that was significantly greater than before treatment. It was 
concluded that the short duration of drug treatment had reduced the immune status of the 
children. Hence, the difference between sub-curative and curative treatment of malaria 
may influence the immune status of an individual and interfere with the development of 
naturally acquired immunity to malaria infection. Conversely the immune status of an 
individual may influence the efficiency of antimalarial chemotherapy. Chloroquine was 
more effective against P. berghei after a degree of immunity had developed following 
exposure to several infections (Golenser et a i, 1978). The efficiency of chemotherapy 
treatment of P. chabaudi infection is reduced in T cell deficient mice compared to intact 
mice (Lwin et a l, 1979). The combination of passively transferred IgG antibodies, from
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hyper-immune mice infected with P. chabaudi, and chemotherapy was more effective 
than either form of therapy used alone (Bjorkman, 1988). This demonstrates that 
chemotherapy may have differing effects on humoral and cell-mediated immunity which 
may have consequences on the development of protective immunity to infection.
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Chapter Ten 
General Discussion
2 0 4
The studies presented in this thesis cover two main areas: firstly, the role of cytokines in 
the development of protective immune responses to P. chabaudi infection in mice and 
secondly, the role of non-specific inflammatory mediators during a primary malaria 
infection in rodents. As already discussed the immune response to P. chabaudi infection 
in mice is mediated by a sequential involvement of Thl and Th2 regulated immunity 
(Langhorne et al., 1989, Taylor-Robinson et al., 1993). The role of Thl and Th2 
cytokines during P. chabaudi infection was investigated using IFNyR gene deficient 
mice, IL-4 and IL-6 gene deficient mice. This allowed a degree of comparison to be 
drawn between the effect of Thl (IFNyR deficient mice) and Th2 (IL-4 and IL-6 
deficient mice) deficiencies during infection.
The development of protective immunity to P. chabaudi infection involves three distinct 
pathways (illustrated in Diagram 3). The first is a rapid inflammatory response initiated 
by malarial antigen or parasite derived toxins stimulating effector cells to produce 
inflammatory mediators such as NO, oxygen radicals, TNFa, IL-1 which have been 
implicated in various mechanisms of parasite killing (Phillips, 1994a, Stevenson et al., 
1995, Taylor-Robinson, 1995). IL-12 and TNFa are important macrophage products 
which can stimulate NK cells and result in further activation of effector cells through the 
production of IFNy. The second pathway is initiated by antigen presentation to CD4"^ T 
cells. The presence of the correct co-stimulatory molecules and microenvironment will 
result in the expansion of Thl type CD4+ T cells which can activate effector cells 
through the production of cytokines such as IFNy and TNFp. IL-12 is a cytokine which 
has been shown to provide the correct microenvironment for the development of Thl 
cells (Trinchieri, 1995). Essentially Thl mediated responses amplify the rapid 
inflammatory response, resulting in an increase in parasite killing.
The third pathway is the development of Th2 mediated responses. Presentation of 
malarial antigen via, for example, B cells and in the presence of IL-4 will promote the
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development of Th2 cell proliferation. This results in the production of several Th2 
associated cytokines important for the development of humoral immunity and thereby, 
involved in parasite removal. This description of the protective immune response to P. 
chabaudi is a gross simplification. There are several crucial interactions between the 
Thl/Th2 associated cytokines which regulate the CD4+ T cell response. The balance 
between IL-12 and IL-4/IL-10 may influence which subset, Thl or Th2 will be 
preferentially induced (von der Weid et a i, 1994). IFNy, a Thl cytokine, can inhibit the 
expansion of Th2 cells (Gajewski and Fitch, 1988, Maggi et al., 1992) whereas IL-10, 
a Th2 cytokine, can inhibit the induction of Thl cell expansion (Fiorentino et al., 1991). 
Furthermore, humoral immunity is not exclusively mediated by Th2 cells because IFNy 
promotes the production of IgG2a (Snapper and Paul, 1987a).
In IFNyR deficient mice, the absence of a functional IFNy receptor and subsequently a 
loss of IFNy mediated responses, it would be expected that during P. chabaudi 
infection, a reduction in inflammatory responses (non-specific and Thl mediated) would 
be observed. The interactions between Thl/Th2 responses may be altered due to an 
abrogation of IFNy mediated down-regulation of Th2 development. The loss of IFNy 
function would also be reflected in the level of IgG2a observed. Consistently, IFNyR 
deficient mice, compared to control mice had an exacerbated peak of parasitaemia 
following P. chabaudi infection (although this was not statistically significant), 
indicative of a reduced inflammatory response. Raised total IgE levels in the serum of 
the IF N '^  deficient mice may indicate a strong Th2 response which could reflect a loss 
of IFNy function in the preferential activation of Thl cells and the inhibition of Th2 cell 
expansion. The total IgG2a response and the parasite-specific antibody level are both 
reduced in IFNyR deficient mice suggesting that IFNy induced humoral responses are 
important during a primary P. chabaudi infection. IFNyR deficient mice, therefore, are 
more susceptible to P. chabaudi infection compared to intact control mice, exhibiting a 
high mortality rate. The IFNyR deficient mice, which survive the acute phase of P.
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chabaudi infection, are unable to reduce the parasitaemia to sub-patent levels and 
consequently have a persistent, low grade parasitaemia.
The results observed for P. chabaudi infection of the mice deficient in IL-4 and IL-6 
production are not as striking as the infection of IFNyR deficient mice. Both IL-4 and 
IL-6 deficient mice recover from P. chabaudi infection, no mortality is observed and the 
efficiency of parasite clearance is broadly similar to that of intact mice. In IL-4 deficient 
mice, reduction in the IL-4 mediated Th2 development would be expected. An alteration 
in the balance of Thl and Th2 activation and expansion might occur. However, IL-10 is 
regarded as the main inhibitory cytokine to Thl development (Fiorentino etaL, 1991). 
Furthermore, a reduction in the production of IL-4 associated Ig isotypes would be 
expected. An exacerbation of the peak parasitaemia in IL-4 deficient mice was 
consistently observed, coupled with a reduction in the total IgGl response. The 
exacerbation of the peak parasitaemia may be attributed to an alteration in the balance 
between Thl/Th2 mediated immunity which results in a reduction of parasite killing. 
However, control of the peak parasitaemia may involve IgGl mediated responses and 
hence, the reduction in total IgGl levels may contribute to the exacerbated peak 
parasitaemia. The involvement of the humoral response in the control of the primary 
peak of parasitaemia is also demonstrated in IL-6 deficient mice. Infection of IL-6 
deficient mice with P. chabaudi results in a significant delay in parasite clearance after 
the peak of the primary parasitaemia. An exacerbation of peak parasitaemia was 
consistently observed (although never statistically significant) using 1x10^ pRBCs as 
the infective dose in the IL-6 deficient mice compared to intact control mice. The 
differences in the course of infection in IL-6 deficient mice coincide with a reduction in 
total IgG2a and total IgGl levels.
The studies using the gene deficient mice have produced some interesting results which 
merit further investigation. IFNy has been shown to be a critical mediator in the 
development of protective immunity to a primary P. chabaudi infection, whereas the
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absence of IL-4 or IL-6 function does not significantly alter the outcome of infection. 
IFNyR deficient mice have been shown to be as equally protected as control mice upon 
re-infection but it would be interesting to re-infect the IL-4 or IL-6 deficient mice 
because the protective response to re-infection is regarded as a Th2 mediated humoral 
response. The studies performed suggest that the Th2 associated cytokines, IL-4 and EL- 
6 are not required for the control of a primary P, chabaudi infection. However, it is 
possible that redundancies in the cytokine network compensate for the loss of either 
cytokine, resulting in only slight deficiencies in the immune response to P. chabaudi 
infection. Further investigations are required to elucidate why IFNyR deficient mice 
succumb to P. chabaudi infection and why mice deficient in the Th2 associated 
cytokines are capable of controlling a primary infection. Analysis of tissue-specific 
cytokine mRNA expression is planned as well as determination of the levels of various 
cytokines in the serum. Problems with the preparation of the parasite lysate antigen, 
prevented parasite-specific analysis of the proliferation and antibody studies which may 
have differentiated between general defects in the immune response due to the gene 
disruption and defective responses to infection.
Non-specific inflammatory mediators are an integral part of the immune response to 
malaria infection. Acute phase proteins are induced rapidly in response to various stimuli 
including malaria infection (Gillespie et a l, 1991). The role of the murine acute phase 
protein, SAP, was investigated during a P. chabaudi infection. P. chabaudi infection of 
mice stimulates a systemic acute phase response indicated by raised SAP levels which 
peak around the peak of the primary parasitaemia. The actual role of SAP during 
infection remains unclear. However, the in vitro studies suggest that SAP may have an 
anti-parasite effect but it is more likely to be an important immunomodulatory molecule. 
It would be interesting to perform infection studies where SAP has been depleted either 
by treatment with antibodies or gene dismption. The effect of the absence of SAP on the 
outcome of infection could be determined. However, it is most probable that SAP has 
only a minor role in the control of infection because IL-6 gene deficient mice do not
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produce SAP during a P. chabaudi infection but are still able to clear the parasite with a 
similar efficiency to that of controls.
The liver is the major site of synthesis of acute phase proteins and preliminary studies 
have suggested that the liver may also be the site of a protective immune response during 
a P. chabaudi infection. An increase in the number of lymphomyeloid cells present in the 
liver during a P. chabaudi infection was observed. Adoptive transfer of the 
lymphomyeloid cells from the liver during a P. chabaudi infection gave some protection 
to recipient mice from a homologous challenge. These studies confirmed previous work 
suggesting that the liver is involved in a protective response to murine malaria parasites 
(Playfair et a l, 1979, Dockrell, De Souza and Playfair, 1980, Playfair and De Souza, 
1982). P. chabaudi is known to sequester to the liver (Cox, Semoff and Hommel, 1987) 
during the latter stages of the asexual erythrocytic cycle of the parasite. Hence the 
parasite is present in the liver, at stages (late trophozoite/schizont and merozoites) which 
are the most likely to be vulnerable to the immune response. Hence, the liver is a 
potential site where parasite killing may occur. The studies using the gene deficient mice 
illustrated that immune responses in the liver may be involved in protective immunity 
because there was a reduction in lymphomyeloid cells present in the liver of these mice 
during a P. chabaudi infection. It is unclear if the increase in the number of LM cells 
present is due to an expansion of intrahepatic lymphomyeloid cells or if there is 
increased migration of cells to the liver during infection. Further investigations of the 
lymphomyeloid cells present in the liver are planned with the focus on identifying what 
these cells are and monitoring the change in the composition of these cells, particularly 
the lymphoid compartment, during the course of a P. chabaudi infection. It would be 
interesting to see if the sequestration of the parasite to the liver is required to induce the 
increase in the number of lymphomyeloid cells present. Non-sequestering murine 
malaria parasites induce a systemic acute phase protein response but it is unknown if 
there is an increase in the number of lymphomyeloid cells present in the liver of mice 
infected with non-sequestering species of murine malaria.
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NO is a non-specific inflammatory molecule which has been shown to inhibit the 
development of intrahepatic malaria parasites (Nussler et a l, 1991). Hence, the liver 
may be a source of NO production during the pre-erythrocytic stage of infection but as 
already mentioned, during a P. chabaudi infection, the parasite may be vulnerable to 
immune attack and molecules such as NO, during sequestration in the liver. The studies 
performed here suggest that at high local concentrations, NO may have a cytotoxic effect 
on malaria parasites. However, a cytostatic effect is more probable. NO has been shown 
to have a direct effect on parasite development both in vivo (Taylor-Robinson et al., 
1993) and in vitro (Rockett et al., 1991) but a protective role for NO which is not anti- 
parasitic, but host protective has also been suggested (Jacobs, Radzioch and Stevenson, 
1996).
Hence the liver may be an important site of a protective immune response mediated by 
the lymphomyeloid cells in the liver during infection and through the production of non­
specific inflammatory molecules such as SAP and NO. Furthermore, the liver may be a 
site where immunity induced to the pre-erythrocytic malaria infection may also be 
protective against an ongoing blood stage infection, because the inflammatory molecules 
produced are not stage specific and may be involved in protective immune responses to 
the different stages. The liver is one of several sites which P. falciparum  sequesters to 
and this highlights a problem facing researchers investigating the immunology of malaria 
infection. Immune responses of infected individuals are analysed by re-stimulating 
PBMN cells. However, there may be tissue-specific responses which are important in 
the development protective immunity. Hence, the development of an effective vaccine is 
further complicated by this issue because observations made from in vitro studies of 
PBMN cells may not reflect the complete protective immune mechanisms. Therefore, if 
a vaccine is designed to induce the responses observed from the in vitro studies, the 
protective response induced will not include a protective mechanism which may be 
critical to the development of effective immunity.
2 1 1
To conclude, the studies reported in this thesis have revealed two areas of work which 
merit further investigation. The first is, to examine why a deficiency in IFNy mediated 
cellular responses results in susceptibility to P. chabaudi infection. IFNyR deficient mice 
provide a model which can be utilised to investigate the failure to develop a protective 
immune response in the absence of IFNy mediated responses. It will be of importance to 
expand the current studies by including analysis of parasite-specific cellular responses in 
the IFNyR deficient mice. Determination of cytokine production by splenocytes (re­
stimulated in vitro) and measurement of cytokine levels in sera is planned. Tissue- 
specific expression of cytokine mRNA will also be investigated to observe if there is 
deficiency or alteration in the development of tissue-specific protective immune 
responses. The second area which merits further investigation is the analysis of the LM 
cells present in the livers of P. chabaudi infected mice. Identification of the cell types 
present is necessary and it would be interesting to perform a time-course experiment 
where the changes in the liver could be analysed, giving an indication of the mechanism 
of the immune response mediated by the LM cells at various times during the course of a 
P. chabaudi infection.
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Appendix
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Phosphate buffered saline (pH 7.2)
60g Na2 HP0 4 . 1 2 H2 0
13.6g Na2HP04.2H20
8.5g NaCl
Made up to 1 litre with de ionised and distilled water.
RPMI 1640 stock medium
10.39g RPMI 1640 powdered medium (with L-glutamine) (Gibco)
5.94g N2-hydroxyethylpiperazine-N-2 ethane sulphonic acid (HEPES)
(25 mM)
Made up to 1 litre with de-ionised and distilled water, filter sterilised (Millipore/Gelman 
filter 0.22|Lim size) and pH adjusted to pH 7.2
Incomplete RPMI 1640 medium
To stock RPMI 1640 medium the following were added:
11 ml L-glutamine (Gibco)
5.5 ml NaHCOs
0.55 ml 2-Mercaptoethanol (O.IM)
22 ml Fungizone (Gibco)
2.2 ml Gentamycin (Sigma)
Complete RPMI 1640 medium
Heat inactivated foetal calf serum (Gibco) was added to incomplete RPMI 1640 medium 
at a final concentration of 10%.
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RPMI 1640 Malaria stock medium
10.39g RPMI 1640 powdered medium (with L-glutamine) (Gibco)
5.94g N2-hydroxyethylpiperazine-N-2 ethane sulphonic acid (HEPES)
(25mM)
Made up to 960 ml with distilled water and filter sterilised.
Incomplete malaria medium
To 100 ml aliquots of RPMI 1640 malaria stock medium, the following were added:
4.2 ml 5% NaHCOs
0.25 ml Gentamycin (Sigma)
Complete malaria medium
Heat inactivated human AB serum was added to incomplete malaria medium at a final 
concentration of 10%.
Giemsa's Buffer
3g Na2HP04
0.6g KH2 PO4
Made up to 1 litre with distilled water and adjusted to pH 7.4 
Giemsa's stain
Giemsa's stain (GurrBDH Ltd) was diluted 1:10 in Giemsa’s buffer
Tris Buffered Saline (TBS)
9g NaCl
1.6g TrisHCl
The pH was adjusted to pH 7.6 with HCl and made up to final volume of 1 litre with de­
ionised and distilled water.
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Carbonate/Bicarbonate Coating Buffer (0.05M)
1.59g NaiCOg
2.93g NaHCOg
0.2g NaNg
Made up to 1 litre with de-ionised and distilled water and adjusted to pH 9.6
Bicarbonate Coating Buffer
8.4g NaHCOg
Made up to 1 litre with de-ionised and distilled water and pH adjusted to 8.2 
PBS/Tween
0.5ml Tween 20 (polyoxyethylene sorbitan monolaurate)
Made up to 1 litre with PBS.
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